| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Award Winners
|
|
|
|
27 |
6S |
p. A5-A6
|
artikel
|
| 2 |
CO178 Access to Preventive Care and Social Determinants of Child Obesity: A Retrospective Cohort Study Using the Pinc AI™ Healthcare Database (PHD)
|
Lopes, G.
|
|
|
27 |
6S |
p. S51
|
artikel
|
| 3 |
CO13 A Claims Analysis To Characterize All-Cause Mortality in Patients With Generalized Pustular Psoriasis in the United States
|
Gottlieb, A.B.
|
|
|
27 |
6S |
p. S18
|
artikel
|
| 4 |
CO187 Acute Pancreatitis Risk Associated with Glucagon-Like Peptide-1 Receptor Agonists Used for Weight Loss: A Retrospective Cohort Study in the United States
|
Sarker, J.
|
|
|
27 |
6S |
p. S52
|
artikel
|
| 5 |
CO161 Adherence and Persistence To Oral Targeted Therapies for Non-Small-Cell Lung Cancer and Association With Survival Outcomes
|
Nduaguba, S.
|
|
|
27 |
6S |
p. S47
|
artikel
|
| 6 |
CO94 Advancing Diabetes Care: Novel Drug Interventions in the Management and Control of Type 2 Diabetes Mellitus
|
Dutta, B.
|
|
|
27 |
6S |
p. S34
|
artikel
|
| 7 |
CO184 A Matching-Adjusted Indirect Comparison of Centanafadine Vs Lisdexamfetamine, Methylphenidate, and Atomoxetine in Adults With Attention-Deficit/Hyperactivity Disorder: Long-Term Safety and Efficacy Outcomes
|
Schein, J.
|
|
|
27 |
6S |
p. S52
|
artikel
|
| 8 |
CO61 Analysis of Healthcare Resource Utilization in the NODE-303 Clinical Trial to Terminate Paroxysmal Supraventricular Tachycardia Episodes
|
Ip, JE.
|
|
|
27 |
6S |
p. S27-S28
|
artikel
|
| 9 |
CO48 A Non-Interventional Chart Review Study of Infliximab Precision-Guided Dosing Tool's Clinical Experience Program: Interim Analysis of Real-World Health Outcomes and Extrapolated Cost Savings
|
Shim, A.
|
|
|
27 |
6S |
p. S25
|
artikel
|
| 10 |
CO47 A Novel Approach to Estimating the Risk of Harm Due to Drug-Drug Interactions: An Exemplary Model With Common Mediations That Interact With Oral Anticoagulants
|
Gómez-Lumbreras, A.
|
|
|
27 |
6S |
p. S24-S25
|
artikel
|
| 11 |
CO103 Antidepressant Adherence Using Group-Based Trajectory Modeling Among Postpartum Women With Texas Medicaid
|
Pennington, EL.
|
|
|
27 |
6S |
p. S35-S36
|
artikel
|
| 12 |
CO210 An Updated Systematic Review and Network Meta-Analysis on Risks of Respiratory Tract Infections with Biologic and Targeted Synthetic Antirheumatic Agents in Psoriatic Arthritis
|
Liu, YS.
|
|
|
27 |
6S |
p. S56
|
artikel
|
| 13 |
CO151 A Preliminary Analysis of Oral Edaravone-Treated Patients With Amyotrophic Lateral Sclerosis Enrolled in a US-Based Administrative Claims Database
|
Ciepielewska, M.
|
|
|
27 |
6S |
p. S45-S46
|
artikel
|
| 14 |
CO133 A Propensity Score Matched Analysis Between an Infrarenal Fixation Device With ePTFE (Device A) and Two Suprarenal Fixation Devices With Dacron Fabric (Devices B and C)
|
Baidoo, B.
|
|
|
27 |
6S |
p. S41
|
artikel
|
| 15 |
CO137 Are Standard Indirect Treatment Comparison Methods Suitable to Compare First-Line Vs Maintenance Therapies? An Assessment of Enfortumab Vedotin + Pembrolizumab Vs Avelumab in Locally Advanced/Metastatic Urothelial Carcinoma
|
Dillon, R.
|
|
|
27 |
6S |
p. S42
|
artikel
|
| 16 |
CO192 A Retrospective Database Analysis of US Medicaid Treatment-Naive People With HIV (PWH) With or Without Mental Health Disorders (MHDs) Initiating Single-Tablet Regimens (STRs) Vs. Multi-Tablet Regimens (MTRs)
|
Chen, M.
|
|
|
27 |
6S |
p. S53-S54
|
artikel
|
| 17 |
CO12 A Review of Goal Attainment Scaling Implementation As a Personalized Clinical Outcome Assessment over the Last Decade
|
George, M.
|
|
|
27 |
6S |
p. S18
|
artikel
|
| 18 |
CO28 Assessing Disparities in Cardiovascular Outcomes across Payers in Patients Diagnosed with Hypertrophic Cardiomyopathy
|
Reza, N.
|
|
|
27 |
6S |
p. S21
|
artikel
|
| 19 |
CO107 Assessing Short and Long-Term Outcomes in Drug-Associated Acute Kidney Injury
|
Suh, K.
|
|
|
27 |
6S |
p. S36-S37
|
artikel
|
| 20 |
CO134 Association between Baseline Lung Function and Oral Corticosteroid Elimination in Patients with Oral Corticosteroid-Dependent Severe Asthma
|
Domingo, C.
|
|
|
27 |
6S |
p. S41-S42
|
artikel
|
| 21 |
CO2 Association Between Classes of Antidiabetic Medications and Their Potential Risk or Protective Effects on Cancer: A Systematic Review and Network Meta-Analysis
|
Kenawy, A.
|
|
|
27 |
6S |
p. S16
|
artikel
|
| 22 |
CO168 Association between Initial Propranolol Dose and Blood Pressure Control in 48 to 72 Hours Among Preterm Infants with Hypertension
|
Kamel, A.
|
|
|
27 |
6S |
p. S49
|
artikel
|
| 23 |
CO21 Association between Pregnant Cigarette Smoking and Offspring Birthweight Using Oracle EHR Real-World Data
|
Perkowski, K.
|
|
|
27 |
6S |
p. S20
|
artikel
|
| 24 |
CO124 Association Between Quality of Life and Viral Load Among People With HIV in the Current Antiretroviral Era
|
Nghiem, V.
|
|
|
27 |
6S |
p. S40
|
artikel
|
| 25 |
CO144 Association of All-Cause and Cause-Specific Mortality with High-Risk NAFLD/NASH in US Adults, NHANES III (1988-1994) Linked to Mortality Data through 2019
|
Fishman, J.
|
|
|
27 |
6S |
p. S44
|
artikel
|
| 26 |
CO43 A Systematic Literature Review of Comparative Efficacy Measures in Randomized Controlled Trials of Darolutamide Treatment in Metastatic Hormone-Sensitive Prostate Cancer
|
Chen, L.
|
|
|
27 |
6S |
p. S24
|
artikel
|
| 27 |
CO77 A Systematic Literature Review of Real-World Treatment Effectiveness and Economic and Humanistic Burden in Patients with Muscle Invasive Bladder Cancer
|
Wright, P.
|
|
|
27 |
6S |
p. S31
|
artikel
|
| 28 |
CO112 A Systematic Literature Review (SLR) and Network Meta-Analysis (NMA) of Ruxolitinib Cream 1.5% Vs Other Pharmacologic Agents in the Treatment of Atopic Dermatitis (AD)
|
Gooderham, M.
|
|
|
27 |
6S |
p. S37
|
artikel
|
| 29 |
CO60 A Vocation for Life on Land, Sea and Air - Health Assessment of Ambulance Workers
|
Sántha, E.
|
|
|
27 |
6S |
p. S27
|
artikel
|
| 30 |
CO174 Baseline Characteristics of Patients with Asthma and Prior Oral Systemic Corticosteroid Use Initiating Dupilumab in a Real-World Registry (RAPID)
|
Lugogo, NL.
|
|
|
27 |
6S |
p. S50
|
artikel
|
| 31 |
CO82 Bayesian Pan-Tumor Multilevel Meta-Regression: An Unanchored Indirect Treatment Comparison (ITC) of Adagrasib Versus Sotorasib in Previously Treated KRASG12C-mutated Advanced/Metastatic Solid Tumors
|
Maciel, D.
|
|
|
27 |
6S |
p. S32
|
artikel
|
| 32 |
CO50 Benefit and Risk of Oral Anticoagulant Initiation Strategies in Patients With Atrial Fibrillation and Cancer: A Target Trial Emulation Using the SEER-Medicare Database
|
Truong, B.
|
|
|
27 |
6S |
p. S25
|
artikel
|
| 33 |
CO29 Bruton's Tyrosine Kinase Inhibitors in B-Cell Lymphoma and Risk of Infection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
|
Zuber, M.
|
|
|
27 |
6S |
p. S21-S22
|
artikel
|
| 34 |
CO69 Burden of Clinical Syndromes Associated with Pneumococcal Disease in Ecuador: A 2019 Perspective
|
Sánchez, X.
|
|
|
27 |
6S |
p. S29
|
artikel
|
| 35 |
CO11 Captopril Response Association With Angiotensin-Converting Enzyme (ACE) Insertion/Deletion Polymorphisms in Mexican Indigenous
|
Navarro-, Pineda D.
|
|
|
27 |
6S |
p. S17-S18
|
artikel
|
| 36 |
CO165 Changes in Mortality Rates With the Introduction of Immuno-Oncology Therapy in Advanced Non-Small Cell Lung Cancer: A Seer-Medicare Analysis
|
Kim, Y.
|
|
|
27 |
6S |
p. S48
|
artikel
|
| 37 |
CO157 Characteristics of Medicare Beneficiaries With Multiple Administrations of CAR-T Therapy
|
Kardel, P.
|
|
|
27 |
6S |
p. S47
|
artikel
|
| 38 |
CO71 Characterization of Physician-Reported Outcomes of People with HIV Switching Treatment: Findings from a Real-World Survey in the United States
|
Zachry, W.
|
|
|
27 |
6S |
p. S30
|
artikel
|
| 39 |
CO114 Clinical Characteristics, Diagnosis, and Impact on Employment in Patients With Obstructive Hypertrophic Cardiomyopathy: Results From a Real-World Survey in Canada
|
Lowe, M.
|
|
|
27 |
6S |
p. S38
|
artikel
|
| 40 |
CO6 Clinical Characterization of Patients with Wilson Disease (WD) Using Performance and Qulaitative Measures
|
Malkus, B.
|
|
|
27 |
6S |
p. S17
|
artikel
|
| 41 |
CO75 Clinical Outcomes Associated with Anti-CD38 Retreatment in Relapsed/Refractory Multiple Myeloma: A Review of the Literature
|
McNamara, S.
|
|
|
27 |
6S |
p. S31
|
artikel
|
| 42 |
CO143 Clinical Outcomes of First-Line (1L) Treatments (Txs) in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (aNSCLC): A Systematic Literature Review (SLR)
|
Reck, M.
|
|
|
27 |
6S |
p. S44
|
artikel
|
| 43 |
CO106 Clinical Outcomes of Patients in the Intensive Care Unit with Infections Caused By Multiresistant Gram-Negative Bacteria in Colombian Patients
|
Varon, FA.
|
|
|
27 |
6S |
p. S36
|
artikel
|
| 44 |
CO104 Clinical Outcomes of Second-Line and Beyond (2L+) Treatments (TXS) in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (aNSCLC): A Systematic Literature Review (SLR)
|
Voon, PJ.
|
|
|
27 |
6S |
p. S36
|
artikel
|
| 45 |
CO62 Clinical Outcomes of Second-Line (2L) Treatments (TXS) in Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC): A Systematic Literature Review (SLR)
|
Augusto, Novis de Figueiredo M.
|
|
|
27 |
6S |
p. S28
|
artikel
|
| 46 |
CO73 Clinical Significance of KL-6 Biomarker in the Development of Connective Tissue Disease-Associated Interstitial Lung Disease: A Systematic Review and Meta-Analysis
|
Chunduri, P.
|
|
|
27 |
6S |
p. S30
|
artikel
|
| 47 |
CO209 Comorbidities in Myasthenia Gravis in the US National Veterans Affairs Health Network.
|
Qi, Z.
|
|
|
27 |
6S |
p. S56
|
artikel
|
| 48 |
CO70 Comparative Bayesian Network Meta-Analysis of BTKi-Specific Adverse Events in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
|
Monica, M.
|
|
|
27 |
6S |
p. S29-S30
|
artikel
|
| 49 |
CO89 Comparative Effectiveness and Safety of Abaloparatide and Teriparatide in the Treatment of Osteoporosis in Postmenopausal Women: A Systematic Review and Meta-Analysis
|
Ren, Y.
|
|
|
27 |
6S |
p. S33
|
artikel
|
| 50 |
CO41 Comparative Effectiveness of Glucagon-like Peptide 1 Agonists Vs Dipeptidyl Peptidase 4 Inhibitors on Liver Outcomes in Patients with Type 2 Diabetes and Metabolic Dysfunction-Associated Fatty Liver Disease
|
Shen, T.H.
|
|
|
27 |
6S |
p. S24
|
artikel
|
| 51 |
CO171 Comparative Effectiveness of KarXT and Selective Second-Generation Antipsychotics for the Treatment of Schizophrenia: A Systematic Literature Review and Network Meta-Analysis
|
McKenna, A.
|
|
|
27 |
6S |
p. S49
|
artikel
|
| 52 |
CO139 Comparative Effectiveness of Rapid Vs. Non-Rapid Start of Anti-Retroviral Therapy in Patients With Human Immunodeficiency Virus Infection on Clinical Outcomes: A Systematic Literature Review and Meta-Analysis
|
Schmutz, H.
|
|
|
27 |
6S |
p. S43
|
artikel
|
| 53 |
CO92 Comparative Effectiveness of Second-Line Immune Targeted Treatments in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL): A Network Meta-Analysis
|
Mohamed, AF.
|
|
|
27 |
6S |
p. S34
|
artikel
|
| 54 |
CO135 Comparative Efficacy, Safety, and Tolerability of KarXT Versus Aripiprazole and Cariprazine for the Acute Treatment of Adults With Schizophrenia: A Network Meta-Analysis
|
Hickey, C.
|
|
|
27 |
6S |
p. S42
|
artikel
|
| 55 |
CO149 Comparative Examination of Performance Metrics in Football and Handball Players within Controlled Laboratory Environments
|
Derkács, E.
|
|
|
27 |
6S |
p. S45
|
artikel
|
| 56 |
CO30 Comparative Genitourinary Safety of in-Class Sodium Glucose Co-Transporter-2 Inhibitors Among Patients with Heart Failure with Preserved Ejection Fraction
|
Riaz, M.
|
|
|
27 |
6S |
p. S22
|
artikel
|
| 57 |
CO126 Competing Risks of Death in Older Adults With Advanced Non-Small Cell Lung Cancer Receiving Programmed Cell Death Protein 1 (PD-1) Inhibitors
|
Kim, Y.
|
|
|
27 |
6S |
p. S40
|
artikel
|
| 58 |
CO81 Cyclosporine Ophthalmic Solution 0.09% Improves the Signs and Symptoms of Dry Eye Disease in Patients Whose Disease Is Inadequately Controlled on Cyclosporine Ophthalmic Emulsion 0.05%
|
Johnston, J.
|
|
|
27 |
6S |
p. S32
|
artikel
|
| 59 |
CO130 Diagnosis, Treatment, and Control of Hypertension Among US Adults: The National Health and Nutrition Examination Survey, 2009 to 2020
|
Gu, A.
|
|
|
27 |
6S |
p. S41
|
artikel
|
| 60 |
CO58 Disease- and Glucocorticoid-Related Comorbidities in Classic Congenital Adrenal Hyperplasia: A Claims-Based Retrospective Cohort Analysis
|
Cheng, H.
|
|
|
27 |
6S |
p. S27
|
artikel
|
| 61 |
CO105 Disease Burden and Treatment in Patients with Essential Tremor in the United States: Real-World Evidence from a Cross-Sectional Survey of Physicians and Patients
|
Williams, J.
|
|
|
27 |
6S |
p. S36
|
artikel
|
| 62 |
CO42 Disease Burden of Anal Carcinoma in Chinese Male Patients Under Current Care: A Model Simulation Study
|
He, S.
|
|
|
27 |
6S |
p. S24
|
artikel
|
| 63 |
CO125 Disease Burden of Epithelial Ovarian Cancer in Chinese Patients Under Current Care: A Model Simulation Study
|
He, J.
|
|
|
27 |
6S |
p. S40
|
artikel
|
| 64 |
CO10 Early Adoption and Utilization of Perfluorohexyloctane for Treatment of Dry Eye Disease
|
Manjelievskaia, J.
|
|
|
27 |
6S |
p. S17
|
artikel
|
| 65 |
CO5 Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Cancer: A Target Trial Emulation From SEER-Medicare Database
|
Truong, B.
|
|
|
27 |
6S |
p. S16-S17
|
artikel
|
| 66 |
CO51 Effect of Donated Plasma on Laboratory Parameters and Motivating Factors of Donated Plasma
|
Czifra, I.
|
|
|
27 |
6S |
p. S25
|
artikel
|
| 67 |
CO185 Efficacy and Safety of Traditional Chinese Medicine for Acute Ischemic Stroke: A Systematic Review and Network Meta-Analysis
|
Yuan, J.
|
|
|
27 |
6S |
p. S52
|
artikel
|
| 68 |
CO150 Efficiacy of Back School Program in Connection with Physical Activity Amongst Hungarian Adolescents
|
Tumpek, N.
|
|
|
27 |
6S |
p. S45
|
artikel
|
| 69 |
CO169 Ensifentrine, an Investigational, Inhaled PDE3/4 Inhibitor, Decreased COPD-Related Healthcare Resource Utilization over 24 Weeks
|
Wan, E.
|
|
|
27 |
6S |
p. S49
|
artikel
|
| 70 |
CO121 Evaluating Disparities in Clinical Outcomes Among Medicare Beneficiaries With Peripheral Artery Disease (PAD): A Call To Action for Health Equity
|
Monteleone, P.
|
|
|
27 |
6S |
p. S39
|
artikel
|
| 71 |
CO159 Evaluating Risk of Complications in CAR-T Cell Therapy Among Patients with Acute Lymphocytic Leukemia
|
Freeman, R.
|
|
|
27 |
6S |
p. S47
|
artikel
|
| 72 |
CO194 Evaluating the Clinical Phenotypes Associated with Progression to Chronic Kidney Disease Using an Unsupervised Machine Learning Approach
|
Al-Mamun, M..
|
|
|
27 |
6S |
p. S54
|
artikel
|
| 73 |
CO36 Evaluating the Impact of State Level Masking Policies on Adherence over Time in Diabetic and Hypertensive Populations
|
Lopez, R.
|
|
|
27 |
6S |
p. S23
|
artikel
|
| 74 |
CO56 Evaluation of Real-World Treatment Outcomes Among Women 50 Years of Age and Older Who Were Treated With Statin + Ezetimibe or Statin Monotherapy in Italy and Belgium
|
Chu, P.
|
|
|
27 |
6S |
p. S26-S27
|
artikel
|
| 75 |
CO96 Evidence Gap Analysis of the Burden of Illness and Treatment of Thyroid Eye Disease
|
Gildea, L.
|
|
|
27 |
6S |
p. S35
|
artikel
|
| 76 |
CO24 Examination of the Effectiveness of a Shoulder Stabilization Programme Among Throwing Athletes
|
Ackermann, A.L.
|
|
|
27 |
6S |
p. S20-S21
|
artikel
|
| 77 |
CO25 Examining the Effectiveness of Rotator Cuff Training on Shoulder Joint Stability, Mobility and Shooting Accuracy Among Basketball Players
|
Füzesi, D.
|
|
|
27 |
6S |
p. S21
|
artikel
|
| 78 |
CO198 Exploring Progression-Free Survival 2 (PFS2) Endpoint Trends and Uptake in the US Healthcare Landscape
|
Okorozo, P.
|
|
|
27 |
6S |
p. S54-S55
|
artikel
|
| 79 |
CO131 Exploring Simplified Screening Cut-Offs: Classification of KCNQ2-DEE Patients into Age-Adjusted Disease Phenotypes
|
Gold, A.
|
|
|
27 |
6S |
p. S41
|
artikel
|
| 80 |
CO44 Exploring the Impact of Non-Steroidal Immunosuppressive Drugs and Steroids on the Development of Comorbidities in Patients With Myasthenia Gravis in the National Veterans Affairs Health Network
|
Qi, Z.
|
|
|
27 |
6S |
p. S24
|
artikel
|
| 81 |
CO117 Factors Associated with Biologic Treatment De-Escalation in Patients with Crohn’s Disease
|
Lien, PW.
|
|
|
27 |
6S |
p. S38
|
artikel
|
| 82 |
CO201 Feasibility of Using Positron Emission Tomography–Computed Tomography (PET-CT) Scans From Real-World Medical Record Data to Support Lymphoma Treatment Response Assessment
|
Swain, R.
|
|
|
27 |
6S |
p. S55
|
artikel
|
| 83 |
CO188 Fit-for-Purpose and Scalable Strategy to Address Mortality Completeness for Oncology Research: Comparison of Multiple Real-World Sources with the National Death Index
|
Aguilar, K.
|
|
|
27 |
6S |
p. S53
|
artikel
|
| 84 |
CO200 Gender Differences in Clinician-Recorded Side Effects Among People With First Episode Psychosis: Real-World Evidence From Electronic Health Record Data
|
Patel, R.
|
|
|
27 |
6S |
p. S55
|
artikel
|
| 85 |
CO34 Glucagon-like Peptide-1 (GLP-1) Receptor Agonists - Efficacy, Safety, and Cost-Effectiveness in Obesity Management: A Systematic Review
|
Ahiwale, RJ.
|
|
|
27 |
6S |
p. S22-S23
|
artikel
|
| 86 |
CO152 Glycemic Control and Long-Term Macrovascular Outcomes in People With Type 2 Diabetes in China: A Retrospective Study
|
Zhang, M.
|
|
|
27 |
6S |
p. S46
|
artikel
|
| 87 |
CO211 Gout Epidemiology, Pharmacotherapy, Healthcare Utilization, and Outcomes for United States Veterans Affairs Patients From 2016 to 2022
|
Vargus, A.
|
|
|
27 |
6S |
p. S56
|
artikel
|
| 88 |
CO95 Growing Acceptance of Minimal Residual Disease (MRD) As a Primary Endpoint in Multiple Myeloma (MM) Clinical Trials
|
Jones, C.
|
|
|
27 |
6S |
p. S34-S35
|
artikel
|
| 89 |
CO22 Health-Related Quality of Life from a Phase 4 Global Clinical Study to Evaluate Discontinuation and Rechallenge of Pexidartinib in Patients with Tenosynovial Giant Cell Tumor (TGCT) Previously Treated with Pexidartinib
|
Desai, J.
|
|
|
27 |
6S |
p. S20
|
artikel
|
| 90 |
CO140 Heterogeneous Treatment Effects of an Intensive Lifestyle Intervention: Evidence From the Look Ahead Study
|
Davis, I.
|
|
|
27 |
6S |
p. S43
|
artikel
|
| 91 |
CO74 Hospitalizations with Initiation of Hydroxychloroquine in Patients with Heart Failure with Preserved Ejection Fraction and Autoimmune Disease
|
Riaz, M.
|
|
|
27 |
6S |
p. S30-S31
|
artikel
|
| 92 |
CO93 Impact of Caring for Persons with Schizophrenia: Review of Burden Assessment Measures
|
Jain, M.
|
|
|
27 |
6S |
p. S34
|
artikel
|
| 93 |
CO57 Impact of Coexisting Mental Illnesses and Chronic Conditions on Healthcare Utilization and Cost at Blue Cross and Blue Shield of Louisiana
|
Kaur, G.
|
|
|
27 |
6S |
p. S27
|
artikel
|
| 94 |
CO18 Impact of Empiric Treatment Failure on Healthcare Resource Utilization and Costs Among Females With Uncomplicated Urinary Tract Infections in a US-Based Integrated Health Delivery Network
|
Ellis, J.
|
|
|
27 |
6S |
p. S19
|
artikel
|
| 95 |
CO205 Impact of GLP-1A Treatment on Eating Disorder Incidence: A Comparative, Real World Data Study in Patients With and Without Pre-Existing Mental Health Conditions
|
Sagarino, T.
|
|
|
27 |
6S |
p. S55-S56
|
artikel
|
| 96 |
CO163 Impact of Glucocorticoid Use on Mortality in Adults with Chronic Diseases: A Systematic Literature Review
|
Rao, V.T.
|
|
|
27 |
6S |
p. S48
|
artikel
|
| 97 |
CO138 Impact of Steroid Withdrawal at Various Time Points After Liver Transplantation on Diabetes Mellitus: A Population-Based Cohort Study in South Korea
|
Lee, H.
|
|
|
27 |
6S |
p. S42-S43
|
artikel
|
| 98 |
CO191 Improving Shooting Accuracy and Center of Gravity with Closed Kinematic Chain Exercises in Handball Players
|
Pupos, LE.
|
|
|
27 |
6S |
p. S53
|
artikel
|
| 99 |
CO145 Incidence of Acute Exacerbations Among Patients With Fibrotic Interstitial Lung Disease in the United States
|
Yang, J.
|
|
|
27 |
6S |
p. S44
|
artikel
|
| 100 |
CO55 Incidence of Adverse Events with Pembrolizumab in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Systematic Review of Literature
|
Singla, D.
|
|
|
27 |
6S |
p. S26
|
artikel
|
| 101 |
CO119 Indirect Treatment Comparison and Cost-Minimization Analysis between Riociguat and Selexipag to WHO Functional Class III Pulmonary Arterial Hipertension (PAH) Patients
|
Saad, R.
|
|
|
27 |
6S |
p. S38-S39
|
artikel
|
| 102 |
CO156 Indirect Treatment Comparison (ITC) of Cabotegravir Long Acting (CAB-LA) for Pre-Exposure Prophylaxis (PREP) Versus No Prep for HIV Prevention
|
Hawkins, N.
|
|
|
27 |
6S |
p. S46
|
artikel
|
| 103 |
CO172 Indirect Treatment Comparison of Efficacy and Safety of Capivasertib-Fulvestrant Versus Alpelisib-Fulvestrant for PIK3CA-Altered, HR-Positive, Advanced Breast Cancer after Disease Progression Following Endocrine-Based Therapy
|
de Wilt, E.
|
|
|
27 |
6S |
p. S49-S50
|
artikel
|
| 104 |
CO39 Influence of Socioeconomic Status on Breast Cancer Treatment in the US: Preliminary Results from a Systematic Literature Review
|
Akkala, S.
|
|
|
27 |
6S |
p. S23
|
artikel
|
| 105 |
CO79 In-Hospital Mortality Among Hospitalized COVID-19 Patients in the United States: How Did It Change in 2022 and 2023?
|
Moon, R.
|
|
|
27 |
6S |
p. S31
|
artikel
|
| 106 |
CO182 Intelligence Quotient (IQ) Scores Among Early-Treated Phenylketonuria (PKU) Patients: Results from a Systematic Literature Review (SLR)
|
O’Sullivan, F.
|
|
|
27 |
6S |
p. S51-S52
|
artikel
|
| 107 |
CO72 Investigating Regional Differences in Cardiovascular Outcomes Among Patients Diagnosed with Hypertrophic Cardiomyopathy
|
Reza, N.
|
|
|
27 |
6S |
p. S30
|
artikel
|
| 108 |
CO8 Leading Predictors of Incident Hypertension Among Patients with Cancer in Community Health Centers: A Machine Learning Approach with Shapley Additive Explanations Using Electronic Health Records
|
Park, C.
|
|
|
27 |
6S |
p. S17
|
artikel
|
| 109 |
CO85 Longitudinal Patterns of Loss of Independence in Parkinson Disease
|
Lee, TY.
|
|
|
27 |
6S |
p. S33
|
artikel
|
| 110 |
CO115 Long-Term Post-Recurrence Survival (PRS) Outcomes for Stage IIB/C Melanoma Patients in Real-World (RW) Settings: Analyses from a Longitudinal Electronic Health Record Database in the United States
|
Kurt, M.
|
|
|
27 |
6S |
p. S38
|
artikel
|
| 111 |
CO190 Lumbar Spine Problems Caused By Hyperextension and It's Prevention, As Well As Balance Development in Rhythmic Gymnasts
|
Fuchs, H.
|
|
|
27 |
6S |
p. S53
|
artikel
|
| 112 |
CO67 Network Meta-Analysis to Compare the Efficacy Between Different Classes of PCSK9 Inhibitors, siRNA Vs. PCSK9 mAb, in Asian Patients With Hypercholesterolemia at Increased Cardiovascular Risk
|
Luo, Y.
|
|
|
27 |
6S |
p. S29
|
artikel
|
| 113 |
CO180 Newer Glucose-Lowering Drugs and Risk of Depression: A Meta-Analysis of Randomized Outcome Trials
|
Tang, H.
|
|
|
27 |
6S |
p. S51
|
artikel
|
| 114 |
CO127 Newer Glucose-Lowering Drugs and Risk of Suicide: A Network Meta-Analysis of Randomized Outcome Trials
|
Lu, Y.
|
|
|
27 |
6S |
p. S40
|
artikel
|
| 115 |
CO129 Novel Endpoints in Chronic Kidney Disease (CKD): Trends in the Use of eGFR Slope and Proteinuria As Efficacy Endpoints in Clinical Trials
|
Robert, A.
|
|
|
27 |
6S |
p. S40-S41
|
artikel
|
| 116 |
CO66 Optimizing GPT-4 Prompts for Population Eligibility Screening in COA Landscape Reviews of Qualitative Studies
|
Thorlund, K.
|
|
|
27 |
6S |
p. S29
|
artikel
|
| 117 |
CO65 Overall Survival in Metastatic NSCLC in HMO From Colombia: A Non-Interventional Study
|
Reyes, Sanchez JM.
|
|
|
27 |
6S |
p. S28-S29
|
artikel
|
| 118 |
CO166 Patient Reported Outcomes of Vonoprazan in Chinese Reflux Esophagitis Patients: A Prospective Real-World Study
|
Xiao, Y.
|
|
|
27 |
6S |
p. S48
|
artikel
|
| 119 |
CO68 Performance Diagnostic Examination of Women's Handball Players
|
Derkács, E.
|
|
|
27 |
6S |
p. S29
|
artikel
|
| 120 |
CO110 Physical Examination of the Functional Status of the Hip and Spine in Junior Swimmers and Synchronised Swimmers
|
Utasi, E.
|
|
|
27 |
6S |
p. S37
|
artikel
|
| 121 |
CO23 Predicting Moderate-to-Severe Plaque Psoriasis From Prescription and Procedure Electronic Health Record Data
|
Rasouliyan, L.
|
|
|
27 |
6S |
p. S20
|
artikel
|
| 122 |
CO153 Predicting Overall Survival (OS) Benefit in Previously Untreated Metastatic Melanoma From Improvements in Response Outcomes: A Correlation Meta-Analysis of Randomized Controlled Trials (RCTs)
|
Leung, L.
|
|
|
27 |
6S |
p. S46
|
artikel
|
| 123 |
CO3 Prediction of Long-Term Factor IX Durability Among Hemophilia B Patients Treated with Fidanacogene Elaparvovec Gene Therapy
|
Morris, A.
|
|
|
27 |
6S |
p. S16
|
artikel
|
| 124 |
CO32 Predictors of Overall Survival (OS) and Time to Next Treatment (TTNT) in Real-World Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) Patients Who Received First-Line (1L) Folfirinox (FFX) or Gemcitabine + Nab-paclitaxel (GnP)
|
Dennen, S.
|
|
|
27 |
6S |
p. S22
|
artikel
|
| 125 |
CO142 Predisposing, Enabling, and Need Factors Associated With Postpartum Depression Treatment Among Women Enrolled in Texas Medicaid
|
Pennington, EL.
|
|
|
27 |
6S |
p. S43
|
artikel
|
| 126 |
CO189 Preliminary Outcomes of a Hearing Loss Screening Program of 5,360 Older Adults at the Medical University of South Carolina
|
Dillard, LK.
|
|
|
27 |
6S |
p. S53
|
artikel
|
| 127 |
CO64 Prevalence of Immunosuppressants and Antifibrotic Use in Patients With Connective Tissue Disease-Related Interstitial Lung Disease
|
Yang, J.
|
|
|
27 |
6S |
p. S28
|
artikel
|
| 128 |
CO154 Prevalence of Unmet Social Needs and Post-Transplant Outcomes Among Adult Sickle Cell Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
|
Mandava, MR.
|
|
|
27 |
6S |
p. S46
|
artikel
|
| 129 |
CO14 Profiling Adverse Events in Multiple Myeloma: Insights from Clinical Trials Via Large Language Models
|
Paek, H.
|
|
|
27 |
6S |
p. S18
|
artikel
|
| 130 |
CO49 Progression of Chronic Kidney Disease Among Older Adults with Hypertension Using Group-Based Trajectory Modeling
|
Gupta, AK.
|
|
|
27 |
6S |
p. S25
|
artikel
|
| 131 |
CO120 Progression of Disease Burden Among Boys with Duchenne Muscular Dystrophy (DMD) According to Ambulatory Status and Age at Loss of Ambulation (LoA)
|
Gordish-Dressman, H..
|
|
|
27 |
6S |
p. S39
|
artikel
|
| 132 |
CO175 Quality of Life and Productivity Loss Cost Associated with Low Back Pain By Severity in Korea
|
Ryu, D.
|
|
|
27 |
6S |
p. S50
|
artikel
|
| 133 |
CO84 Racial/Ethnic Differences in Healthcare Resource Utilization Among Patients With Amyotrophic Lateral Sclerosis in Texas
|
Kuo, T.
|
|
|
27 |
6S |
p. S32-S33
|
artikel
|
| 134 |
CO183 Real-World Clinical Outcomes and Genomic Profiles of Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) Harboring Both AR-LBD Missense Mutations and AR Copy Number Amplifications
|
Saha, J.
|
|
|
27 |
6S |
p. S52
|
artikel
|
| 135 |
CO63 Real-World Comparative Effectiveness of the First COVID-19 mRNA Booster, mRNA-1273 Versus BNT162b2, Among US Medicare Fee-for-Service Non-Immunocompromised Beneficiaries Aged 65 and Older
|
Zurovac, J.
|
|
|
27 |
6S |
p. S28
|
artikel
|
| 136 |
CO122 Real-World Data on Inequity in Clinical Outcomes Among Adult Patients Diagnosed with Hypertrophic Cardiomyopathy
|
Krishnaswami, S.
|
|
|
27 |
6S |
p. S39
|
artikel
|
| 137 |
CO86 Real-World Evaluation of Intracardiac Echocardiography Guided Radio-Frequency Catheter Ablation for Atrial Fibrillation: A Retrospective Cohort Study
|
Tong, Y.
|
|
|
27 |
6S |
p. S33
|
artikel
|
| 138 |
CO53 Real-World Evidence of the Effectiveness of Inhaled Corticosteroid-Containing Therapies in Reducing Exacerbations and Medical Costs in COPD
|
Siddharthan, T.
|
|
|
27 |
6S |
p. S26
|
artikel
|
| 139 |
CO193 Real-World Retrospective Analysis Comparing a Bilayered Living Cellular Construct and a Fetal Bovine Collagen Dressing for Use in Venous Leg Ulcers
|
Sabolinski, M.
|
|
|
27 |
6S |
p. S54
|
artikel
|
| 140 |
CO170 Real-World Survival Outcomes in Patients with Intermediate-to-High-Risk Non-Muscle Invasive Bladder Cancer Utilizing Medicare Claims Data: Estimating Event Free Survival and Evaluating Its Prediction of Overall Survival
|
Eccleston, A.
|
|
|
27 |
6S |
p. S49
|
artikel
|
| 141 |
CO37 Real-World Treatment Patterns, Healthcare Resource Utilization (HCRU) and Clinical Outcomes of Patients with Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) in Alberta, Canada
|
Suri, G.
|
|
|
27 |
6S |
p. S23
|
artikel
|
| 142 |
CO202 Relationship between Loss of Ambulation (LoA) and Timing of Pulmonary Outcomes Among Boys with Duchenne Muscular Dystrophy (DMD)
|
Gordish-Dressman, H..
|
|
|
27 |
6S |
p. S55
|
artikel
|
| 143 |
CO160 Relationship between Loss of Ambulation (LoA), Disease Burden, and Physical Functioning Among Boys with Duchenne Muscular Dystrophy (DMD)
|
Gordish-Dressman, H..
|
|
|
27 |
6S |
p. S47
|
artikel
|
| 144 |
CO33 Risk Factors for Increased Initial Hospital Length of Stay and 30-Day Readmissions in Patients with Relapsed/Refractory Large B-Cell Lymphoma Treated with Chimeric Antigen Receptor T-Cell Therapy at an Academic Cancer Center
|
Yeung, P.
|
|
|
27 |
6S |
p. S22
|
artikel
|
| 145 |
CO196 Saturation Reporting in COA Development and Validation Studies: A Scoping Overview
|
Girardi, A.
|
|
|
27 |
6S |
p. S54
|
artikel
|
| 146 |
CO83 Screening Articles in a Qualitative Literature Review Using Large Language Models: A Comparison of GPT Versus Open Source, Trained Models Against Expert Researcher Screening
|
Hudgens, S.
|
|
|
27 |
6S |
p. S32
|
artikel
|
| 147 |
CO16 Shared Identity and Patient Care: Examining Racial and Gender Concordance on Treatment and Testing Adherence in CML
|
Montano-Campos, J.F.
|
|
|
27 |
6S |
p. S19
|
artikel
|
| 148 |
CO118 Sickle Cell Disease Outcomes in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Literature Review
|
Nair, R.
|
|
|
27 |
6S |
p. S38
|
artikel
|
| 149 |
CO141 Situation Report: Health Status of Hungarian Ambulance Workers in the COVID Era
|
Sántha, E.
|
|
|
27 |
6S |
p. S43
|
artikel
|
| 150 |
CO123 Socio-Demographics, Clinical Characteristics, and Quality of Life in Patients with Parkinson’s Disease with and without Comorbid Insomnia
|
Bhattacharya, S.
|
|
|
27 |
6S |
p. S39-S40
|
artikel
|
| 151 |
CO27 Survival and Cost of Care By Type of First-Line Therapy in Metastatic Non-Small Lung Cancer Using SEER-Medicare Data
|
Danese, M.
|
|
|
27 |
6S |
p. S21
|
artikel
|
| 152 |
CO162 Systematic Literature Review (SLR) and Meta-Analysis of Crizotinib Versus Conventional Chemotherapy in First-Line Treatment for ROS-1 Rearranged Non-Small Cell Lung Cancer
|
Tomer, R.
|
|
|
27 |
6S |
p. S47-S48
|
artikel
|
| 153 |
CO17 Systematic Literature Review (SLR) of Randomized Controlled Trials (RCTs) of Immuno-Oncology (IO) for First-Line (1L) Esophageal Squamous Cell Carcinoma (ESCC) in Adult Patients
|
Smyth, E.
|
|
|
27 |
6S |
p. S19
|
artikel
|
| 154 |
CO91 Systemic Therapy Eligibility Criteria of the International Psoriasis Council (IPC) May Reduce Undertreatment of PsO Patients with Low Body Surface Area Involvement Associated with High Disease Burden
|
Litvintchouk, A.
|
|
|
27 |
6S |
p. S34
|
artikel
|
| 155 |
CO26 Targeted Literature Review Exploring Burden of Disease in Junctional and Dystrophic Epidermolysis Bullosa
|
Kaler, N.
|
|
|
27 |
6S |
p. S21
|
artikel
|
| 156 |
CO179 The Association Between Social Determinants of Health, COVID-19, and Incidence of De Novo Depression Following Traumatic Brain Injury
|
Edalat, C.
|
|
|
27 |
6S |
p. S51
|
artikel
|
| 157 |
CO4 The Burden of Illness of Treatment-Induced Vasomotor Symptoms in Patients With Breast Cancer: A Systematic Literature Review
|
Morga, A.
|
|
|
27 |
6S |
p. S16
|
artikel
|
| 158 |
CO206 The Clinical and Financial Impact of Sustained Annual Wellness Visit Engagement in the Blue Cross and Blue Shield of Louisiana Medicare Advantage Population
|
Vandergrift, T.
|
|
|
27 |
6S |
p. S56
|
artikel
|
| 159 |
CO108 The Effect of Approved Anti-Obesity Medications in Patients With Alcohol and Substance Abuse Disorder
|
Baser, O.
|
|
|
27 |
6S |
p. S37
|
artikel
|
| 160 |
CO177 The Effect of Newly Approved Obesity Medications on Cardiovascular Complications
|
Baser, O.
|
|
|
27 |
6S |
p. S50
|
artikel
|
| 161 |
CO113 The Financial Effect of Closing the Hypertension Blood Pressure Care Gap at Blue Cross and Blue Shield of Louisiana
|
Cong, M.
|
|
|
27 |
6S |
p. S37-S38
|
artikel
|
| 162 |
CO15 The Hungarian Nurses Knowledge about Palliative Care
|
Lukács, M.
|
|
|
27 |
6S |
p. S18-S19
|
artikel
|
| 163 |
CO148 The Impact of Approved Anti-Obesity Medications on Osteoarthritis Risk in Patients With Obesity: A Retrospective Cohort Study
|
Baser, O.
|
|
|
27 |
6S |
p. S45
|
artikel
|
| 164 |
CO102 The Importance of Potassium Ion Disturbances in Emergency Care
|
Póhr, K.
|
|
|
27 |
6S |
p. S35
|
artikel
|
| 165 |
CO87 The Patient Journey of Bariatric Surgery – a Study Comparing the Healthcare and Medication Utilization before and after the Bariatric Surgery
|
Wang, X.
|
|
|
27 |
6S |
p. S33
|
artikel
|
| 166 |
CO147 The Potential Long-Term Comparative Effectiveness of Larotrectinib Vs. Entrectinib for Treatment of Metastatic Fusion-Positive Cancers in Children and Young Adults
|
Suh, K.
|
|
|
27 |
6S |
p. S44-S45
|
artikel
|
| 167 |
CO1 The Rate of Ward to Intensive Care Transfer and Its Predictors Among Hospitalized COPD Patients: A Retrospective Study in a Local Tertiary Center in Saudi Arabia
|
Naser, A.
|
|
|
27 |
6S |
p. S16
|
artikel
|
| 168 |
CO173 The Role of Mindfulness, Pelvic Floor Physical Therapy (PFPT), and Hypopressive Exercises for Chronic Pelvic Pain (CPP): Preliminary Results in Productivity Gain and Loss
|
Bittelbrunn, CC.
|
|
|
27 |
6S |
p. S50
|
artikel
|
| 169 |
CO54 Timely Rheumatoid Arthritis Control With Biologic or Targeted Synthetic DMARDs in Clinical Practice: Separating Successes From Opportunities for Care Improvement
|
Helfgott, S.M..
|
|
|
27 |
6S |
p. S26
|
artikel
|
| 170 |
CO78 Transfusion Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Transfusion-Dependent Beta-Thalassemia: A Systematic Literature Review
|
Nair, R.
|
|
|
27 |
6S |
p. S31
|
artikel
|
| 171 |
CO52 Treatment History, Healthcare Resource Use, and Costs Among Patients With Pulmonary Arterial Hypertension (PAH) Initiating Treatment With Macitentan: A Retrospective Claims Analysis
|
Worden, C.
|
|
|
27 |
6S |
p. S25-S26
|
artikel
|
| 172 |
CO20 Treatment Regimens and Persistence in Colombian Patients Diagnosed With Rheumatologic Diseases After Failure of Conventional Disease-Modifying Antirheumatic Drugs
|
Valladales, Restrepo L.
|
|
|
27 |
6S |
p. S19-S20
|
artikel
|
| 173 |
CO146 Treatment Use and Overall Survival of Patients with Unresectable/Metastatic Melanoma in Colombia: A Real World Study
|
Reyes, Sanchez JM.
|
|
|
27 |
6S |
p. S44
|
artikel
|
| 174 |
CO97 Trial-and-Error Treatment Leads To Delayed Disease Control of Moderate-to-Severe Rheumatoid Arthritis
|
Huston, K.
|
|
|
27 |
6S |
p. S35
|
artikel
|
| 175 |
CO167 Type of Pre-Existing Chronic Conditions and Their Associations with Merkel Cell Carcinoma Treatment: Prediction and Interpretation Using Machine Learning Methods
|
Mbous, Y.
|
|
|
27 |
6S |
p. S48
|
artikel
|
| 176 |
CO136 Unmet Treatment Needs in the Management of Patients With Eosinophilic Esophagitis: Insights From a Real-world Survey
|
Mascia, D.
|
|
|
27 |
6S |
p. S42
|
artikel
|
| 177 |
CO181 Upadacitinib in Moderate-to-Severe Crohn's Disease (CD): A Systematic Review of Remission Outcomes in Adults With Inadequate Response or Intolerance to Biologic Drugs
|
Sirumalla, Y.
|
|
|
27 |
6S |
p. S51
|
artikel
|
| 178 |
CO80 Using Machine Learning to Understand Predictors of Frequent Surveillance Testing in Colorectal Cancer Patients
|
Dickerson, R.
|
|
|
27 |
6S |
p. S31-S32
|
artikel
|
| 179 |
CO99 Validation of Overall Survival (OS) Extrapolations Using 5-Year Follow-up Data From the Keynote-177 MSI-H/dMMR Metastatic Colorectal Cancer (mCRC) Study
|
McCarthy, G.
|
|
|
27 |
6S |
p. S35
|
artikel
|
| 180 |
CO197 Vaso-Occlusion Definitions Can Impact Efficacy Assessments in Clinical Studies of Sickle Cell Disease
|
Frangoul, H.
|
|
|
27 |
6S |
p. S54
|
artikel
|
| 181 |
Cover
|
|
|
|
27 |
6S |
p. OFC
|
artikel
|
| 182 |
CO40 Zero Dollar Drug Co-Pay Program Increases Medication Adherence and Utilization Among Members With Diabetes in Louisiana
|
Tang, T.
|
|
|
27 |
6S |
p. S23-S24
|
artikel
|
| 183 |
Disclaimer
|
|
|
|
27 |
6S |
p. A1
|
artikel
|
| 184 |
EE189 A Budget Impact Analysis of Finerenone in Patients with Chronic Kidney Disease and Type 2 Diabetes Being Treated with Standard of Care in Tertiary Hospital, Riyadh, Saudi Arabia
|
Alhawwashi, ST
|
|
|
27 |
6S |
p. S92
|
artikel
|
| 185 |
EE494 A Budget Impact Analysis of Newer Pneumococcal Conjugate Vaccine Use in All US Adults Aged 50-64 Years Old Compared to Current Recommendations from US Payer Perspective
|
Vadlamudi, N
|
|
|
27 |
6S |
p. S147-S148
|
artikel
|
| 186 |
EE438 A Budget Impact Model (BIM) for the Introduction of the TEARCARE® System to a United States (US) Health Plan for the Treatment of Meibomian Gland Dysfunction (MGD)-Associated Dry Eye Disease (DED)
|
Masseria, C
|
|
|
27 |
6S |
p. S137
|
artikel
|
| 187 |
EE162 A Claims Analysis to Characterize the Economic Burden of Generalized Pustular Psoriasis Among Patients in the United States
|
Gottlieb, A.B.
|
|
|
27 |
6S |
p. S87
|
artikel
|
| 188 |
EE425 A Comparison of Payer Costs for Patients with and without Revascularization in Thoracic Endovascular Aortic Repair Stent Grafting Procedures
|
Marti, AK
|
|
|
27 |
6S |
p. S135
|
artikel
|
| 189 |
EE341 A Comparison of Stapling Costs Used in Hybrid vs Robotic Surgery
|
Villas, E
|
|
|
27 |
6S |
p. S120
|
artikel
|
| 190 |
EE165 A Cost-Consequence Analysis of Ponatinib Versus Imatinib in Patients with Newly Diagnosed Philadelphia-Positive Acute Lymphoblastic Leukemia in the United States
|
Hernandez, LG
|
|
|
27 |
6S |
p. S88
|
artikel
|
| 191 |
EE404 A Cost-Effectiveness Analysis of a Triple-Agent Topical Fixed-Dose Combination of 1.2% Clindamycin Phosphate, 0.15% Adapalene, and 3.1% Benzoyl Peroxide Gel for the Treatment of Moderate-to-Severe Acne Vulgaris in the United States
|
Dey, D
|
|
|
27 |
6S |
p. S131
|
artikel
|
| 192 |
EE231 A Cost-Effectiveness Analysis of Intrauterine Spacers Used to Prevent the Formation of Intrauterine Adhesions Following Endometrial Cavity Surgery
|
Martin, C
|
|
|
27 |
6S |
p. S99
|
artikel
|
| 193 |
EE463 A Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab (NIVO+IPI) Vs Pembrolizumab Plus Axitinib (PEM+AXI) for the First-Line Treatment of Intermediate or Poor (I/P)-Risk Advanced Renal Cell Carcinoma Patients in Peru
|
Youn, JH
|
|
|
27 |
6S |
p. S142
|
artikel
|
| 194 |
EE53 A Cost of Illness Analysis of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML) With FLT3 Mutations in Chile: A Public Payer Perspective
|
Ariza, JG
|
|
|
27 |
6S |
p. S66-S67
|
artikel
|
| 195 |
EE142 A Cost Utility Analysis of Zuranolone in the Treatment of Major Depressive Disorder
|
Kim, HS
|
|
|
27 |
6S |
p. S83
|
artikel
|
| 196 |
EE322 Addressing Decision Uncertainty in a Cost-Effectiveness Model of Opioid Use Disorder Treatments: Estimating the Value of Information and the Sample Size to Provide It
|
Rittenhouse, B
|
|
|
27 |
6S |
p. S117
|
artikel
|
| 197 |
EE451 Advancing Economic Evaluation Models in Colorectal Cancer Screening: A Comprehensive Methodological Review
|
Adunlin, G
|
|
|
27 |
6S |
p. S139-S140
|
artikel
|
| 198 |
EE59 Advancing Value of Information Methods: Does Conducting Further Research Directly Translate Into Changes in Clinical Practice, or Do Implementation Rates of Interventions Depend on the Levels and Types of Information Generated?
|
Carrandi, L
|
|
|
27 |
6S |
p. S68
|
artikel
|
| 199 |
EE479 Adverse Event Costs Associated With Systemic Therapies for Metastatic Colorectal Cancer Previously Treated With Standard Therapies and Biologics in the United States, Italy, Portugal, and Spain
|
Hernandez, LG
|
|
|
27 |
6S |
p. S145
|
artikel
|
| 200 |
EE54 A Framework for Evaluating the Economic Impact of Artificial Intelligence for Screening Mammography: Implications for Facilities and Payers from the US Perspective
|
Olsen, J
|
|
|
27 |
6S |
p. S67
|
artikel
|
| 201 |
EE293 A Framework to Assess Uncertainties of Polygenic Risk Scores in Disease Screening and Prevention in Cost-Effectiveness Analyses
|
Jiang, S
|
|
|
27 |
6S |
p. S111
|
artikel
|
| 202 |
EE35 Air Pollution-Related Health Disutility and Mitigation Policy Favorability Amongst California’s San Joaquin Valley Residents: A Health Economics Perspective on Equity
|
Zarate-Gonzalez, G.
|
|
|
27 |
6S |
p. S63
|
artikel
|
| 203 |
EE122 Analyses of Cancer Prevalence and Healthcare Costs for Metastatic and Non-Metastatic Cancers Among Employees Using Claims Data
|
Kansal, AR
|
|
|
27 |
6S |
p. S80
|
artikel
|
| 204 |
EE51 Analysis of Direct Costs of Treating Severe Hemophilia A in Brazil
|
Ozelo, MC
|
|
|
27 |
6S |
p. S66
|
artikel
|
| 205 |
EE24 Analysis of out-of Pocket Payment Associated to Female Infertility in Hungary between 2015-2022
|
Pónusz-Kovács, D.
|
|
|
27 |
6S |
p. S61
|
artikel
|
| 206 |
EE330 Analysis of Public Expenditure of Pharmaceutical Utilization of Female Infertility in Hungary between 2015-2022
|
Pónusz-Kovács, D.
|
|
|
27 |
6S |
p. S118
|
artikel
|
| 207 |
EE362 Analysis of the Cost of Pharmacological Care for Patients With Type 2 Diabetes Mellitus on the Colombian Atlantic Coast: 2019-2022 Risk Cohort Analysis
|
Fernandez, Mercado J
|
|
|
27 |
6S |
p. S124
|
artikel
|
| 208 |
EE353 An Analysis of Stakeholders’ Contribution to High-WAC and Low-WAC Adalimumab Products in 2025 Under the Inflation Reduction Act in the United States
|
Yoo, H
|
|
|
27 |
6S |
p. S122
|
artikel
|
| 209 |
EE409 An Applicable Method to Estimate the Broader Value of Antibiotics: Dynamic Transmission Model
|
Yang, W
|
|
|
27 |
6S |
p. S132
|
artikel
|
| 210 |
EE46 An Early Cost-Effectiveness Analysis of Abelacimab Versus Rivaroxaban, a Standard of Care Direct Oral Anticoagulant (DOAC), in Patients with Atrial Fibrillation Using Preliminary Results from the AZALEA-TIMI 71 Trial
|
Benner, J
|
|
|
27 |
6S |
p. S65
|
artikel
|
| 211 |
EE201 An Economic Model Evaluating the Cost of Nocturia-Related Falls in Older Women in the Community
|
Kelly, T
|
|
|
27 |
6S |
p. S94
|
artikel
|
| 212 |
EE200 An Economic Systematic Literature Review for Hypertrophic Obstructive Cardiomyopathy
|
Krause, T
|
|
|
27 |
6S |
p. S94
|
artikel
|
| 213 |
EE253 An Evaluation of the Prevalence of Diagnosed Opioid Use Disorder and the Economic Burden of Opioid Use Disorder–Related Healthcare Costs in the United States
|
Schoenfeld, AJ
|
|
|
27 |
6S |
p. S103
|
artikel
|
| 214 |
EE232 Annual Health Insurance Treatment Cost of Female Infertility Associated with Male Factors Based on Routinely Collected Financing Data between 2010-2019
|
Pónusz-Kovács, D.
|
|
|
27 |
6S |
p. S99-S100
|
artikel
|
| 215 |
EE287 Annual Treatment Cost of Biologic Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis
|
Hosseini, R
|
|
|
27 |
6S |
p. S110
|
artikel
|
| 216 |
EE96 An “R-Shiny” Tool for Estimating Transition Probabilities From Various Published Literature for Health Economic Models
|
Pandey, S
|
|
|
27 |
6S |
p. S75
|
artikel
|
| 217 |
EE76 Anterior-Based Muscle-Sparing Approach (ABLE) Is Cost-Effective When Compared with Posterolateral and Direct Anterior Approaches for Total Hip Arthroplasties
|
Askew, N
|
|
|
27 |
6S |
p. S71
|
artikel
|
| 218 |
EE448 A Recent Adoption of Cost-Effectiveness Thresholds in Brazil and Its Repercussions
|
Menezes, F
|
|
|
27 |
6S |
p. S139
|
artikel
|
| 219 |
EE228 A Return on Investment Evaluation of the Bariatric Surgery
|
Peng, C
|
|
|
27 |
6S |
p. S98-S99
|
artikel
|
| 220 |
EE393 Assessing Cost-Effectiveness in Diabetes Management: A US Healthcare Payer’s Perspective on 15MG Tirzepatide Versus 1MG Semaglutide
|
Almasuood, R
|
|
|
27 |
6S |
p. S129
|
artikel
|
| 221 |
EE174 Assessing the Cost-Effectiveness of an mRNA-Based Rsv Vaccine (mRNA-1345) Amongst Canadian Adults Aged ≥60 Years
|
Fust, K
|
|
|
27 |
6S |
p. S89-S90
|
artikel
|
| 222 |
EE157 Assessing the Cost-Effectiveness of Sodium Phenylbutyrate/Taurursodiol and Oral Edaravone in the Treatment of Amyotrophic Lateral Sclerosis
|
Suh, K
|
|
|
27 |
6S |
p. S86
|
artikel
|
| 223 |
EE230 Assessing the Fiscal Burden of Obesity Disease in Japan Through Application of a Public Economic Framework
|
Copeland, C
|
|
|
27 |
6S |
p. S99
|
artikel
|
| 224 |
EE379 Assessing Trends in the Distribution of Prescription Claim Payments (2011-2021) and Implications for Retail Pharmacies
|
Johnsrud, M
|
|
|
27 |
6S |
p. S127
|
artikel
|
| 225 |
EE218 Assessment of Unmet Clinical Needs and Healthcare Resource Use Among Statin-Treated Patients with or at Risk of Developing ASCVD
|
Hsieh, A
|
|
|
27 |
6S |
p. S97
|
artikel
|
| 226 |
EE509 Association between Body Mass Index and Medical Cost Among U.S. Adults in 2022
|
Wang, S
|
|
|
27 |
6S |
p. S151
|
artikel
|
| 227 |
EE360 Association Between Public Health Partnership and Telehealth Infrastructure and Medicare Cost and Disparities Among Patients With Depression
|
Chen, J
|
|
|
27 |
6S |
p. S124
|
artikel
|
| 228 |
EE164 A Systematic Review and Meta-Analysis of Economic Burden of Breast Cancer Among Adult Females: Based on the Perspective of Social Development Level and Progression of Disease
|
Han, L
|
|
|
27 |
6S |
p. S88
|
artikel
|
| 229 |
EE114 A Systematic Review of Cost-Effectiveness Analyses of Gene Therapy Treatments for Hemophilia Type A and B
|
Alshehri, A
|
|
|
27 |
6S |
p. S78
|
artikel
|
| 230 |
EE495 A Targeted Literature Review of Lung Function Decline in Idiopathic Pulmonary Fibrosis to Improve Survival Predictions in Cost-Effectiveness Analyses
|
Dong, OM
|
|
|
27 |
6S |
p. S148
|
artikel
|
| 231 |
EE98 A Theory-Based Framework to Incorporate Health Equity in Economic Assessments
|
Subramanian, S
|
|
|
27 |
6S |
p. S75
|
artikel
|
| 232 |
EE68 A UK Cost-Utility Analysis of Ferric Carboxymaltose Versus Ferric Derisomaltose in Patients with Iron Deficiency Anemia and Inflammatory Bowel Disease: Incorporation of Fracture Data
|
Zoller, H
|
|
|
27 |
6S |
p. S69-S70
|
artikel
|
| 233 |
EE296 A United States Payer Budget Impact Analysis of Myocardial Perfusion Imaging Modalities Positron Emission Tomography with Flurpiridaz Compared to Single Photon Emission Computed Tomography in Coronary Artery Disease Diagnosis
|
Priest, S
|
|
|
27 |
6S |
p. S112
|
artikel
|
| 234 |
EE205 Automating Economic Modeling: Potential of Generative AI for Updating Modeling Reports
|
Rawlinson, W
|
|
|
27 |
6S |
p. S95
|
artikel
|
| 235 |
EE168 Avoidable Costs in Patients with Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated with Darolutamide
|
Roa, M
|
|
|
27 |
6S |
p. S88
|
artikel
|
| 236 |
EE112 Baricitinib in Alopecia Areata: A Budget Impact Analysis in Saudi Setting
|
Alshahrani, A
|
|
|
27 |
6S |
p. S78
|
artikel
|
| 237 |
EE56 Bearing the Brunt: Disproportionate Burden Among Female Parent-Caregivers in Rare Disease
|
O'Ruanaidh, K
|
|
|
27 |
6S |
p. S67
|
artikel
|
| 238 |
EE434 Benefits of a Polymer Tip in Torsional Phacoemulsification: A Targeted Literature Search and Budget Impact Model
|
Hsiao, CW
|
|
|
27 |
6S |
p. S136-S137
|
artikel
|
| 239 |
EE109 BoNT-As for Adult Upper Limb Spasticity: Cost of Treatment and Response to Therapy in Canadian Patients
|
Privolnev, Y
|
|
|
27 |
6S |
p. S77
|
artikel
|
| 240 |
EE155 Budget Impact Analysis: Alteplase for Stroke Treatment in Argentina
|
Denamiel, JP
|
|
|
27 |
6S |
p. S86
|
artikel
|
| 241 |
EE277 Budget Impact Analysis of Anaprazole for the Treatment of Duodenal Ulcer in China
|
Shi, J
|
|
|
27 |
6S |
p. S108
|
artikel
|
| 242 |
EE11 Budget Impact Analysis of a Triple-Agent Fixed-Dose Combination of 1.2% Clindamycin Phosphate, 0.15% Adapalene, and 3.1% Benzoyl Peroxide Topical Gel for the Treatment of Patients With Moderate-to-Severe Acne Vulgaris in the US
|
Thomas, A
|
|
|
27 |
6S |
p. S59
|
artikel
|
| 243 |
EE267 Budget Impact Analysis of Introducing Fruquintinib for the Treatment of Previously Treated Metastatic Colorectal Cancer in the United States From the Payer Perspective
|
Hernandez, LG
|
|
|
27 |
6S |
p. S106
|
artikel
|
| 244 |
EE134 Budget Impact Analysis of Machine Learning Models for Diagnosing Alzheimer's Dementia
|
Frazer, C
|
|
|
27 |
6S |
p. S82
|
artikel
|
| 245 |
EE199 Budget Impact Analysis of the Anti-Vegfs Injections for Treating Diabetic Macular Oedema: Assessing Their Affordability in the UK Healthcare System
|
Mahmoud, F
|
|
|
27 |
6S |
p. S93-S94
|
artikel
|
| 246 |
EE320 Budget Impact Analysis of TPMT and NUDT15 Pharmacogenomic Testing for 6-Mercaptopurine in Pediatric Acute Lymphocytic Leukemia Patients
|
Fuerte, B
|
|
|
27 |
6S |
p. S116
|
artikel
|
| 247 |
EE190 Budget Impact Analysis of Zanubrutinib + Obinutuzumab for the Treatment of Relapsed or Refractory Follicular Lymphoma in the United States
|
Gaballa, S
|
|
|
27 |
6S |
p. S92
|
artikel
|
| 248 |
EE321 Budget Impact Model for Dasiglucagon in the Prevention and Treatment of Hypoglycemia in Pediatric Patients with Congenital Hyperinsulinism in the United States
|
Kloster, B
|
|
|
27 |
6S |
p. S116
|
artikel
|
| 249 |
EE116 Budget Impact Model Framework of Positron Emission Tomography Compared to Single Photon Emission Computed Tomography Myocardial Perfusion Imaging for Coronary Artery Disease Diagnosis
|
Walczyk, Mooradally A
|
|
|
27 |
6S |
p. S79
|
artikel
|
| 250 |
EE428 Budget Impact of Elranatamab-bcmm in Patients with Relapsed or Refractory Multiple Myeloma (RRMM) in the United States
|
Shah, B
|
|
|
27 |
6S |
p. S136
|
artikel
|
| 251 |
EE84 Budget Impact of Factor VIII Treatments for Hemophilia A in the United States
|
Q(, Fan
|
|
|
27 |
6S |
p. S73
|
artikel
|
| 252 |
EE247 Budget Impact of Infliximab Subcutaneous from the US Healthcare Perspective
|
Yoo, H
|
|
|
27 |
6S |
p. S102
|
artikel
|
| 253 |
EE245 Budget Impact of Inotersen for the Treatment of Stage I or II Polyneuropathy in Adult Patients With Hereditary Transthyretin Amyloidosis (hATTR) in Public Health Mexico
|
Soto, H
|
|
|
27 |
6S |
p. S102
|
artikel
|
| 254 |
EE329 Budget Impact of Low-Dose Computed Tomography Screening for Lung Cancer in Argentina
|
Silvestrini, Viola C
|
|
|
27 |
6S |
p. S118
|
artikel
|
| 255 |
EE333 Budget Impact of Oral Nirmatrelvir/Ritonavir in Patients at High Risk for Progression to Severe COVID-19 in the U.S.: An Updated Analysis
|
Campbell, D
|
|
|
27 |
6S |
p. S119
|
artikel
|
| 256 |
EE471 Budget Impact of Pirtobrutinib for Patients With Mantle Cell Lymphoma (MCL) or Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) in the United States (US)
|
Winfree, KB
|
|
|
27 |
6S |
p. S143
|
artikel
|
| 257 |
EE217 Budget Impact of RSVpreF Maternal Vaccine Among Pregnant Women for Prevention of Respiratory Syncytial Virus Among Privately Insured Infants in Dubai, UAE
|
Zayed, M
|
|
|
27 |
6S |
p. S97
|
artikel
|
| 258 |
EE403 Budget Impact of Selinexor Combination Regimens in Previously Treated Multiple Myeloma
|
Carter, JA
|
|
|
27 |
6S |
p. S131
|
artikel
|
| 259 |
EE500 Budget Impact of Subcutaneous Immunoglobulin, Intravenous Immunoglobulin, and Efgartigimod Alfa in Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in the United States
|
Mallick, R
|
|
|
27 |
6S |
p. S149
|
artikel
|
| 260 |
EE482 Building Better Models: A Simulation Case Study Demonstrating the Crucial Role of Ergodicity in Building Robust Markov Chains
|
Cornell, M
|
|
|
27 |
6S |
p. S145
|
artikel
|
| 261 |
EE335 Burden of Disease in Patients Who Are Eligible for Bcma-Targeted Immunotherapy for Multiple Myeloma: A Retrospective Claims Database Analysis
|
Giri, S
|
|
|
27 |
6S |
p. S119
|
artikel
|
| 262 |
EE133 Burden of Illness for Adults Living With Primary Chronic Immune Thrombocytopenia in the United States
|
Arvin-Berod, C.
|
|
|
27 |
6S |
p. S82
|
artikel
|
| 263 |
EE18 Burden of Illness for Adults With Chronic Inflammatory Demyelinating Polyneuropathy in the United States
|
Guptill, JG
|
|
|
27 |
6S |
p. S60
|
artikel
|
| 264 |
EE355 Can Large Language Models Generate Conceptual Health Economic Models?
|
Chhatwal, J
|
|
|
27 |
6S |
p. S123
|
artikel
|
| 265 |
EE259 Care-Seeking Pattern and Costs of Health Services in Individuals with Multiple Chronic Conditions
|
Cheng, JS
|
|
|
27 |
6S |
p. S105
|
artikel
|
| 266 |
EE2 Challenges of Evaluating and Modelling Vaccination for Prevention of Dengue Illness in United Kingdom (UK) Travelers: A Systematic Literature Review (SLR)
|
Famuboni, A
|
|
|
27 |
6S |
p. S57
|
artikel
|
| 267 |
EE385 Changes in Direct Costs of Breast Cancer in Colombia From 2011 to 2022
|
Vargas, R
|
|
|
27 |
6S |
p. S128
|
artikel
|
| 268 |
EE263 Characterization of End-Stage Kidney Disease Patients With and Without Autosomal Dominant Polycystic Kidney Disease and Receiving Kidney Transplantation in the United States
|
Clark, L
|
|
|
27 |
6S |
p. S105
|
artikel
|
| 269 |
EE229 Characterizing the Clinical and Economic Burden of COVID-19 Among Individuals with Immunocompromising Conditions in Ontario, Canada – A Matched, Population-Based Observational Study
|
Qian, C
|
|
|
27 |
6S |
p. S99
|
artikel
|
| 270 |
EE144 Chimerism Testing for Patients With Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: A Cost-Utility Analysis
|
Fulcher, J
|
|
|
27 |
6S |
p. S84
|
artikel
|
| 271 |
EE368 Claims-Based Comparison of Characteristics and Healthcare Costs Between Mothers With and Without Postpartum Depression
|
Evans, KA
|
|
|
27 |
6S |
p. S125
|
artikel
|
| 272 |
EE151 Clinical and Economic Benefits of Adjuvanted and High-Dose Influenza Vaccines in the Elderly in Argentina
|
Giglio, N
|
|
|
27 |
6S |
p. S85
|
artikel
|
| 273 |
EE135 Clinical and Economic Burden of Obesity in Low- and Middle-Income Countries: A Systematic Review
|
Fatoye, F
|
|
|
27 |
6S |
p. S82
|
artikel
|
| 274 |
EE115 Clinical and Economic Impact of Glucagon-like Peptide-1 Agonists in Patients with Obstructive Sleep Apnea: An Exploratory Analysis
|
Moreno-Calderón, A.
|
|
|
27 |
6S |
p. S78-S79
|
artikel
|
| 275 |
EE138 Clinical and Economic Value of a Biosimilar Portfolio to Stakeholders: A Conceptual Framework
|
Fox, GE
|
|
|
27 |
6S |
p. S82-S83
|
artikel
|
| 276 |
EE484 Clinical and Healthcare Resource Burden of Disease in Patients With Lennox-Gastaut Syndrome (LGS): Results From a US Claims Matched-Control Analysis
|
Lu, M
|
|
|
27 |
6S |
p. S145-S146
|
artikel
|
| 277 |
EE331 Clinical and Health Outcomes Associated With Different Treatment Sequences for Moderate-to-Severe Ulcerative Colitis
|
Paul, D
|
|
|
27 |
6S |
p. S118
|
artikel
|
| 278 |
EE91 Clinical Consequences and Associated Costs of Treating Patients With Chronic Lymphocytic Leukemia (CLL) With Bruton Tyrosine Kinase Inhibitors (BTKis) in the First-Line (1L) and Relapsed/Refractory (R/R) Settings
|
Crawford, S
|
|
|
27 |
6S |
p. S74
|
artikel
|
| 279 |
EE506 Clinical Consequences and Associated Costs of Treating Patients With Waldenström Macroglobulinemia in the First-Line Setting With Bruton Tyrosine Kinase Inhibitors
|
Crawford, S
|
|
|
27 |
6S |
p. S150
|
artikel
|
| 280 |
EE525 Comparative Analysis of Launch Prices for Orphan Drugs in the US and EU4
|
Mietus, Z
|
|
|
27 |
6S |
p. S152-S153
|
artikel
|
| 281 |
EE381 Comparative Analysis of Patient Outcomes and Hospital Costs: Robotic-Assisted Surgery Versus Conventional Laparoscopic Surgery Across Five Procedures
|
Sosa, M
|
|
|
27 |
6S |
p. S127
|
artikel
|
| 282 |
EE146 Comparative Analysis of the Burden of Illness Among Juvenile Idiopathic Inflammatory Myopathy Versus Juvenile Idiopathic Arthritis in the United States
|
Xenakis, J
|
|
|
27 |
6S |
p. S84
|
artikel
|
| 283 |
EE1 Comparative Cost-Effectiveness Analysis of Interventions for Perinatal Methamphetamine Use Disorder: A Decision Modeling Method
|
Tawfik, AG
|
|
|
27 |
6S |
p. S57
|
artikel
|
| 284 |
EE528 Comparative Effectiveness Modeling of an Anti-Pd-1 Antibody Drug Intervention for Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in the U.S.
|
Ventura, N
|
|
|
27 |
6S |
p. S153
|
artikel
|
| 285 |
EE402 Comparing the Expenditure and Health-Related Quality of Life between SGLT2 Inhibitors and GLP-1 Agonists
|
Hu, S
|
|
|
27 |
6S |
p. S130-S131
|
artikel
|
| 286 |
EE36 Comparison of Healthcare Resource Utilization and Costs in Patients With Venous Thromboembolism Receiving Direct-Acting Oral Anticoagulants or Low Molecular Weight Heparins: A Real-World Data Analysis
|
Okoye, G
|
|
|
27 |
6S |
p. S63
|
artikel
|
| 287 |
EE202 Conceptualization and Validation of a Health Economic Model for Osteogenesis Imperfecta
|
Edmonds, T
|
|
|
27 |
6S |
p. S94
|
artikel
|
| 288 |
EE246 Consideration of the Cost of Adverse Events for Oncology Treatment: A Review of Cost-Effectiveness Evaluations in Japan
|
Onishi, H
|
|
|
27 |
6S |
p. S102
|
artikel
|
| 289 |
EE22 COPD-Related Healthcare Resource Utilization Before and After Initiating Inhaled Corticosteroid-Containing Maintenance Regimens: Real World Claims Data
|
Siddharthan, T
|
|
|
27 |
6S |
p. S60-S61
|
artikel
|
| 290 |
EE426 Cost-Comparison Analysis of Non-Invasive Testing Strategies for Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Veteran Population
|
Boltyenkov, A
|
|
|
27 |
6S |
p. S135
|
artikel
|
| 291 |
EE372 Cost-Effectiveness Analyses of Continuous Renal Replacement Therapy (CRRT) System in Health Care System in LMIC/LATAM/Brazil
|
Santos, LDS
|
|
|
27 |
6S |
p. S126
|
artikel
|
| 292 |
EE325 Cost-Effectiveness Analyses of Immune Checkpoint Inhibitors in Renal Cell Carcinoma: A Scoping Review
|
Tugwete, C
|
|
|
27 |
6S |
p. S117
|
artikel
|
| 293 |
EE206 Cost-Effectiveness Analysis for Acalabrutinib in the Treatment of Patients With Relapsed/Refractory Mantle Cell Lymphoma (r/r MCL) in China
|
Chang, S
|
|
|
27 |
6S |
p. S95
|
artikel
|
| 294 |
EE106 Cost-Effectiveness Analysis of Belimumab for the Treatment of Adults With Active Lupus Nephritis in China
|
Wu, B
|
|
|
27 |
6S |
p. S77
|
artikel
|
| 295 |
EE275 Cost-Effectiveness Analysis of Biologics Used for the Treatment of Ankylosing Spondylitis in China
|
Shi, J
|
|
|
27 |
6S |
p. S108
|
artikel
|
| 296 |
EE279 Cost-Effectiveness Analysis of Biosimilars and Novel Biologics for Patients With Moderate-to-Severe Psoriasis
|
Leong, NW
|
|
|
27 |
6S |
p. S108-S109
|
artikel
|
| 297 |
EE289 Cost-Effectiveness Analysis of Blinatumomab for Advanced Acute Lymphoblastic Leukemia in Japan
|
Ozeki, S
|
|
|
27 |
6S |
p. S111
|
artikel
|
| 298 |
EE13 Cost-Effectiveness Analysis of Duodenal–Jejunal Bypass Sleeve Device for People With Obesity
|
Xu, Q
|
|
|
27 |
6S |
p. S59
|
artikel
|
| 299 |
EE455 Cost-Effectiveness Analysis of Elacestrant in ER+/HER2- Advanced Breast Cancer Patient from US Payer Perspective
|
Chan, H
|
|
|
27 |
6S |
p. S140
|
artikel
|
| 300 |
EE488 Cost-Effectiveness Analysis of Faricimab and Others Treatment Schemes for Diabetic Macular Edema and Age-Related Macular Degeneration
|
Figallo, M
|
|
|
27 |
6S |
p. S146
|
artikel
|
| 301 |
EE332 Cost-Effectiveness Analysis of Implementing a Field Hospital during a Pandemic
|
Tavares, Malheiro D
|
|
|
27 |
6S |
p. S118-S119
|
artikel
|
| 302 |
EE19 Cost-Effectiveness Analysis of Infliximab, Adalimumab, and Certolizumab for Crohn's Disease: A Markov Model Study
|
Ajala, C
|
|
|
27 |
6S |
p. S60
|
artikel
|
| 303 |
EE152 Cost-Effectiveness Analysis of Infliximab Versus Cyclosporine in Steroid-Refractory Acute Severe Ulcerative Colitis
|
Luong, J
|
|
|
27 |
6S |
p. S85
|
artikel
|
| 304 |
EE274 Cost-Effectiveness Analysis of Large-Scale Screening for Celiac Disease in the Pediatric Population
|
Corrado, M
|
|
|
27 |
6S |
p. S107-S108
|
artikel
|
| 305 |
EE284 Cost-Effectiveness Analysis of Larotrectinib and Entrectinib for Adult Patients with NTRK Gene Fusion-Positive Breast Cancer
|
Dheer, P
|
|
|
27 |
6S |
p. S110
|
artikel
|
| 306 |
EE105 Cost-Effectiveness Analysis of Linperlisib for Relapsed or Refractory Follicular Lymphoma Based on Matching Adjusted Indirect Comparison in China
|
Bai, X
|
|
|
27 |
6S |
p. S77
|
artikel
|
| 307 |
EE395 Cost-Effectiveness Analysis of Nivolumab Plus Relatlimab (NIVO+RELA) Versus Current Standard of Care (SOC) for Patients with Unresectable or Metastatic Melanoma in Canada
|
Mameri, E
|
|
|
27 |
6S |
p. S130
|
artikel
|
| 308 |
EE283 Cost-Effectiveness Analysis of NRICM101 Compared to Usual Care for Treating COVID-19
|
Chen, PJ
|
|
|
27 |
6S |
p. S109
|
artikel
|
| 309 |
EE204 Cost-Effectiveness Analysis of Patient Self-Management for Managing Warfarin in Patients with Non-Valvular Atrial Fibrillation in the US
|
Kategeaw, W
|
|
|
27 |
6S |
p. S94-S95
|
artikel
|
| 310 |
EE81 Cost-Effectiveness Analysis of Pegmolesatide Compared to Darbepoetin in Patients With Anemia Caused by Chronic Kidney Disease: The Case of China
|
Zhang, P
|
|
|
27 |
6S |
p. S72
|
artikel
|
| 311 |
EE66 Cost-Effectiveness Analysis of Pembrolizumab + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer in Japan
|
Akai, M
|
|
|
27 |
6S |
p. S69
|
artikel
|
| 312 |
EE508 Cost-Effectiveness Analysis of Pembrolizumab for Advanced Colorectal Cancer with MSI-High or dMMR in Japan
|
Taniguchi, S
|
|
|
27 |
6S |
p. S150-S151
|
artikel
|
| 313 |
EE278 Cost-Effectiveness Analysis of Premature Infant Oral Motor Intervention (PIOMI) in the Neonatal Intensive Care Unit in Colombia, 2022
|
Eusse-Solano, P.A.
|
|
|
27 |
6S |
p. S108
|
artikel
|
| 314 |
EE294 Cost-Effectiveness Analysis of the Implementation of Single-Dose Vitamin D, Omega 3, or Co-Supplementation on Individuals with PCOS
|
Olin, S
|
|
|
27 |
6S |
p. S111-S112
|
artikel
|
| 315 |
EE492 Cost-Effectiveness Analysis of the Use of Negative Pressure Wound Therapy in the Treatment of Diabetic Foot Disease in Colombia
|
Olivares-Cerpa, F.
|
|
|
27 |
6S |
p. S147
|
artikel
|
| 316 |
EE504 Cost-Effectiveness Analysis of Tremelimumab As First-Line Therapy for Metastatic Non-Small Cell Lung Cancer in Japan
|
Sakai, R
|
|
|
27 |
6S |
p. S150
|
artikel
|
| 317 |
EE215 Cost-Effectiveness Analysis of Turoctocog Alfa Pegol in Patients With Hemophilia A Without Inhibitors in Colombia
|
Moreno-Calderón, A.
|
|
|
27 |
6S |
p. S96
|
artikel
|
| 318 |
EE309 Cost-Effectiveness Analysis of Velmanase Alfa in Patients with Alpha Mannosidosis from a UK Health Service Perspective
|
Stevenson, A
|
|
|
27 |
6S |
p. S114
|
artikel
|
| 319 |
EE350 Cost-Effectiveness Analysis of Xigduo (EXTENDED-RELEASE DAPAGLIFLOZIN-METFORMIN TABLETS) for Managing Type 2 Diabetes Mellitus (T2DM) Patients
|
Bao, H
|
|
|
27 |
6S |
p. S122
|
artikel
|
| 320 |
EE63 Cost-Effectiveness and Budget Impact of Pembrolizumab Monotherapy As the First-Line Treatment for Metastatic Non-Small Cell Lung Cancer Patients with PD-L1 ≥ 50% in Thailand
|
Thamlikitkul, L
|
|
|
27 |
6S |
p. S68-S69
|
artikel
|
| 321 |
EE167 Cost-Effectiveness Evaluations of CAR-T Cell Therapies By Health Technology Assessment Agencies
|
Dorneles, G
|
|
|
27 |
6S |
p. S88
|
artikel
|
| 322 |
EE3 Cost Effectiveness Model on Four Preventive Treatment for Clostridioides Difficile Infection Recurrence From a US Payer Perspective
|
Gómez-Lumbreras, A.
|
|
|
27 |
6S |
p. S57
|
artikel
|
| 323 |
EE441 Cost-Effectiveness of a Comprehensive Team-Based Intervention for Pregnant Women with Diabetes: A Markov Cohort Study
|
Gupta, D
|
|
|
27 |
6S |
p. S137-S138
|
artikel
|
| 324 |
EE485 Cost-Effectiveness of Active Surveillance for Incidentally Detected Early-Staged Papillary Thyroid Cancer: A Microsimulation Study
|
Li, M
|
|
|
27 |
6S |
p. S146
|
artikel
|
| 325 |
EE440 Cost-Effectiveness of Adjuvanted RSVPreF3 Vaccination in Adults Aged 50-59 Years With Cardiopulmonary Diseases in the United States
|
Singer, D
|
|
|
27 |
6S |
p. S137
|
artikel
|
| 326 |
EE317 Cost-Effectiveness of Adjuvant Olaparib in Germline BRCA1/2-Mutated, High-Risk, Human Epidermal Growth Factor-2-Negative Early Breast Cancer: A Canadian Perspective
|
Parackal, A
|
|
|
27 |
6S |
p. S115-S116
|
artikel
|
| 327 |
EE33 Cost-Effectiveness of Aducanumab, Lecanemab, and Donanemab for Early Alzheimer Disease in the US
|
Haile, F
|
|
|
27 |
6S |
p. S63
|
artikel
|
| 328 |
EE88 Cost-Effectiveness of Apixaban Compared to Warfarin, Dabigatran and Rivaroxaban in Patients with Nonvalvular Atrial Fibrillation: Results for High-Risk Patient Subgroups Based on the Aristophanes Real-World Evidence Study
|
Spalding, C
|
|
|
27 |
6S |
p. S73-S74
|
artikel
|
| 329 |
EE364 Cost-Effectiveness of Artificial-Intelligence Enabled Kidney Disease Risk Stratification in US Veterans With Early-Stage Diabetic Kidney Disease
|
Sarker, J
|
|
|
27 |
6S |
p. S124-S125
|
artikel
|
| 330 |
EE319 Cost-Effectiveness of Assigning Early Interventions to Infants at High Risk for Autism Spectrum Disorder Using MRI Screening
|
Seibert-Jeffrey, A.
|
|
|
27 |
6S |
p. S116
|
artikel
|
| 331 |
EE312 Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Stabilized Prefusion F Subunit Vaccine (RSVpreF) in Pregnant Individuals for the Prevention of Respiratory Tract Disease (RTD) Caused by RSV Among Infants in Canada
|
Goyette, A
|
|
|
27 |
6S |
p. S114
|
artikel
|
| 332 |
EE27 Cost-Effectiveness of Chondroitin Sulfate Plus Glucosamine Versus Celecoxib for Moderate To Severe Knee Osteoarthritis
|
Eriakha, E
|
|
|
27 |
6S |
p. S62
|
artikel
|
| 333 |
EE281 Cost-Effectiveness of Every Two Month Cabotegravir Long-Acting (CAB-LA) for Pre-Exposure Prophylaxis (PREP) Compared with Daily Oral Tenofovir Disoproxil Fumarate (TDF)/ Emtricitabine (FTC) As Prep to Prevent HIV-1 in the UK
|
O'Brien, P
|
|
|
27 |
6S |
p. S109
|
artikel
|
| 334 |
EE256 Cost-Effectiveness of Ferric Carboxymaltose in the Treatment of Iron-Deficiency Anemia in Pregnant Women
|
Alves, Junior JM
|
|
|
27 |
6S |
p. S104
|
artikel
|
| 335 |
EE349 Cost-Effectiveness of First-Line Treatment With Pembrolizumab for Unresectable or Metastatic MSI-H/dMMR Colorectal Cancer (CRC) in the United States Based on 5-Year Follow-up Data
|
McCarthy, G
|
|
|
27 |
6S |
p. S121-S122
|
artikel
|
| 336 |
EE264 Cost-Effectiveness of GLP-1 Medications in Non-Diabetic Obesity Population
|
Lin, LY
|
|
|
27 |
6S |
p. S105-S106
|
artikel
|
| 337 |
EE179 Cost Effectiveness of Mastectomies of BRCA1 and BRCA2 Positive Women over Olaparib
|
Stephen, BL
|
|
|
27 |
6S |
p. S91
|
artikel
|
| 338 |
EE300 Cost Effectiveness of Momelotinib Vs Other Treatments for Myelofibrosis from a US Payer Perspective
|
Liu, T
|
|
|
27 |
6S |
p. S112
|
artikel
|
| 339 |
EE29 Cost-Effectiveness of Niraparib Plus Abiraterone Acetate and Prednisone for Metastatic Castration-Resistant Prostate Cancer
|
Duru, E
|
|
|
27 |
6S |
p. S62
|
artikel
|
| 340 |
EE315 Cost-Effectiveness of Obicetrapib As Adjunctive Therapy Compared to Maximally Tolerated Statins for Lowering LDL-c
|
Davidson, D
|
|
|
27 |
6S |
p. S115
|
artikel
|
| 341 |
EE223 Cost-Effectiveness of Olorofim in Invasive Aspergillosis Patients Lacking Suitable Alternative Treatment Options from a US Payer Perspective
|
Walsh, T
|
|
|
27 |
6S |
p. S98
|
artikel
|
| 342 |
EE141 Cost-Effectiveness of Pembrolizumab for Adjuvant Treatment of Patients With Renal-Cell Carcinoma Who Have Undergone Nephrectomy in Colombia
|
Urrego-Reyes, J.
|
|
|
27 |
6S |
p. S83
|
artikel
|
| 343 |
EE391 Cost-Effectiveness of Radar: An Innovative Model to Organize Diabetes Care in First Nations Communities in Canada
|
Ghule, P
|
|
|
27 |
6S |
p. S129
|
artikel
|
| 344 |
EE65 Cost-Effectiveness of Remote Patient Monitoring for Hypertension Management Among Older Adults with Hypertension: A Semi-Markov Modeling Study
|
Acharya, M
|
|
|
27 |
6S |
p. S69
|
artikel
|
| 345 |
EE416 Cost-Effectiveness of Sulbactam-Durlobactam Compared to Colistin in Treating Carbapenem-Resistant Acinetobacter Baumannii Infections in Critical Care Setting in the United States: A Decision Analysis
|
Ologunowa, A
|
|
|
27 |
6S |
p. S133
|
artikel
|
| 346 |
EE123 Cost-Effectiveness of the Brexu-Cel in Relapsed/Refractory Mantle Cell Lymphoma and B-Cell Acute Lymphoblastic Leukemia: A Systematic Review
|
Khatiwada, A
|
|
|
27 |
6S |
p. S80
|
artikel
|
| 347 |
EE86 Cost-Effectiveness of Tivozanib in Advanced Renal Cell Carcinoma in the US
|
Ta, R
|
|
|
27 |
6S |
p. S73
|
artikel
|
| 348 |
EE258 Cost-Effectiveness of Transcatheter Aortic Valve Implantation (TAVI) for High-Risk Patients in Chile
|
Paredes, D
|
|
|
27 |
6S |
p. S104
|
artikel
|
| 349 |
EE520 Cost-Effectiveness of Tremelimumab Plus Durvalumab for the First-Line Treatment of Patients with Unresectable Hepatocellular Carcinoma in the United States
|
Xiong, X
|
|
|
27 |
6S |
p. S152
|
artikel
|
| 350 |
EE103 Cost-Effectiveness of Universal Newborn Screening for Spinal Muscular Atrophy With Disease-Modifying Therapies in Taiwan
|
Chiang, W
|
|
|
27 |
6S |
p. S76
|
artikel
|
| 351 |
EE61 Cost-Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine in Mexican Adults Population
|
Huerta, JL
|
|
|
27 |
6S |
p. S68
|
artikel
|
| 352 |
EE411 Cost-Effectiveness of Venetoclax in Combination with Azacitidine in Unfit Patients With Previously Untreated Acute Myeloid Leukemia in China
|
Wu, Y
|
|
|
27 |
6S |
p. S132
|
artikel
|
| 353 |
EE468 Cost-Effectiveness Study of the Use of Fibrinogen Concentrate (Clottafact®) in Patients with Major Bleeding and Trauma Requiring Surgery in Mexican Public Health Institutions
|
Gay, Molina J
|
|
|
27 |
6S |
p. S142-S143
|
artikel
|
| 354 |
EE449 Cost-Effectiveness Thresholds Around the World: How Brazil Positions Itself Compared to Other Countries
|
Laranjeira, F
|
|
|
27 |
6S |
p. S139
|
artikel
|
| 355 |
EE282 Cost-Equalization Approach to Estimate the Minimum Duration of Effect of Cell and Gene Therapies to Demonstrate Cost Savings to Payors: A Methodological Approach Using Late-Onset Pompe Disease
|
Quon, P
|
|
|
27 |
6S |
p. S109
|
artikel
|
| 356 |
EE196 Cost-Minimization Analysis on Vaccination Strategies of DTaP-Containing Combination Vaccines: Evidence from China
|
Wang, S
|
|
|
27 |
6S |
p. S93
|
artikel
|
| 357 |
EE153 Cost-Minimization of Oral Valganciclovir Vs Intravenous Ganciclovir for Cytomegalovirus Prophylaxis in Renal Transplant Recipients
|
Alves, Junior JM
|
|
|
27 |
6S |
p. S85
|
artikel
|
| 358 |
EE496 Cost of Anti-CD38 Monoclonal Antibodies in Combination With Carfilzomib and Dexamethasone for Relapsed Refractory Multiple Myeloma
|
Lin, P
|
|
|
27 |
6S |
p. S148
|
artikel
|
| 359 |
EE14 Cost of Care Comparison of Elranatamab-bcmm and Teclistamab-cqyv in Adult Patients with Relapsed or Refractory Multiple Myeloma (RRMM)
|
Shah, B
|
|
|
27 |
6S |
p. S59
|
artikel
|
| 360 |
EE476 Cost of COVID-19 Vaccine Delivery Integration into Routine Immunization and Service Delivery in South Africa
|
Matsela, L
|
|
|
27 |
6S |
p. S144
|
artikel
|
| 361 |
EE415 Cost of Hypoglycemia Among Hospitalized Patients With Diabetes Mellitus
|
Naser, A
|
|
|
27 |
6S |
p. S133
|
artikel
|
| 362 |
EE47 Cost Per Recurrence-Free Survivor (CPRS) and Cost Per Recurrence-Free Life Month (CPRLM) of Adjuvant Nivolumab (NIVO) Versus Pembrolizumab (PEMBRO) Among Patients With Resected Stage IIB/IIC Melanoma
|
Davis, JM
|
|
|
27 |
6S |
p. S65
|
artikel
|
| 363 |
EE219 Cost per Responder for FcRn Inhibitors for Generalized Myasthenia Gravis
|
Betts, A
|
|
|
27 |
6S |
p. S97
|
artikel
|
| 364 |
EE255 Costs and Healthcare Resource Utilization Evaluation in Myotonic Dystrophy Type 1: Results from the Real-World Care-DM1 Study
|
Hamel, J
|
|
|
27 |
6S |
p. S104
|
artikel
|
| 365 |
EE261 Costs and Outcomes Associated with COVID-19 Hospitalisation in the South African Public-Sector during the First-Wave
|
Govender, K
|
|
|
27 |
6S |
p. S105
|
artikel
|
| 366 |
EE20 Cost Saving Analysis of Implementing Subcutaneous Formulation of Atezolizumab in a Danish Context (CS-ASSIST)
|
Beck, C
|
|
|
27 |
6S |
p. S60
|
artikel
|
| 367 |
EE375 Cost Savings and the Opportunity for Expanded Treatment Access with Increased Use of Biosimilar Adalimumab in the United States
|
Shastri, K
|
|
|
27 |
6S |
p. S126
|
artikel
|
| 368 |
EE131 Cost Savings Associated With Use of 3D Heads-up Display (3D-HUD) in Macular Hole Surgeries: An Academic Hospital Perspective
|
Siegfried, C
|
|
|
27 |
6S |
p. S81
|
artikel
|
| 369 |
EE314 Costs of Transcatheter Versus Surgical Aortic Valve Replacement in Brazil
|
Etges, AP
|
|
|
27 |
6S |
p. S115
|
artikel
|
| 370 |
EE523 Costs Per Responder With Venetoclax in Combination With Azacitidine in Unfit Patients With Previously Untreated Acute Myeloid Leukemia in China
|
Xu, H
|
|
|
27 |
6S |
p. S152
|
artikel
|
| 371 |
EE169 Cost to Achieve Seizures Reduction or Seizure Freedom in Dravet Syndrome in the USA: An Analysis Based on NNT (NUMBER NEEDED TO TREAT) of Stiripentol, Fenfluramine and Cannabidiol
|
Fourcroy, M
|
|
|
27 |
6S |
p. S89
|
artikel
|
| 372 |
EE383 Cost-Utility Analysis of Adapted Problem Adaptation Therapy for Depression in Mild to Moderate Dementia Caused by Alzheimer's Disease: Pathfinder Randomized Controlled Trial
|
Panca, M
|
|
|
27 |
6S |
p. S127-S128
|
artikel
|
| 373 |
EE270 Cost-Utility Analysis of Add-on Stiripentol Vs Cannabidiol and Vs Fenfluramine in Dravet Syndrome in the USA
|
Weston, G
|
|
|
27 |
6S |
p. S107
|
artikel
|
| 374 |
EE302 Cost-Utility Analysis of Eptinezumab Versus Erenumab for Episodic Migraine Headaches Patients in the United States
|
Dong, W
|
|
|
27 |
6S |
p. S113
|
artikel
|
| 375 |
EE198 Cost-Utility of Belimumab in Treating Lupus Nephritis: A Brazilian Private Healthcare System Perspective
|
Silva, D
|
|
|
27 |
6S |
p. S93
|
artikel
|
| 376 |
EE128 Customer Service Analytics Improve Health Outcomes at Blue Cross and Blue Shield of Louisiana
|
Cannon, C
|
|
|
27 |
6S |
p. S81
|
artikel
|
| 377 |
EE288 Decision Model to Evaluate the Cost of Clinical Events Associated with Switching from Apixaban to Rivaroxaban Among Patients with Non-Valvular Atrial Fibrillation in Germany
|
Subash, R
|
|
|
27 |
6S |
p. S110-S111
|
artikel
|
| 378 |
EE188 Decision Model to Evaluate the Cost of Clinical Events Associated with Switching from Apixaban to Rivaroxaban Among Patients with Non-Valvular Atrial Fibrillation in the United States
|
Subash, R
|
|
|
27 |
6S |
p. S92
|
artikel
|
| 379 |
EE324 Describing the Clinical and Economic Burden of Women Diagnosed With Uterine Fibroid (UF) and Heavy Menstrual Bleeding (HMB) in a United States (US) Commercial Database 2015-2022
|
McKain, L
|
|
|
27 |
6S |
p. S117
|
artikel
|
| 380 |
EE32 Determining the Expected Pricing Advantage of First-in-Indication and First-in-Class Non-Oncology Orphan Products
|
Donnelly, E
|
|
|
27 |
6S |
p. S62
|
artikel
|
| 381 |
EE420 Development and Validation of a Markov Model for the Evaluation of a One-Time Universal Screening for Hepatitis B in Adults
|
Pan, A
|
|
|
27 |
6S |
p. S134
|
artikel
|
| 382 |
EE342 Development of a Markov Model for Assessing the Cost-Effectiveness of Chronic Weight Management Interventions
|
Richard, E
|
|
|
27 |
6S |
p. S120
|
artikel
|
| 383 |
EE227 Development of a Tool for Quality Assessment of Health Economic Evaluations
|
Borges, Migliavaca C
|
|
|
27 |
6S |
p. S98
|
artikel
|
| 384 |
EE90 Diagnostic Yield and Downstream Lung Cancer Treatment Revenue From Shape-Sensing Robotic-Assisted Bronchoscopy Compared to Transthoracic Needle Aspiration Biopsy
|
Wing, S
|
|
|
27 |
6S |
p. S74
|
artikel
|
| 385 |
EE73 Direct Healthcare Costs Associated With Primary Symptomatic Cytomegalovirus in the United States
|
Georgieva, M
|
|
|
27 |
6S |
p. S70-S71
|
artikel
|
| 386 |
EE269 Direct Medical Costs in Patients with Metastatic Hormone Sensitive Prostate Cancer (mHSPC) in Colombia
|
Roa, M
|
|
|
27 |
6S |
p. S106-S107
|
artikel
|
| 387 |
EE328 Direct Medical Costs in Patients with Non-Metastatic Castration Resistant Prostate Cancer (nmCRPC) in Colombia
|
López-Cabra, C.
|
|
|
27 |
6S |
p. S118
|
artikel
|
| 388 |
EE430 Does One Comparator Fit All Scenarios? An Example from the Institute for Clinical and Economic Review’s 2023 Assessment of Relapsing-Remitting Multiple Sclerosis
|
Rittenhouse, B
|
|
|
27 |
6S |
p. S136
|
artikel
|
| 389 |
EE260 Economic Analysis of a Low-Threshold Mobile Medical Unit Dispensing Buprenorphine for Opioid Use Disorder
|
Shah, KK
|
|
|
27 |
6S |
p. S105
|
artikel
|
| 390 |
EE16 Economic Analysis of the Impact of Delandistrogene Moxeparvovec Gene Therapy on Work Opportunity in Caregivers of Individuals with Duchenne Muscular Dystrophy
|
Innis, B
|
|
|
27 |
6S |
p. S59-S60
|
artikel
|
| 391 |
EE242 Economic and Clinical Impact of Cost-Effective Kidney-Related Healthcare Interventions to Manage the Burden of CKD in the UK: Estimates for the Next 10 Years (2023 to 2033)
|
Agathangelou, G
|
|
|
27 |
6S |
p. S101
|
artikel
|
| 392 |
EE78 Economic and Comorbidity Burden of Prurigo Nodularis and Drivers of Higher Healthcare Costs in the US: A Retrospective Analysis of Claims Data of Patients Diagnosed Between 2017 and 2022
|
Elmariah, S
|
|
|
27 |
6S |
p. S71-S72
|
artikel
|
| 393 |
EE25 Economic Benefit of Faricimab Compared to Aflibercept 8mg in Treating Patients with Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema in the United States
|
Tabano, D
|
|
|
27 |
6S |
p. S61
|
artikel
|
| 394 |
EE176 Economic Burden and Healthcare Resource Utilization in Patients with Psoriatic Arthritis (PsA): A Systematic Literature Review
|
Varga, S
|
|
|
27 |
6S |
p. S90
|
artikel
|
| 395 |
EE74 Economic Burden and Healthcare Resource Utilization in Patients with Systemic Lupus Erythematosus (SLE): A Systematic Literature Review (SLR)
|
Choi, J
|
|
|
27 |
6S |
p. S71
|
artikel
|
| 396 |
EE295 Economic Burden Associated With Managing Patients With Sickle Cell Disease Receiving Frequent Red Blood Cell Transfusions in the United States
|
Udeze, C
|
|
|
27 |
6S |
p. S112
|
artikel
|
| 397 |
EE220 Economic Burden Associated With Sjögren's Disease (SjD): Findings From a Systematic Literature Review (SLR)
|
Xi, A
|
|
|
27 |
6S |
p. S97-S98
|
artikel
|
| 398 |
EE137 Economic Burden for Adults With Sickle Cell Disease and Matched Controls in the United States: Retrospective Analysis of a Commercial Insurance Database
|
Barcelos, GT
|
|
|
27 |
6S |
p. S82
|
artikel
|
| 399 |
EE457 Economic Burden Impact of Thyroid Eye Disease in the United Arab Emirates
|
Eatamadimadi, H
|
|
|
27 |
6S |
p. S141
|
artikel
|
| 400 |
EE26 Economic Burden of Acquired Hemophilia- A Systematic Literature Review
|
Rai, D
|
|
|
27 |
6S |
p. S61
|
artikel
|
| 401 |
EE389 Economic Burden of Diagnosed Congenital Cytomegalovirus in the United States and Japan
|
Buck, P
|
|
|
27 |
6S |
p. S128-S129
|
artikel
|
| 402 |
EE301 Economic Burden of Disease Recurrence in Elderly Patients With High-Risk Endometrial Cancer (HR-EC) Receiving Adjuvant Therapy (AT)
|
Prabhu, V
|
|
|
27 |
6S |
p. S113
|
artikel
|
| 403 |
EE458 Economic Burden of Disease Recurrence in Elderly Patients With Human Epidermal Growth Factor Receptor 2-Negative (HER2–) Early Breast Cancer (eBC)
|
Earla, JR
|
|
|
27 |
6S |
p. S141
|
artikel
|
| 404 |
EE356 Economic Burden of Diseases Caused By Overweight and Obesity in Mexico
|
Ordoñez, J
|
|
|
27 |
6S |
p. S123
|
artikel
|
| 405 |
EE316 Economic Burden of Fabry Disease in Colombia
|
Upegui, Pachon A
|
|
|
27 |
6S |
p. S115
|
artikel
|
| 406 |
EE9 Economic Burden of Gaucher Disease in Colombia
|
Upegui, Pachon A
|
|
|
27 |
6S |
p. S58
|
artikel
|
| 407 |
EE285 Economic Burden of Gestational Diabetes: A Global Targeted Literature Review
|
Gautam, R
|
|
|
27 |
6S |
p. S110
|
artikel
|
| 408 |
EE354 Economic Burden of ICU Diseases and Injuries in Brazil During the COVID-19 Pandemic
|
Bezerra, I
|
|
|
27 |
6S |
p. S122-S123
|
artikel
|
| 409 |
EE72 Economic Burden of Long-Term Care (LTC) in Patients with Advanced Huntington's Disease (HD) and the Impact on Caregivers in North America: A Systematic Literature Review (SLR)
|
Knott, C
|
|
|
27 |
6S |
p. S70
|
artikel
|
| 410 |
EE359 Economic Burden of Managing Acute and Chronic Pain in the United States: National Estimates from 2022 Data
|
Schoenfeld, AJ
|
|
|
27 |
6S |
p. S123-S124
|
artikel
|
| 411 |
EE454 Economic Burden of Mild and Moderate Asthma in Adult Patients From Public Health Institutions Perspective in Mexico
|
Palomo, Paz EJ
|
|
|
27 |
6S |
p. S140
|
artikel
|
| 412 |
EE446 Economic Burden of Mild or Moderate Asthma in Pediatric Patients from the Perspective of Public Health Institutions in Mexico
|
Palomo, Paz EJ
|
|
|
27 |
6S |
p. S138-S139
|
artikel
|
| 413 |
EE378 Economic Burden of Non-Hodgkin Lymphoma Among Patients with Commercial Insurance
|
Li, M
|
|
|
27 |
6S |
p. S126
|
artikel
|
| 414 |
EE175 Economic Burden of Pneumococcal Disease Among US Children — A Review of Cost-Effectiveness Analyses of Pneumococcal Vaccines
|
Huang, M
|
|
|
27 |
6S |
p. S90
|
artikel
|
| 415 |
EE120 Economic Burden of Pompe Disease in Colombia
|
Upegui, Pachon A
|
|
|
27 |
6S |
p. S79
|
artikel
|
| 416 |
EE499 Economic Burden of Prescription Opioid Abuse in the United States: A Systematic Literature Review
|
Kaushik, P
|
|
|
27 |
6S |
p. S148-S149
|
artikel
|
| 417 |
EE352 Economic Burden of Prostate Cancer in the US: A Disease Stage-Based Cost Analysis
|
Desmaras, H
|
|
|
27 |
6S |
p. S122
|
artikel
|
| 418 |
EE130 Economic Burden of Seasonal Influenza in Mainland China from 2011 to 2019
|
Chen, C
|
|
|
27 |
6S |
p. S81
|
artikel
|
| 419 |
EE149 Economic Burden of Treating Chronic Peripheral Neuropathic Pain in the United States: National Estimates From 2022 Data
|
Schoenfeld, AJ
|
|
|
27 |
6S |
p. S85
|
artikel
|
| 420 |
EE121 Economic Consequences of Persistence and Adherence to Lifelong Therapy for Patients with Presymptomatic Spinal Muscular Atrophy (SMA)
|
Kleintjens, J
|
|
|
27 |
6S |
p. S79-S80
|
artikel
|
| 421 |
EE303 Economic Costs of Informal Care for Individuals with Disabilities and Chronic Diseases in Hong Kong
|
Yi, X
|
|
|
27 |
6S |
p. S113
|
artikel
|
| 422 |
EE388 Economic Evaluation and Budget Impact of Brigatinib Versus Other ALK-Inhibitors for First-Line ALK-Positive Non-Small Cell Lung Cancer (NSCLC) Treatment in the Brazilian Private Healthcare System
|
Souza, P
|
|
|
27 |
6S |
p. S128
|
artikel
|
| 423 |
EE390 Economic Evaluation and Healthcare Resource Utilization (HCRU) Among Breast Cancer Patients Treated with Palbociclib: A Systematic Literature Review (SLR)
|
Shaw, P.D.
|
|
|
27 |
6S |
p. S129
|
artikel
|
| 424 |
EE41 Economic Evaluation for the United States (US) of the Overall Survival Analysis of Cemiplimab Plus Chemotherapy Treatment in Advanced Non-Small Cell Lung Cancer (NSCLC) With at Least 50% PD-L1 Positivity
|
Alfayoumi, I
|
|
|
27 |
6S |
p. S64
|
artikel
|
| 425 |
EE307 Economic Evaluation of a Screening Programme for Diabetes, Hypertension and Hyperlipidaemia in Middle-Aged Adults in Hong Kong: A Simulation Analysis
|
Huo, Z
|
|
|
27 |
6S |
p. S113-S114
|
artikel
|
| 426 |
EE351 Economic Evaluation of Botulinum Toxin Type a (XEOMEEN) in the Treatment of Adult Patients With Spasticity in the "IMSS” and “ISSSTE”
|
Del, Rosal y Hermosillo A
|
|
|
27 |
6S |
p. S122
|
artikel
|
| 427 |
EE39 Economic Evaluation of Botulinum Toxin Type A (XEOMEEN) in the Treatment of Pediatric Patients With Spasticity in the "IMSS” and “ISSSTE”
|
Del, Rosal y Hermosillo A
|
|
|
27 |
6S |
p. S64
|
artikel
|
| 428 |
EE158 Economic Evaluation of Duvelisib Versus Ofatumumab in Relapsed/Refractory CLL/SLL in Japan
|
Shimizu, K
|
|
|
27 |
6S |
p. S86-S87
|
artikel
|
| 429 |
EE191 Economic Evaluation of Mental Health Interventions: A Cost-Consequence Analysis
|
Colimon, S
|
|
|
27 |
6S |
p. S92
|
artikel
|
| 430 |
EE524 Economic Evaluation of Pronase Granules for Gastric Cancer Screening in High-Risk Population in China
|
Ma, Y
|
|
|
27 |
6S |
p. S152
|
artikel
|
| 431 |
EE211 Economic Evaluations of Cancer Screening Tests in the US: A Systematic Literature Review (SLR)
|
Cong, Z
|
|
|
27 |
6S |
p. S95-S96
|
artikel
|
| 432 |
EE519 Economic Evaluations of Digital Health Interventions: Is Existing Guidance Being Used?
|
Baisley, W
|
|
|
27 |
6S |
p. S152
|
artikel
|
| 433 |
EE313 Economic Impact of Cancer Related to Human Papilloma Virus in Ecuador
|
Mino, A
|
|
|
27 |
6S |
p. S115
|
artikel
|
| 434 |
EE240 Economic Impact of Direct Costs Associated with Stroke in Patients with Type 2 Diabetes from the Perspective of the Social Security and Private Healthcare Providers in Argentina
|
Zambon, F
|
|
|
27 |
6S |
p. S101
|
artikel
|
| 435 |
EE252 Economic Impact of Relapses in Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD): A Systematic Literature Review
|
Park, J
|
|
|
27 |
6S |
p. S103
|
artikel
|
| 436 |
EE406 Economic Impact of Upadacitinib for the Treatment of Moderate-to-Severe Crohn’s Disease and Ulcerative Colitis: Induction and Maintenance Phase 3 Results on Work Productivity Loss
|
Yu, T
|
|
|
27 |
6S |
p. S131-S132
|
artikel
|
| 437 |
EE225 Economic Modeling of Topical and Systemic Treatments for Atopic Dermatitis: A Structured Literature Review
|
Silverberg, J
|
|
|
27 |
6S |
p. S98
|
artikel
|
| 438 |
EE132 Economic Outcomes and Real-World Adherence of Patients With Sickle Cell Disease With Recurrent Vaso-Occlusive Crises Treated With L-Glutamine, Voxelotor, and Crizanlizumab in the United States
|
Udeze, C
|
|
|
27 |
6S |
p. S81
|
artikel
|
| 439 |
EE363 Economic Value of Early Genetic Testing in Inherited Retinal Dystrophy Diagnosis
|
Zhang, Q
|
|
|
27 |
6S |
p. S124
|
artikel
|
| 440 |
EE382 Effect and Economic Outcomes of the Polypharmacy Management System Platform for Common Diseases in the Elderly in China
|
Tang, X
|
|
|
27 |
6S |
p. S127
|
artikel
|
| 441 |
EE251 Effect of Anticholinergic Burden on Healthcare Costs in Patients With Overactive Bladder: A Retrospective Database Claims Analysis
|
Richter, HE
|
|
|
27 |
6S |
p. S103
|
artikel
|
| 442 |
EE365 Empowering Access: Evaluating the Impact of Partnerships for Productive Development (PDP) on Access to Rituximab in Brazil
|
Mayor, K
|
|
|
27 |
6S |
p. S125
|
artikel
|
| 443 |
EE94 End-of-Life Costs Among Older Adults Living with HIV
|
Bazzazzadehgan, S
|
|
|
27 |
6S |
p. S74-S75
|
artikel
|
| 444 |
EE102 Estimate Broader Economic Impact of Lecanemab for Medicare Beneficiaries Alzheimer's Disease Patients: Budget Impact and Input-Output Models
|
Sanogo, V
|
|
|
27 |
6S |
p. S76
|
artikel
|
| 445 |
EE69 Estimating a Drug's Price After Loss of Exclusivity As a Function of the Cost of Goods Sold
|
Whittington, M
|
|
|
27 |
6S |
p. S70
|
artikel
|
| 446 |
EE516 Estimating the Benefits of Reduced Fracture Incidence for Patients Living with Osteogenesis Imperfecta and for Healthcare Payers
|
Edmonds, T
|
|
|
27 |
6S |
p. S151-S152
|
artikel
|
| 447 |
EE101 Estimating the Burden of Osteogenesis Imperfecta on Patients and Healthcare Payers: A Health Economic Modelling Study
|
Edmonds, T
|
|
|
27 |
6S |
p. S76
|
artikel
|
| 448 |
EE50 Estimating the Clinical and Economic Outcomes of Universal Varicella and Herpes Zoster Vaccination in Belgium Using a Dynamic Transmission Model With Dynamic Population
|
Lang, J
|
|
|
27 |
6S |
p. S66
|
artikel
|
| 449 |
EE143 Estimating the Cost and Efficiency of Differentiated Direct-to-Pharmacy PrEP Refill Model in Kenya
|
Nwogu, IB
|
|
|
27 |
6S |
p. S83
|
artikel
|
| 450 |
EE501 Estimating the Impact of Delayed Treatment for Major Depressive Disorder Using a Continuous-Time Patient-Level Simulation Model
|
Chapman, R
|
|
|
27 |
6S |
p. S149
|
artikel
|
| 451 |
EE244 Estimating Treatment Cost Savings of Gender-Neutral Nonavalent HPV Vaccination in Mexico
|
Jalil, Kentros Hl
|
|
|
27 |
6S |
p. S102
|
artikel
|
| 452 |
EE467 Estimation of Budget Impact With the Substitution of Biologic Reference Product for Biosimilars in Patients With Rheumatoid Arthritis From the Perspective of Medium Size Healthcare Insurance in Brazil
|
Alves, Junior JM
|
|
|
27 |
6S |
p. S142
|
artikel
|
| 453 |
EE178 Evaluating the Budget Impact of Introducing Preventive Therapy in the Preclinical Phase for Rheumatoid Arthritis : A Focus on Algerian Female Population at Risk
|
Abdalli, I
|
|
|
27 |
6S |
p. S90
|
artikel
|
| 454 |
EE447 Evaluating the Impact of Disease Prevalence and Product Administration on Launch Pricing Trends for Non-Oncology Orphan Products
|
Donnelly, E
|
|
|
27 |
6S |
p. S139
|
artikel
|
| 455 |
EE125 Evaluating the Impact of Hybrid Closed-Loop Systems (HCLS) on Healthcare Utilization and Costs Compared to Standard of Care Therapy Among Patients with Type 1 Diabetes New to Pump Therapy
|
Manjelievskaia, J
|
|
|
27 |
6S |
p. S80
|
artikel
|
| 456 |
EE212 Evaluating the Potential Health and Economic Impact of V116, an Adult Specific 21-Valent Pneumococcal Conjugate Vaccine, on Invasive Pneumococcal Disease in the United States
|
Yi, Z
|
|
|
27 |
6S |
p. S96
|
artikel
|
| 457 |
EE437 Evaluating Various Predictors Suspected of Influencing Biosimilar Market Share in the U.S.
|
Mueller, C
|
|
|
27 |
6S |
p. S137
|
artikel
|
| 458 |
EE23 Evaluation of the Relative Impact of Factors Influencing Originator U.S. Market Share Following Biosimilar Launch
|
Mueller, C
|
|
|
27 |
6S |
p. S61
|
artikel
|
| 459 |
EE160 Evidence to Inform Forecasts of Biopharmaceutical Policy Impact
|
Axelsen, K
|
|
|
27 |
6S |
p. S87
|
artikel
|
| 460 |
EE346 Expanding Cost-Effectiveness Analysis to Demonstrate Population-Level Treatment Impact on Patients and Society
|
EI, Moustaid F
|
|
|
27 |
6S |
p. S121
|
artikel
|
| 461 |
EE344 Expected Economic Savings Associated With Surgical Aortic Valve Replacement Using a Novel Tissue Bioprosthesis: An Update Based on the 7-Year Commence Trial Results
|
Keuffel, E
|
|
|
27 |
6S |
p. S120
|
artikel
|
| 462 |
EE311 Exploring Environmental Impacts of Switching Salmeterol/Fluticasone Propionate (SAL/FP) from Metered Dose Inhaler (MDI) to Dry Powder Inhaler (DPI) in Respiratory Illness in the United Kingdom
|
Siddiqui, AH
|
|
|
27 |
6S |
p. S114
|
artikel
|
| 463 |
EE100 Exploring Frameworks and Methodologies to Incorporate Equity in Health Economics Evaluation: A Scoping Review
|
Lai, T
|
|
|
27 |
6S |
p. S75-S76
|
artikel
|
| 464 |
EE173 Exploring the Financial Burden Associated with the Management of Dystrophic Epidermolysis Bullosa (DEB): A Systematic Literature Review (SLR) with Database Review of Future Disease-Modifying Therapies (DMTs)
|
Bodke, A
|
|
|
27 |
6S |
p. S89
|
artikel
|
| 465 |
EE487 Exploring the Healthcare Resource Utilization (HCRU) Associated with Rare Diseases (RD) in the United States (US): A Systematic Literature Review (SLR) across Six Disease Areas
|
Crossley, O
|
|
|
27 |
6S |
p. S146
|
artikel
|
| 466 |
EE380 Exploring the Impact of a Rare Disease (RD) Diagnosis on Work Productivity and Social Activity Impairment: A Systematic Literature Review (SLR) across Six Disease Areas
|
Crossley, O
|
|
|
27 |
6S |
p. S127
|
artikel
|
| 467 |
EE512 Fluticasone Furoate/Umeclidinium/Vilanterol Vs Open Triple Therapy for Treating Severe to Very Severe Chronic Obstructive Pulmonary Disease (COPD) from a Brazilian Public Healthcare Perspective: A Budget Impact Analysis
|
Araujo, M
|
|
|
27 |
6S |
p. S151
|
artikel
|
| 468 |
EE507 Frontline TKI Strategies for Chronic Myeloid Leukemia Patients: Balancing Outcomes and Costs in Pursuit of Treatment-Free Remission and Dose Reduction
|
Metsemakers, S
|
|
|
27 |
6S |
p. S150
|
artikel
|
| 469 |
EE397 Health and Budget Impact of Liquid Biopsy (LBx)-Based Comprehensive Genomic Profiling (CGP) in Patients With Tissue-Limited Advanced Non-Small Cell Lung Cancer (aNSCLC)
|
Hong, S
|
|
|
27 |
6S |
p. S130
|
artikel
|
| 470 |
EE5 Healthcare Costs Among Commercially-Insured Patients with Hereditary Angioedema Managed with Long-Term Prophylaxis: A Retrospective US Claims Database
|
Tachdjian, R
|
|
|
27 |
6S |
p. S57-S58
|
artikel
|
| 471 |
EE408 Healthcare Costs Among Patients Diagnosed With Estrogen Receptor Positive (ER+) Breast Cancer: Relationship With Comorbid Depression and Adherence to Anti-Depressant Medication
|
Noxon, V
|
|
|
27 |
6S |
p. S132
|
artikel
|
| 472 |
EE366 Healthcare Costs Comparison of Dupilumab Vs. Omalizumab, Benralizumab and Mepolizumab in Patients with Moderate-to-Severe Asthma: A US Payer Perspective
|
Sheth, KK
|
|
|
27 |
6S |
p. S125
|
artikel
|
| 473 |
EE235 Health Care Related Costs of Treatment Delay Among Medicare Beneficiaries Diagnosed With Colon Cancer
|
Seo, D
|
|
|
27 |
6S |
p. S100
|
artikel
|
| 474 |
EE417 Healthcare Resource Use and Costs of Care in HR+/HER2- Metastatic Breast Cancer: A Retrospective US Claims Data Study
|
Collin, S
|
|
|
27 |
6S |
p. S134
|
artikel
|
| 475 |
EE82 Health Care Resource Use Associated with Generalized Anxiety Disorder Among Adults in the United States
|
Duong, P
|
|
|
27 |
6S |
p. S72
|
artikel
|
| 476 |
EE473 Health Care Resource Use in the Management of Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Canada
|
Guinan, K
|
|
|
27 |
6S |
p. S143
|
artikel
|
| 477 |
EE369 Healthcare Resource Utilization Among Patients With Sickle Cell Disease With Recurrent Vaso-Occlusive Crises in Canada
|
Lilly, L
|
|
|
27 |
6S |
p. S125
|
artikel
|
| 478 |
EE502 Healthcare Resource Utilization and Cost Burden in Patients with Primary Biliary Cholangitis
|
Gish, RG
|
|
|
27 |
6S |
p. S149
|
artikel
|
| 479 |
EE304 Healthcare Resource Utilization and Cost of Care of Different IV Iron Treatments in Heart Failure Patients Diagnosed With Iron Deficiency/Iron Deficiency Anemia Using a Real-World Database
|
Wang, Y
|
|
|
27 |
6S |
p. S113
|
artikel
|
| 480 |
EE326 Health Care Resource Utilization and Costs Among Patients with Paroxysmal Nocturnal Hemoglobinuria Initiating Eculizumab and Ravulizumab: A U.S. Claims Analysis
|
Lin, CW
|
|
|
27 |
6S |
p. S117
|
artikel
|
| 481 |
EE6 Healthcare Resource Utilization and Costs Associated With a Peptide-Based Enteral Formula With Fruit and Vegetable Ingredients: Retrospective Analysis of Children and Adults in Post-Acute Care
|
Desai, A
|
|
|
27 |
6S |
p. S58
|
artikel
|
| 482 |
EE21 Healthcare Resource Utilization Comparison of Balloon-Expandable Valve Versus Self-Expandable Valve for Transcatheter Aortic Valve Replacement in China
|
Tan, B
|
|
|
27 |
6S |
p. S60
|
artikel
|
| 483 |
EE387 Healthcare Resource Utilization for Patients With Alzheimer's Disease Versus Non-Alzheimer's Disease Controls in Israel
|
Sanchez-Solino, O.
|
|
|
27 |
6S |
p. S128
|
artikel
|
| 484 |
EE236 Healthcare Resource Utilization (HCRU) and Direct Medical Costs Following Acute SARS-Cov-2 Infection: Findings From a Literature Review
|
Łukomska, E
|
|
|
27 |
6S |
p. S100
|
artikel
|
| 485 |
EE147 Healthcare Resource Utilization of Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF): A Retrospective Claims Analysis
|
Ali, A
|
|
|
27 |
6S |
p. S84
|
artikel
|
| 486 |
EE194 Health Care Resource Utilization, Total and out of Pocket Expenditures Among Adults with Rheumatoid Arthritis: Medical Expenditure Panel Survey Study
|
Bazzazzadehgan, S
|
|
|
27 |
6S |
p. S92-S93
|
artikel
|
| 487 |
EE249 Healthcare Utilization and Costs Associated with Remote Blood Pressure Monitoring in a US Integrated Healthcare System
|
Novelli, AT
|
|
|
27 |
6S |
p. S102-S103
|
artikel
|
| 488 |
EE462 Healthcare Utilization in Non-Alcoholic Steatohepatitis (NASH) Patients with Elevated Nafld Activity Score (NAS): Impact of Fibrosis Levels
|
Fishman, J
|
|
|
27 |
6S |
p. S141
|
artikel
|
| 489 |
EE67 Health Economic Evaluation As a Tool for Sustainable Financing of the Unified Health System: The Case of Hemodialysis
|
Pedreira, MM
|
|
|
27 |
6S |
p. S69
|
artikel
|
| 490 |
EE435 Hospitalization Costs of Common Grade 3/4 Adverse Events Associated With Oncology Treatments in the United States
|
Graham, CN
|
|
|
27 |
6S |
p. S137
|
artikel
|
| 491 |
EE12 Hypertension-Associated Medical Expenditures Among Privately Insured US Individuals Aged 18 to 64 Years in 2021
|
Kumar, A
|
|
|
27 |
6S |
p. S59
|
artikel
|
| 492 |
EE442 Impact of Benralizumab on Asthma and COPD Exacerbation-Related Healthcare Resource Utilization in Patients with Asthma and Concomitant COPD
|
Carstens, D
|
|
|
27 |
6S |
p. S138
|
artikel
|
| 493 |
EE486 Impact of COVID-19 Pandemic on IV Iron (IVI) Cost and Utilization in Commercially-Insured Patients With Iron Deficiency Anemia (IDA)
|
Polson, M
|
|
|
27 |
6S |
p. S146
|
artikel
|
| 494 |
EE118 Impact of Different Thresholds on Recommendations Made Through Cost-Effectiveness Studies: An Example From Chronic Lymphocytic Leukemia
|
Motta-Santos, A.S.
|
|
|
27 |
6S |
p. S79
|
artikel
|
| 495 |
EE38 Impact of Expenditure on Medicines for STD/AIDS on the Instituted Budget after the End of the Regime That Established a Ceiling on Public Expenditure in Brazil
|
Nascimento, H
|
|
|
27 |
6S |
p. S64
|
artikel
|
| 496 |
EE273 Impact of Mental Health Screening Access on Incremental Cost Estimates Among Patients with Postpartum Depression
|
Park, J
|
|
|
27 |
6S |
p. S107
|
artikel
|
| 497 |
EE163 Impact of Slowing Alzheimer’s Disease (AD) Progression: A Simulation Model in a Population of Patients with Early AD in the United States
|
Bloudek, L
|
|
|
27 |
6S |
p. S87-S88
|
artikel
|
| 498 |
EE113 Impact of Type 1 Diabetes and Severe Hypoglycemia on Productivity and Out-of-Pocket Costs of Adult Continuous Glucose Monitor Users: Results From a Cross-Sectional Survey in the United States
|
Boateng-Kuffour, A.
|
|
|
27 |
6S |
p. S78
|
artikel
|
| 499 |
EE181 Impact of Type 1 Diabetes on Productivity and Out-of-Pocket Costs of Adult Continuous Glucose Monitoring Users in the United States: Results From a Cross-Sectional Survey in the United States
|
Callahan, P
|
|
|
27 |
6S |
p. S91
|
artikel
|
| 500 |
EE466 Implementing the Generalized Risk-Adjusted Cost-Effectiveness (GRACE) Model for Sickle-Cell Disease: A Case Study
|
Kleintjens, J
|
|
|
27 |
6S |
p. S142
|
artikel
|
| 501 |
EE45 Influential Factors on the Economic Justifiable Price: Systematic Investigation of Factors and Mechanisms Beyond the Incremental Cost Effectiveness Ratio
|
Poirrier, JE
|
|
|
27 |
6S |
p. S65
|
artikel
|
| 502 |
EE117 Insights Into Sickle Cell Disease Hospitalizations and Outcomes: A Tale of 2 HCUP Databases
|
Ambegaonkar, AJ
|
|
|
27 |
6S |
p. S79
|
artikel
|
| 503 |
EE421 Integrating Payer Reimbursement Strategies Into Modeling and Simulation (M&S)-Based Methods to Redefine Drug Development
|
Kadambi, A
|
|
|
27 |
6S |
p. S134
|
artikel
|
| 504 |
EE139 Intensification with Insulin Glargine 300 U/Ml (Gla-300) or First- Generation Basal Insulins (BIs) in People with Type 2 Diabetes (T2D) on Once-Weekly Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs): Deliver New-G
|
Umpierrez, G
|
|
|
27 |
6S |
p. S83
|
artikel
|
| 505 |
EE527 Is List Price the Key Driver of ICER Assessments? Exploring Drivers of Cost-Effectiveness
|
Olivier, D
|
|
|
27 |
6S |
p. S153
|
artikel
|
| 506 |
EE286 Japan-Specific Risk Equations for Modeling Diabetes in the Japanese Setting: Does It Make a Difference?
|
Willis, M
|
|
|
27 |
6S |
p. S110
|
artikel
|
| 507 |
EE34 JAV-RARAS: Methodological Aspects of Adherence Analysis to Clinical Protocols and Therapeutic Guidelines in Brazil
|
Ogata, G
|
|
|
27 |
6S |
p. S63
|
artikel
|
| 508 |
EE241 JAV-RARAS: Microscopic Analysis of Patients with Familial Amyloidotic Polyneuropathy in Brazil
|
Ogata, G
|
|
|
27 |
6S |
p. S101
|
artikel
|
| 509 |
EE347 JAV-RARAS: Preliminary Results of Measuring Adherence to the Phenylketonuria Treatment Protocol in Brazil
|
Ogata, G
|
|
|
27 |
6S |
p. S121
|
artikel
|
| 510 |
EE450 JAV-RARAS: Valoriza a Jornada De Cuidado De Pacientes Com Mucopolissacaridose Tipo 2: Resultados Preliminares De Um Estudo Real No Sistema Único De Saúde (SUS)
|
Ogata, G
|
|
|
27 |
6S |
p. S139
|
artikel
|
| 511 |
EE110 Leading Predictors of Medicare Payments Vary Across Different Phases of Care Among Older Hodgkin's Lymphoma Survivors: Application of Interpretable Machine Learning Models
|
Siddiqui, ZA
|
|
|
27 |
6S |
p. S77-S78
|
artikel
|
| 512 |
EE345 Lifetime Cost-Effectiveness of Hereditary Breast and Ovarian Cancer Prevention Based on FinnGen and Biobank Data, Data Returning Process, and Prophylaxis
|
Soini, E
|
|
|
27 |
6S |
p. S120-S121
|
artikel
|
| 513 |
EE271 Lifetime Productivity Loss Due to HIV Mortality in the United States
|
Islam, MH
|
|
|
27 |
6S |
p. S107
|
artikel
|
| 514 |
EE37 Lifetime Survival, Societal Costs and Cost-Effectiveness of Nine Options to Treat Alcohol Use Disorder
|
Kc, G
|
|
|
27 |
6S |
p. S63-S64
|
artikel
|
| 515 |
EE107 Long-Term Cost-Effectiveness of iGlarLixi Versus IDegLira in Patients With Uncontrolled Type 2 Diabetes Treated With Basal Insulin or Oral Antidiabetic Drug in China
|
Mo, X
|
|
|
27 |
6S |
p. S77
|
artikel
|
| 516 |
EE481 Long-Term Cost-Effectiveness of Tirzepatide Versus Placebo for Individuals With Type 2 Diabetes and Obesity
|
Tang, M
|
|
|
27 |
6S |
p. S145
|
artikel
|
| 517 |
EE257 Management of Psoriasis and Atopic Dermatitis Costs in the Poor Insured Population of the Colombian Atlantic Coast
|
Fernandez, Mercado J
|
|
|
27 |
6S |
p. S104
|
artikel
|
| 518 |
EE213 Measuring Healthcare's Environmental Impact: Data Availability across a Spectrum of Interventions and Therapeutic Areas
|
Silber, A
|
|
|
27 |
6S |
p. S96
|
artikel
|
| 519 |
EE55 Medico-Economic Contribution of Multiplex PCR To the Diagnosis of Meningitis
|
Mansouri, K
|
|
|
27 |
6S |
p. S67
|
artikel
|
| 520 |
EE182 Mepolizumab Impact on Healthcare Resource Utilization and Work Productivity in Patients with Severe Asthma: REALITI-A 2-Year Analysis
|
Canonica, GW
|
|
|
27 |
6S |
p. S91
|
artikel
|
| 521 |
EE97 Micro-Costing of Relapse and Refractory EGPA Treatment in Brazil Using the Lens of Experts
|
Silva, D
|
|
|
27 |
6S |
p. S75
|
artikel
|
| 522 |
EE57 Missed Opportunities? Gaps in Capturing the Full Value of Vaccination Across Health Economic Studies of COVID-19 Vaccination
|
Bem, D
|
|
|
27 |
6S |
p. S67
|
artikel
|
| 523 |
EE491 Modeling Costs of Variations in Healthcare Utilization Following the COVID-19 Pandemic: Exploring How Model Choices and Fit Impact Interpretation
|
Pack, C
|
|
|
27 |
6S |
p. S147
|
artikel
|
| 524 |
EE465 Modeling the Effects of Improving Varicella Vaccination Coverage Rates on Clinical and Economic Outcomes in Peru Over a 10-Year Time-Horizon
|
Lang, J
|
|
|
27 |
6S |
p. S142
|
artikel
|
| 525 |
EE510 Navigating Economics of Telehealth in Oncology
|
Swami, S
|
|
|
27 |
6S |
p. S151
|
artikel
|
| 526 |
EE338 NICE Reconsideration for Oncology Drugs Based on Single-Arm Trials Referred to Cancer Drug Fund
|
Wu, S
|
|
|
27 |
6S |
p. S119
|
artikel
|
| 527 |
EE77 Non-Quality Costs of Unsafe Healthcare in a Hospital Institution
|
Galvan-Barrios, J.P.
|
|
|
27 |
6S |
p. S71
|
artikel
|
| 528 |
EE203 Number Needed to Treat and Cost of Preventing an Event Analysis for Pembrolizumab in Non-Squamous Metastatic Non-Small Cell Lung Cancer in Colombia
|
Wurcel, V
|
|
|
27 |
6S |
p. S94
|
artikel
|
| 529 |
EE392 Number Needed to Treat (NNT) Comparing Sacituzumab Govitecan and Single-Agent Chemotherapy in Relapsed or Refractory Metastatic Triple-Negative Breast Cancer
|
Marasco, G
|
|
|
27 |
6S |
p. S129
|
artikel
|
| 530 |
EE111 Optimization of the Health Economic Model of Type 2 Diabetes Based on Glycemic Variability Mechanism
|
Gu, Z
|
|
|
27 |
6S |
p. S78
|
artikel
|
| 531 |
EE348 Optimizing Economic Modelling Approaches in Health Disparities Research: Essential Insights
|
Adunlin, G
|
|
|
27 |
6S |
p. S121
|
artikel
|
| 532 |
EE429 Optimizing Multicancer Early Detection (MCED) Testing Based on Patient Stratification: A Comprehensive Analysis of Economic and Clinical Impact from a US Payer Perspective
|
Long, B
|
|
|
27 |
6S |
p. S136
|
artikel
|
| 533 |
EE44 Outcomes and Cost-Effectiveness of Hospital Outpatient Versus Ambulatory Surgery Center Lumbar Decompression Surgery
|
Rana, P
|
|
|
27 |
6S |
p. S65
|
artikel
|
| 534 |
EE505 Predictive Analysis Comparing Economic and Clinical Consequences of Treatment-related Hepatotoxicity in KRASG12C-mutated Advanced Non-small Cell Lung Cancer (aNSCLC) Patients Treated Post-immunotherapy (IO)
|
Keeping, S
|
|
|
27 |
6S |
p. S150
|
artikel
|
| 535 |
EE413 Predictive and Interpretable Machine Learning of Economic Burden: The Role of Chronic Conditions Among Patients with Incident Primary Merkel Cell Carcinoma
|
Mbous, Y
|
|
|
27 |
6S |
p. S133
|
artikel
|
| 536 |
EE239 Predictive Cost-Effectiveness Evaluation of Using a Machine Learning-Based Alzheimer’s Disease Risk Prediction Tool for Users of Social and Health Services Aged over 65 in Finland
|
Haikonen-Salo, L.
|
|
|
27 |
6S |
p. S101
|
artikel
|
| 537 |
EE526 Predictors of Annual Eyewear Expenditures in the United States
|
Li, Z
|
|
|
27 |
6S |
p. S153
|
artikel
|
| 538 |
EE207 Prevalence and Economic Burden for Diabetic Multimorbid Patients in China: Based on Longitudinal Claims Data
|
Chen, X
|
|
|
27 |
6S |
p. S95
|
artikel
|
| 539 |
EE452 Prevalence, Real-World Healthcare Resource Utilization, and Costs of Patients With Paroxysmal Nocturnal Hemoglobinuria in the US: A Retrospective Claims Database Analysis
|
Tantravahi, S
|
|
|
27 |
6S |
p. S140
|
artikel
|
| 540 |
EE159 Price, Spending, and Utilization of Second-Generation Antipsychotics and the Impact of Generic Entry on Market Shares: Trend Analysis of Medicaid Database From 1991 to 2022
|
Alamri, K
|
|
|
27 |
6S |
p. S87
|
artikel
|
| 541 |
EE280 Price Trends and Analysis of Targeted Immunomodulatory (TIM) Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis Therapy
|
Adekunle, O
|
|
|
27 |
6S |
p. S109
|
artikel
|
| 542 |
EE297 Pricing Strategies and Trends of FDA Approved NSCLC Therapies From 2018 to 2023
|
Cheng, SY
|
|
|
27 |
6S |
p. S112
|
artikel
|
| 543 |
EE514 Private Hospital Acute Stroke Care Costs: Patient's Viewpoint
|
Ching, Siang T
|
|
|
27 |
6S |
p. S151
|
artikel
|
| 544 |
EE226 Productivity Loss Among Persons With Multiple Sclerosis Treated With Ocrelizumab Vs Other Disease-Modifying Therapies
|
Geiger, CK
|
|
|
27 |
6S |
p. S98
|
artikel
|
| 545 |
EE49 Public Health Impact and Cost-Effectiveness of a New Dengue Vaccine (TAK-003) in a Large Catch-up Cohort in Puerto Rico
|
Shen, J
|
|
|
27 |
6S |
p. S66
|
artikel
|
| 546 |
EE327 Public Preferences for Improving Health Equity: A Qualitative Focus Group Study
|
Cadham, C
|
|
|
27 |
6S |
p. S117-S118
|
artikel
|
| 547 |
EE234 Quality of Life and Burden of Epilepsy Patients in United States: A Comparative Study of Matched Case-Control Based on Medical Expenditure Panel Survey (MEPS), 2017-2021
|
Mazumder, D
|
|
|
27 |
6S |
p. S100
|
artikel
|
| 548 |
EE58 Quantifying the Lifetime Economic Impact of Pediatric Oral Nutritional Supplements in Lower-Middle Income Countries in Asia
|
Than, KS
|
|
|
27 |
6S |
p. S67-S68
|
artikel
|
| 549 |
EE172 Quantifying the Relationship between Time to Diagnosis and Potential System Level Burden in Obstructive Hypertrophic Cardiomyopathy (HCM)
|
Lemmer, T
|
|
|
27 |
6S |
p. S89
|
artikel
|
| 550 |
EE79 Real-World Clinical and Economic Burden of Primary Biliary Cholangitis in the United States
|
Shamseddine, N
|
|
|
27 |
6S |
p. S72
|
artikel
|
| 551 |
EE412 Real-World Cost-Effectiveness Analysis of Ustekinumab-Based Therapies Vs Non-Biologic Therapies for Moderate to Severe Crohn’s Disease in Chinese Population
|
Chen, H
|
|
|
27 |
6S |
p. S132-S133
|
artikel
|
| 552 |
EE340 Real-World Healthcare Resource Utilization and Costs of Patients with Alzheimer’s Disease By Stage: A Retrospective Observational Study
|
Fazio-Eynullayeva, E.
|
|
|
27 |
6S |
p. S120
|
artikel
|
| 553 |
EE124 Real-World Mental Health Burden in Patients With Chronic Lymphocytic Leukemia
|
Lien, PW
|
|
|
27 |
6S |
p. S80
|
artikel
|
| 554 |
EE503 Real-World Treatment Patterns, Healthcare Resource Utilization (HCRU) and Healthcare Costs (HCC) of Patients with Small-Cell Lung Cancer (SCLC) in the US
|
Suri, G
|
|
|
27 |
6S |
p. S149
|
artikel
|
| 555 |
EE394 Redefining the Scope: The Urgent Need for Holistic Multiple Sclerosis Modeling in Health Economics
|
Bergemann, R
|
|
|
27 |
6S |
p. S129-S130
|
artikel
|
| 556 |
EE318 Reduction of Costs Associated With the Use of Emicizumab in Prophylaxis in Pediatric Patients Diagnosed With Severe Hemophilia A and Inhibitors in El Salvador
|
Estrada, A
|
|
|
27 |
6S |
p. S116
|
artikel
|
| 557 |
EE477 Reductions in Real-World Healthcare Resource Utilization Among United States Hereditary Angioedema (HAE) Patients Following Berotralstat Initiation
|
Christiansen, S
|
|
|
27 |
6S |
p. S144
|
artikel
|
| 558 |
EE187 Remdesivir Reduced Healthcare Resource Utilization in Patients Hospitalized With COVID-19 During the Omicron-Dominant Period
|
Gupta, R
|
|
|
27 |
6S |
p. S91-S92
|
artikel
|
| 559 |
EE214 Remote Monitoring As a Digital Health Intervention in the Management of Heart Failure in the United Kingdom: A Cost-Effectiveness Analysis
|
Gangar, K
|
|
|
27 |
6S |
p. S96
|
artikel
|
| 560 |
EE453 Research and Clinical Delivery Costs of a Mobile Health Approach for Hypertension Management in Uncontrolled Hypertensive African Americans: A Cost Analysis
|
Zhang, H
|
|
|
27 |
6S |
p. S140
|
artikel
|
| 561 |
EE405 Residual Burden in Adalimumab-Treated Patients with Hidradenitis Suppurativa
|
Kimball, A.B.
|
|
|
27 |
6S |
p. S131
|
artikel
|
| 562 |
EE386 Restoration of Endodontically Treated Teeth: A Cost-Effectiveness Analysis of Endocrown Versus Complete Crown
|
Naved, N
|
|
|
27 |
6S |
p. S128
|
artikel
|
| 563 |
EE291 Schizophrenia and Bipolar Disorder Burden and Economic Burden Under an Impact Analysis by Therapeutic Scheme
|
Colimon, S
|
|
|
27 |
6S |
p. S111
|
artikel
|
| 564 |
EE4 Should NICE Consider Adoption of a Societal Perspective? Comparison of the ICER 2023 Value Assessment Framework with the NICE 2022 Methods Guide
|
Lee, A
|
|
|
27 |
6S |
p. S57
|
artikel
|
| 565 |
EE170 Social and Clinical Factors Influencing ED Utilization Behavior Amongst Blue Cross Blue Shield of Louisiana Members: A Cluster Analysis
|
Mousavian, M
|
|
|
27 |
6S |
p. S89
|
artikel
|
| 566 |
EE469 Societal Costs of Alzheimer's Disease: Informal Caregiver Burden and Patient Productivity Loss
|
Fox, J
|
|
|
27 |
6S |
p. S143
|
artikel
|
| 567 |
EE424 Societal Costs of Spinal Muscular Atrophy Type 1 for Patients Treated with Onasemnogene Abeparvovec or Nusinersen in the United Kingdom
|
Kleintjens, J
|
|
|
27 |
6S |
p. S135
|
artikel
|
| 568 |
EE493 Sociodemographic Factors of Asthma Prevalence and Costs for Children in the United States, 2016-2021
|
Wang, N
|
|
|
27 |
6S |
p. S147
|
artikel
|
| 569 |
EE85 Sources of Increased Expenditures for Young Children with Autism Spectrum Disorder Diagnoses in Employer-Sponsored Plans, 2016–2021
|
Lamsal, R
|
|
|
27 |
6S |
p. S73
|
artikel
|
| 570 |
EE358 Systematic Literature Review of Cost-Effectiveness Analyses of Adult 15- and 20-Valent Pneumococcal Vaccines
|
Cho, JY
|
|
|
27 |
6S |
p. S123
|
artikel
|
| 571 |
EE8 Targeted Literature Review for Estimating Median Age of Causal Human Papilloma Virus Infection to Oropharyngeal Cancer
|
Mohamed, AF
|
|
|
27 |
6S |
p. S58
|
artikel
|
| 572 |
EE243 Targeted Literature Review of Cost-Effectiveness Analyses in Sickle Cell Disease: Identifying the Optimal Modeling Approach for Therapies Targeting Sickle Hemoglobin Polymerization
|
Taylor, A
|
|
|
27 |
6S |
p. S101
|
artikel
|
| 573 |
EE290 Targeted Literature Review of Cost-Effectiveness Models in Relapsed/Refractory Follicular Lymphoma
|
Gaballa, S
|
|
|
27 |
6S |
p. S111
|
artikel
|
| 574 |
EE444 Target Trial Emulation with Real-World Data to Determine the Population-Level Cost-Effectiveness of Multi-Gene Panel Sequencing for Advanced Melanoma
|
Krebs, E
|
|
|
27 |
6S |
p. S138
|
artikel
|
| 575 |
EE156 Temporal Excess Hospital Costs of Complications in Chinese Patients With Type 2 Diabetes: Results from the Joint Asia Diabetes Evaluation (JADE) Register (2007-2018)
|
Lui, J
|
|
|
27 |
6S |
p. S86
|
artikel
|
| 576 |
EE31 The Annual Economic Burden of PFO-Related Cryptogenic Stroke in the U.S.: A Cost-of-Illness Study
|
Nakum, M
|
|
|
27 |
6S |
p. S62
|
artikel
|
| 577 |
EE475 The Benefit-Cost Analysis Adjustment Through the Generalized Risk-Adjustment Cost-Effectiveness (GRACE) Framework: An Application on Acute Ischemic Stroke Patients
|
Hsu, L
|
|
|
27 |
6S |
p. S144
|
artikel
|
| 578 |
EE339 The Biosimilars’ Economic Evaluation in Contrast With Judicializations’ Economic Impacts of the Pharmaceutical Assistance in Brazil
|
Tanaka, E
|
|
|
27 |
6S |
p. S119-S120
|
artikel
|
| 579 |
EE238 The Budget Impact of Establishing a County-Level Cancer Prevention and Care Center in China
|
Huang, E
|
|
|
27 |
6S |
p. S100
|
artikel
|
| 580 |
EE376 The Budget Impact of Introducing Multiparametric MRI (mpMRI) As a Monitoring Tool to Identify Non-Responders Undergoing Thyroid Hormone Receptor Treatment for MASH
|
French, M
|
|
|
27 |
6S |
p. S126
|
artikel
|
| 581 |
EE310 The Burden of Blood Transfusions Associated With Lower-Risk Myelodysplastic Syndromes (LR-MDS): Findings From a Survey of Health Care Professionals (HCPs) in Brazil, Germany, and Japan
|
Hnoosh, A
|
|
|
27 |
6S |
p. S114
|
artikel
|
| 582 |
EE52 The Burden of Intravenous vs Subcutaneous Oncological Products Application in Honduras
|
Hidalgo, J
|
|
|
27 |
6S |
p. S66
|
artikel
|
| 583 |
EE254 The Cost-Consequence of Budesonide/Formoterol Plus As-Needed Saba As Treatment for 6-12 Years Old Pediatric Asthma Patients in ChinaBased on Real-World Data
|
Zuo, C
|
|
|
27 |
6S |
p. S103-S104
|
artikel
|
| 584 |
EE177 The Cost-Effectiveness Analysis of Anaprazole Versus Ilaprazole for Treating Duodenal Ulcers in China
|
Ni, H
|
|
|
27 |
6S |
p. S90
|
artikel
|
| 585 |
EE497 The Cost-Effectiveness of Semaglutide 2.4MG in Patients With Overweight/Obesity and Cardiovascular Disease From the Select Trial
|
McEwan, P
|
|
|
27 |
6S |
p. S148
|
artikel
|
| 586 |
EE70 The Cost of Chronic Lung Allograft Dysfunction (CLAD) in Lung Transplant (LTx) Recipients By Stage 0-4: A Claims Database Analysis
|
Minshall, ME
|
|
|
27 |
6S |
p. S70
|
artikel
|
| 587 |
EE195 The Cost of Missing Physiotherapy Appointments
|
Mohammed, Selim S
|
|
|
27 |
6S |
p. S93
|
artikel
|
| 588 |
EE456 The Cost of Reusable Cystoscopy: A Microcosting Evaluation at a U.S. Academic Medical Center
|
Hassig, S
|
|
|
27 |
6S |
p. S140-S141
|
artikel
|
| 589 |
EE334 The Diagnostic Odyssey and Cost-Effectiveness of Genomic Testing in Indigenous Children in British Columbia, Canada
|
Regier, DA
|
|
|
27 |
6S |
p. S119
|
artikel
|
| 590 |
EE216 The Direct Economic Burden of Obesity and Obesity-Related Comorbidities (ORC) in the United States (US): A Systematic Review
|
Bjornson, A.M.
|
|
|
27 |
6S |
p. S97
|
artikel
|
| 591 |
EE414 The Disparities in the Willingness to Pay for Health Benefits Between Prevention and Treatment Among Patients With Chronic Diseases in Saudi Arabia
|
Almalki, Z
|
|
|
27 |
6S |
p. S133
|
artikel
|
| 592 |
EE161 The Economic Burden of BRCA+ Metastatic Castration Resistant Prostate Cancer: Expert Perspective in LATAM Countries
|
La-Gatta, L.
|
|
|
27 |
6S |
p. S87
|
artikel
|
| 593 |
EE154 The Economic Burden of HER2+ Breast Cancer and the Epidemiological & Economic Impact of Targeted Therapies in the Dominican Republic
|
Hidalgo, J
|
|
|
27 |
6S |
p. S85-S86
|
artikel
|
| 594 |
EE419 The Economic Burden of Thyroid Eye Disease in the Kingdom of Saudi Arabia
|
Alzahrani, A
|
|
|
27 |
6S |
p. S134
|
artikel
|
| 595 |
EE89 The Economic Impact of Anti-Scorpion Serum in the Management of Scorpion Envenomation in Algeria
|
Benazzouz, S
|
|
|
27 |
6S |
p. S74
|
artikel
|
| 596 |
EE145 The Economic Impact of Overweight and Obesity-Related Diseases in Colombia
|
Ordoñez, J
|
|
|
27 |
6S |
p. S84
|
artikel
|
| 597 |
EE266 The Economics Promises of a Cure: Best Practices to Guide Economic Negotiations for the Reimbursement of Curative Therapies for Cancer
|
Perez-Kempner, L.
|
|
|
27 |
6S |
p. S106
|
artikel
|
| 598 |
EE60 The Excessive Burden of Low SES Caregivers: Evidence from Stroke Survivors Through CHARLS Data (2011-2018)
|
Hsu, L
|
|
|
27 |
6S |
p. S68
|
artikel
|
| 599 |
EE80 The Health Equity Impact of a Hypothetical Disease-Modifying Treatment for Alzheimer's Disease in the United States: A Distributional Cost-Effectiveness Analysis
|
Synnott, P
|
|
|
27 |
6S |
p. S72
|
artikel
|
| 600 |
EE470 The Impact of a Cost Savings Cap on the Cost Effectiveness of Valoctocogene Roxaparvovec for the Treatment of Hemophilia A in the United States
|
Sarker, J
|
|
|
27 |
6S |
p. S143
|
artikel
|
| 601 |
EE197 The Impact of Funding Tocilizumab for the Inpatient Treatment of COVID-19 in the United States: A Distributional Cost-Effectiveness Analysis
|
Rosettie, KL
|
|
|
27 |
6S |
p. S93
|
artikel
|
| 602 |
EE10 The Impact of Spinal Muscular Atrophy Type 1 (SMA1) on Caregivers in Brazil: Results of a Global Survey
|
Patel, A
|
|
|
27 |
6S |
p. S58
|
artikel
|
| 603 |
EE148 The Institutional Level Impact of Additional Apheresis Days for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation on Costs and Healthcare Resource Utilization
|
Skaar, J
|
|
|
27 |
6S |
p. S84-S85
|
artikel
|
| 604 |
EE460 Theoretical Exploration of the Inclusion of Non-Traditional Multiple Sclerosis Measurement Variables on the Cost-Effectiveness of Future Treatments
|
Poirrier, JE
|
|
|
27 |
6S |
p. S141
|
artikel
|
| 605 |
EE427 The Reduction in Medical and Care Costs for Diseases Associated with Being Bedridden in Rural Residents in Japan
|
Shoji, A
|
|
|
27 |
6S |
p. S135
|
artikel
|
| 606 |
EE422 “This Isn’t a Life”: An Analysis of EQ-5D in a Cohort of Individuals with Long COVID Symptoms
|
McCullough, A
|
|
|
27 |
6S |
p. S134-S135
|
artikel
|
| 607 |
EE87 Time-Driven Activity Based Costing of Advanced Ovarian Cancer From the Perspective of a Brazilian Public Hospital
|
Costa, R
|
|
|
27 |
6S |
p. S73
|
artikel
|
| 608 |
EE129 Tools for the Critical Appraisal of Health Economic Analyses: A Scoping Review
|
Borges, Migliavaca C
|
|
|
27 |
6S |
p. S81
|
artikel
|
| 609 |
EE83 Total Costs and Cost Savings of Comprehensive Knee Osteoarthritis Management Combined With Total Knee Arthroplasty in an Ambulatory Surgical Center
|
Sauder, N
|
|
|
27 |
6S |
p. S72-S73
|
artikel
|
| 610 |
EE272 Treating Patients With Non-Valvular Atrial Fibrillation With Apixaban Provides Substantial Consumer Value and Surplus Compared With Warfarin and Rivaroxaban
|
Johannesen, K
|
|
|
27 |
6S |
p. S107
|
artikel
|
| 611 |
EE407 Treatment Patterns and Healthcare Resource Utilization in Ruxolitinib-Treated Patients with Myelofibrosis with and without Anemia: A Real-World Analysis
|
Liu, T
|
|
|
27 |
6S |
p. S132
|
artikel
|
| 612 |
EE371 Treatment Patterns, Healthcare Resource Use, and Costs Among US Patients With Epidermal Growth Factor Receptor Mutated (EGFRm) Metastatic Non-Small Cell Lung Cancer (mNSCLC) After Discontinuation of Osimertinib
|
Moore-Schiltz, L.
|
|
|
27 |
6S |
p. S125-S126
|
artikel
|
| 613 |
EE265 Treatment Patterns, Healthcare Resource Utilization and Costs, and Clinical Outcomes Among Elderly Patients With Advanced HER2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma
|
Wang, L
|
|
|
27 |
6S |
p. S106
|
artikel
|
| 614 |
EE64 Treatment-Related Costs of Ponatinib and Asciminib in Adults Patients with T315I-Positive Chronic Phase Chronic Myeloid Leukemia with Resistance or Intolerance to at Least Two Prior Kinase Inhibitors in the United States
|
Hernandez, LG
|
|
|
27 |
6S |
p. S69
|
artikel
|
| 615 |
EE186 Trends in Cost of Treatment with Immuno-oncology Drugs in the US
|
Ranjan, S
|
|
|
27 |
6S |
p. S91
|
artikel
|
| 616 |
EE92 Trends in Incidence and Economic Burden of Pneumonia in the United States from 2016-2021
|
Bandy, S
|
|
|
27 |
6S |
p. S74
|
artikel
|
| 617 |
EE71 Understanding Pharmacy Costs and the Changing Treatment Landscape in Huntington's Disease (HD) in the US: A Systematic Literature Review (SLR) and Database Review for Disease-Modifying Therapies (DMT) in Development
|
Knott, C
|
|
|
27 |
6S |
p. S70
|
artikel
|
| 618 |
EE43 Understanding the Humanistic and Economic Burden Associated with Early-Stage HR+/HER2- Breast Cancer: A Systematic Literature Review
|
Earla, JR
|
|
|
27 |
6S |
p. S64-S65
|
artikel
|
| 619 |
EE276 Understanding Trends in Launch Prices across Canada, EU4, UK and the US for High-Revenue Drugs
|
Das, M
|
|
|
27 |
6S |
p. S108
|
artikel
|
| 620 |
EE401 Unlocking the Economic Potential of Digital Health Interventions in Cardiovascular and Metabolic Diseases
|
Gautam, R
|
|
|
27 |
6S |
p. S130
|
artikel
|
| 621 |
EE357 Using a Computer Vision-Based System for Reading Skin Prick Test Results: A Cost-Minimisation Analysis
|
Uwitonze, J
|
|
|
27 |
6S |
p. S123
|
artikel
|
| 622 |
EE490 Utilization and Costs of Patients With Type-2 Diabetes and Cardiovascular Disease Treated With Sodium Glucose Cotransporter-2 Inhibitors and Glucagon Like Peptide-1 Receptor Agonists
|
Shrikhande, M
|
|
|
27 |
6S |
p. S146-S147
|
artikel
|
| 623 |
EE208 Utilization, Expenditure and Price of Muscular Dystrophy-Duchenne Medications in the US Medicaid Programs: Trends From 2017 to 2022
|
Ghawaa, Y
|
|
|
27 |
6S |
p. S95
|
artikel
|
| 624 |
EE104 Value Assessment of Emerging Treatments for Nonalcoholic Steatohepatitis: Lessons from Institute for Clinical and Economic Review Evaluations
|
Herring, W
|
|
|
27 |
6S |
p. S76
|
artikel
|
| 625 |
EE474 Value Assessment Under Uncertainty: Measuring Insurance Value and Risk Aversion for a Novel Neurological Treatment Using a Stated Preference Survey
|
Shafrin, J
|
|
|
27 |
6S |
p. S144
|
artikel
|
| 626 |
EE95 Value Comparison of BACT/ALERT®; VIRTUO® System Versus BD BACTEC™ FX Blood Culture System from a Provider Perspective
|
Krishnamurthy, P
|
|
|
27 |
6S |
p. S75
|
artikel
|
| 627 |
EE42 Value of Being the First Biosimilar Entrant
|
McGeeney, J.D.
|
|
|
27 |
6S |
p. S64
|
artikel
|
| 628 |
EE28 Value of Knowing Risk of Developing Neurodegenerative Disease: A Discrete Choice Experiment
|
Crummer, E
|
|
|
27 |
6S |
p. S62
|
artikel
|
| 629 |
EE498 What Are the Total Costs of Comprehensive Outpatient Management of Carpal Tunnel and Trigger Finger Using Time Driven Activity Based Costing Models?
|
Sauder, N
|
|
|
27 |
6S |
p. S148
|
artikel
|
| 630 |
EE433 Why Economic Methods for Discounting Are Wrong, What Are the Consequences, and How to Fix It
|
Phelps, C
|
|
|
27 |
6S |
p. S136
|
artikel
|
| 631 |
EE478 Willingness to Pay Study for Migraine Medications in Argentina
|
Ares L, Rey
|
|
|
27 |
6S |
p. S144-S145
|
artikel
|
| 632 |
EE443 Work Loss Associated with Adult Vaccinations in Pharmacy and Healthcare Professional Office Settings in the United States
|
La, E
|
|
|
27 |
6S |
p. S138
|
artikel
|
| 633 |
EE250 Work Productivity Loss Among Adults Aged 18–64 Years With Osteoarthritis in the United States: 2016-2020
|
Khalid, J
|
|
|
27 |
6S |
p. S103
|
artikel
|
| 634 |
EPH196 A Claims-Based Analysis of Weight Management in Pediatric Populations Covered By Commercial or Medicaid Insurance
|
Brady, B
|
|
|
27 |
6S |
p. S187
|
artikel
|
| 635 |
EPH131 Adolescent Pregnancy Before and During the SARS Cov-2 Pandemic in Cartagena De Indias, Colombia 2015 - 2021
|
Alvis, Zakzuk NR
|
|
|
27 |
6S |
p. S177
|
artikel
|
| 636 |
EPH132 Adverse Drug Reaction-Related Hospital Admission in Older Australians With Dementia
|
Parameswaran, Nair N
|
|
|
27 |
6S |
p. S177-S178
|
artikel
|
| 637 |
EPH139 Adverse Events Associated with Enzyme Replacement Therapies Lysosomal Glycogen-Specific Enzyme (GAA) Medications for the Treatment of Pompe Disease
|
Halloush, S
|
|
|
27 |
6S |
p. S178-S179
|
artikel
|
| 638 |
EPH191 Age-Related Trends of Blood Glucose, Hyperglycemia, and Type 2 Diabetes in Youth Prescribed Second-Generation Antipsychotic Medications
|
Zeng, Z
|
|
|
27 |
6S |
p. S187
|
artikel
|
| 639 |
EPH198 Analyzing the Impact of Colorectal Cancer Diagnosis on Treatment Adherence Amongst Patients With Preexisting Hypertension
|
Patel, CM
|
|
|
27 |
6S |
p. S188
|
artikel
|
| 640 |
EPH217 Annual Epidemiological and Health Insurance Disease Burden of Endometriosis in Hungary Based on Real-World Health Insurance Claims Data
|
Kajos, L
|
|
|
27 |
6S |
p. S191
|
artikel
|
| 641 |
EPH38 Antimicrobial Susceptibility of Klebsiella Pneumoniae Clinical Isolates From the Lower Respiratory Tract Infection During the COVID-19 Pandemic in Brazil (SMART 2020-2021)
|
Bittencourt, AA
|
|
|
27 |
6S |
p. S160
|
artikel
|
| 642 |
EPH55 An Updated View on the Initial Opioid Prescription Characteristics and Pain Etiologies That Influence Long-Term Opioid Use Among Opioid Naïve Patients
|
Smith, A
|
|
|
27 |
6S |
p. S163
|
artikel
|
| 643 |
EPH102 Application of a Quasi-Experimental Study Design to Pharmacoepidemiology: An Evaluation of Immune Checkpoint Inhibitor Therapy and Cholangitis Using Real-World Data As a Case Study
|
Izadi, Z
|
|
|
27 |
6S |
p. S171-S172
|
artikel
|
| 644 |
EPH171 A Qualitative Survey Analysis for Understanding COVID-19 Vaccine Hesitancy in the United States
|
Pathan, M
|
|
|
27 |
6S |
p. S184
|
artikel
|
| 645 |
EPH12 A Retrospective Natural History Study of Incident Adult Dermatomyositis and Polymyositis Patients Using Real World Data
|
Barnes, D
|
|
|
27 |
6S |
p. S156
|
artikel
|
| 646 |
EPH160 A Risk Stratification Analysis of ASCVD Events Post-Statin Discontinuation in Bariatric Surgery Patients
|
Alsuhibani, A
|
|
|
27 |
6S |
p. S181-S182
|
artikel
|
| 647 |
EPH212 Assessing Intersectional Differences in Myocardial Infarction Among Same Race/Ethnicity Transgender and Cisgender Adults Using 2017-2022 Behavioral Risk Factor Surveillance System Data
|
Mercer, J
|
|
|
27 |
6S |
p. S190
|
artikel
|
| 648 |
EPH207 Assessing Secular Trends in Cancer Stage at Initial Diagnosis in the United States Community Oncology Setting from 2015 to 2023
|
Su, Z
|
|
|
27 |
6S |
p. S189-S190
|
artikel
|
| 649 |
EPH4 Assessing the Association Between Body Mass Index, Cholesterol, and Cancer Among United States Adults in the Medical Expenditure Panel Survey Using a Cross-Sectional Design
|
Martinovic, A
|
|
|
27 |
6S |
p. S154
|
artikel
|
| 650 |
EPH64 Assessing the Relationship Between Pain Intensity and Health Status Among Older US Adult Opioid Users With Pain
|
Axon, D
|
|
|
27 |
6S |
p. S164-S165
|
artikel
|
| 651 |
EPH202 Assessing Trends in Utilization and Off-Label Prescribing for Ozempic, a Glucagon-like Peptide Receptor Agonist
|
Muñoz, E
|
|
|
27 |
6S |
p. S188
|
artikel
|
| 652 |
EPH175 Assessment of Streptococcus Pneumoniae as Cause of Acute Otitis Media in Young Children in Colombia: A Prospective Study
|
Coronell-Rodriguez, W
|
|
|
27 |
6S |
p. S184
|
artikel
|
| 653 |
EPH98 Association Between Social Vulnerability and Opioid Dispensing By Contiguous County in the United States
|
Yip, WCO
|
|
|
27 |
6S |
p. S171
|
artikel
|
| 654 |
EPH14 Association between the Use of Macrolide Antibiotics and Recurrent Wheezing in Hospitalized Infants with Bronchiolitis
|
Suh, HS
|
|
|
27 |
6S |
p. S156
|
artikel
|
| 655 |
EPH86 Association of Long-COVID with Depression Among Adults in the United States
|
Akpan, N
|
|
|
27 |
6S |
p. S169
|
artikel
|
| 656 |
EPH127 Association of Marijuana Use With Poor Mental Health Among Non-Institutionalized Adults in the US
|
Pathak, M
|
|
|
27 |
6S |
p. S176-S177
|
artikel
|
| 657 |
EPH226 Associations between Antimicrobial Susceptibility of Streptococcus Pneumoniae and Disease Severity Outcomes in Older Adults with Invasive Pneumococcal Disease in Sao Paulo, Brazil
|
Ferraz, Cereda R
|
|
|
27 |
6S |
p. S193
|
artikel
|
| 658 |
EPH126 A Systematic Review of the Application of Health Behavioral Theories in Drug Disposal and Reuse
|
Pathan, M
|
|
|
27 |
6S |
p. S176
|
artikel
|
| 659 |
EPH59 A Systematic Review on the Health Equity Disparities in Lupus Treatment: Medicaid Vs. Private Payer Outcomes
|
Wang, B
|
|
|
27 |
6S |
p. S164
|
artikel
|
| 660 |
EPH92 A Targeted Literature Review on Medication Adherence: A Biologics and Biosimilars Collective Intelligence Consortium (BBCIC) Study
|
Smith, S
|
|
|
27 |
6S |
p. S170
|
artikel
|
| 661 |
EPH39 A Targeted Literature Review (TLR) of Clinical, Humanistic, and Economic Burden of Alzheimer’s Disease (AD) in the United States (US)
|
Kern, R
|
|
|
27 |
6S |
p. S160
|
artikel
|
| 662 |
EPH68 Baseline Characteristics of Pediatric and Adult Patients with ADHD Prescribed Viloxazine ER, Stimulants or Atomoxetine, in Open Claims Data
|
Chorniy, A
|
|
|
27 |
6S |
p. S165
|
artikel
|
| 663 |
EPH32 Behaviors and Characteristics of Current and Previous Users of Glucagon-like Peptide-1 Receptor Agonists (GLP-1) in an Online Health Community
|
Marshall, NJ
|
|
|
27 |
6S |
p. S159
|
artikel
|
| 664 |
EPH241 Benzodiazepines and Adrenergic beta2-Agonists: A Synergistic Impact on Health-Related Quality of Life Among Older Adults with Prostate Cancer
|
Yue, Z
|
|
|
27 |
6S |
p. S195
|
artikel
|
| 665 |
EPH148 Bridging the Gap: Understanding Prostate Cancer Patient Characteristics in Clinical Trials
|
McGovern, A
|
|
|
27 |
6S |
p. S180
|
artikel
|
| 666 |
EPH159 Burden of COVID-19 and Its Associated Clinical Characteristics in Colombia: A Retrospective Database Analysis
|
Arciniegas, J
|
|
|
27 |
6S |
p. S181
|
artikel
|
| 667 |
EPH213 Burden of Heart Failure After Hospitalization for Myocardial Infarction in the United States: A Targeted Literature Review
|
Bjornson, AM
|
|
|
27 |
6S |
p. S190-S191
|
artikel
|
| 668 |
EPH65 Burden of Illness of Osteogenesis Imperfecta in Ontario, Canada
|
Yang, E
|
|
|
27 |
6S |
p. S165
|
artikel
|
| 669 |
EPH21 Burden of Unresectable/Metastatic Melanoma(u-mMel) and Advanced/Metastatic Colorectal Cancer(mCRC), and Their Associated BRAF-mutations in Four LATAM Countries: A Targeted Literature Review of Epidemiological and Economic Evidence
|
Baldi, Castro JJ
|
|
|
27 |
6S |
p. S157
|
artikel
|
| 670 |
EPH16 Changes in Neutropenia Outcomes Following Implementation of the Clozapine Risk Evaluation and Mitigation Strategy Update
|
Chang, J
|
|
|
27 |
6S |
p. S156
|
artikel
|
| 671 |
EPH34 Changes in the Epidemiological Burden of Breast Neoplasms in Colombia After the Cancer Control Model
|
Vargas, R
|
|
|
27 |
6S |
p. S159
|
artikel
|
| 672 |
EPH6 Changes in the Midwives Density per 1,000 Live Births in Europe
|
Elmer, D
|
|
|
27 |
6S |
p. S154-S155
|
artikel
|
| 673 |
EPH58 Changes in the Number of Different Categories of Specialists in Europe
|
Elmer, D
|
|
|
27 |
6S |
p. S163-S164
|
artikel
|
| 674 |
EPH40 Changing Role of Comorbidities in Risk of Mortality Among Elderly Patients Diagnosed with COVID-19 in the United States: Examining Pre- and Post-Vaccine Clinical Risk Factors
|
Doshi, R
|
|
|
27 |
6S |
p. S160
|
artikel
|
| 675 |
EPH225 Characteristics of Patients with Transthyretin Amyloidosis and Methodological Approaches for Establishing Clinical Subtype in the Netherlands
|
Jeswani, N
|
|
|
27 |
6S |
p. S193
|
artikel
|
| 676 |
EPH107 Characteristics of the COVID-19 Epidemic in Three Hungarian Disctricts
|
Kokos, R
|
|
|
27 |
6S |
p. S173
|
artikel
|
| 677 |
EPH197 Characterization of Adult Patients With Primary Chronic Immune Thrombocytopenia Using US Administrative Claims Data
|
Blein, C
|
|
|
27 |
6S |
p. S188
|
artikel
|
| 678 |
EPH162 Characterizing Antimicrobial Resistance Post-Hospitalization: A Retrospective Analysis Using Administrative Claims Data
|
Arackal, J
|
|
|
27 |
6S |
p. S182
|
artikel
|
| 679 |
EPH50 Characterizing the Prevalence of Metabolic Dysfunction-Associated Steatohepatitis (MASH) Among Adults ≥65 Years of Age in the United States (US) Using Three Real-World Cohorts
|
Kim, Y
|
|
|
27 |
6S |
p. S162
|
artikel
|
| 680 |
EPH204 Chronic Liver Disease Is Associated with Greater Risk of Hospital Readmission in Patients with Heart Failure: A Nationwide Database Study in the US
|
Chen, HK
|
|
|
27 |
6S |
p. S189
|
artikel
|
| 681 |
EPH26 Claims-Based Analysis of the Prevalence, Characteristics, Healthcare Utilization, and Costs of Adolescents and Young Adults With Non-Remission Major Depressive Disorder in the United States, 2016-2022
|
Evans, KA
|
|
|
27 |
6S |
p. S158
|
artikel
|
| 682 |
EPH177 Clinical and Sociodemographic Characteristics of Patients With Vitiligo in Colombia: Preliminary Results From REVIC
|
Moyano, Tamara L
|
|
|
27 |
6S |
p. S185
|
artikel
|
| 683 |
EPH73 Clinical Characteristics of Patients in the Intensive Care Unit with Infections Caused By Multiresistant Gram-Negative Bacteria
|
Reyes, Sanchez JM
|
|
|
27 |
6S |
p. S166-S167
|
artikel
|
| 684 |
EPH108 Clopidogrel Resistance in Patients With Recurrent Ischaemic Stroke on Dual Antiplatelet Therapy and Its Economic Impact in a Lower-Middle Income Country: A Single Centered Study in Southern India
|
Carlman, C
|
|
|
27 |
6S |
p. S173
|
artikel
|
| 685 |
EPH140 Comparative Effectiveness of Direct Oral Anticoagulants Versus Low-Molecular Weight Heparins in Cancer Associated Thrombosis
|
Yande, S
|
|
|
27 |
6S |
p. S179
|
artikel
|
| 686 |
EPH8 Comparison of Patient Identification Methodologies in Chronic Inflammatory Demyelinating Polyneuropathy Using United States Administrative Claims Data
|
Blein, C
|
|
|
27 |
6S |
p. S155
|
artikel
|
| 687 |
EPH176 Comparison of Superoxide Dismutase Activities (Mn-SOD AND Cu/Zn-SOD) in Patients Infected with Dengue Virus or Zika Virus
|
Castro-Orozco, R
|
|
|
27 |
6S |
p. S184-S185
|
artikel
|
| 688 |
EPH230 County-Level Social Vulnerability Is Associated With Lower Pneumococcal Vaccine Uptake Among Medicare Beneficiaries in the United States (2016-2019)
|
Mohanty, S
|
|
|
27 |
6S |
p. S194
|
artikel
|
| 689 |
EPH5 COVID-19 Vaccine Acceptance Disparities Among Foreign-Born and US-Born Individuals in California: A 2021 Cross-Sectional Analysis
|
Sepassi, A
|
|
|
27 |
6S |
p. S154
|
artikel
|
| 690 |
EPH203 Cytomegalovirus Prevalence in Allogeneic Hematopoietic Stem Cell Transplant Recipients From a Mexican Oncologic Reference Center
|
Valero-Saldaña, LM
|
|
|
27 |
6S |
p. S189
|
artikel
|
| 691 |
EPH96 Descriptive Statistics and Disease Prevalence from an Electronic Health Record Data Collective across 30+ US Health Systems
|
Guin, S
|
|
|
27 |
6S |
p. S171
|
artikel
|
| 692 |
EPH37 Determinants of COVID-19 Vaccine Acceptance Among Nigerian Adults
|
Afolayan, OK
|
|
|
27 |
6S |
p. S159-S160
|
artikel
|
| 693 |
EPH11 Determinants of Mammography Screening Participation– A Cross-Sectional Analysis of the Hungarian Sample
|
Vajda, R
|
|
|
27 |
6S |
p. S155-S156
|
artikel
|
| 694 |
EPH111 Diabetes' Prevalence by Gender, Age, and Race in the United States (Trends Between 2005 and 2019)
|
Umoru, D
|
|
|
27 |
6S |
p. S173-S174
|
artikel
|
| 695 |
EPH134 Difference in E-Cigarette Use Prevalence in Adolescents between 2019 and 2021 in Georgia, United States
|
Gannavarapu, P
|
|
|
27 |
6S |
p. S178
|
artikel
|
| 696 |
EPH228 Disability and Workers’ Compensation Absences Associated With Major Depressive Disorder and the Overlap With Family Medical Leaves Among United States Employees
|
Brook, R
|
|
|
27 |
6S |
p. S193
|
artikel
|
| 697 |
EPH157 Does COVID-19 Related Lockdown Restrictions Impact People With Musculoskeletal Disorders? A Systematic Review
|
Fatoye, F
|
|
|
27 |
6S |
p. S181
|
artikel
|
| 698 |
EPH133 Economic Burden of Invasive Meningococcal Disease in Individuals With Commercial and Medicare Insurance in the United States
|
Herrera-Restrepo, O
|
|
|
27 |
6S |
p. S178
|
artikel
|
| 699 |
EPH224 Effectiveness of COVID-19 Vaccines in Colombia: Findings from Two Highly Specialized Healthcare Centers
|
Cortés, Luna JA
|
|
|
27 |
6S |
p. S192
|
artikel
|
| 700 |
EPH54 Enhancing BMI Data Accuracy: A Comparison of Claims and Electronic Health Records (EHR) Database
|
Noman, A
|
|
|
27 |
6S |
p. S163
|
artikel
|
| 701 |
EPH200 Epidemiological Disease Burden of Female Infertility Associated with Male Factors Based on Routinely Collected Health Data between 2010-2019
|
Pónusz-Kovács, D
|
|
|
27 |
6S |
p. S188
|
artikel
|
| 702 |
EPH63 Epidemiological Disease Burden of Female Infertility of Other Origin Based on Routinely Collected Health Insurance Claims Data between 2010-2019
|
Pónusz-Kovács, D.
|
|
|
27 |
6S |
p. S164
|
artikel
|
| 703 |
EPH22 Epidemiology and Treatment Patterns of Colombian Patients With Metastatic Colorectal
|
Bolaños-López, J.
|
|
|
27 |
6S |
p. S157
|
artikel
|
| 704 |
EPH173 Estimating the Utilization of Doxycycline Post-Exposure Prophylaxis (DoxyPEP) and the Impact on Syphilis Rates in Colorado
|
Bianchini, M
|
|
|
27 |
6S |
p. S184
|
artikel
|
| 705 |
EPH101 Estimating Total Number of Influenza Cases From Reported Hospitalizations: A Multi-Country Comparison of the Multiplier Method
|
Park, Y
|
|
|
27 |
6S |
p. S171
|
artikel
|
| 706 |
EPH161 Estimation of the Size of the Eligible Population in the United States for Resmetirom: A Novel Investigational Therapy for NASH
|
Kim, Y
|
|
|
27 |
6S |
p. S182
|
artikel
|
| 707 |
EPH42 Evaluating the Public Health Impact of Dengue Vaccination in Indonesia: A Dynamic Transmission Modeling Assessment amidst Uncertainties in the Implementation Strategies
|
Garba, S
|
|
|
27 |
6S |
p. S160
|
artikel
|
| 708 |
EPH187 Examinating the Safety of Recently Approved Drugs for Cardiovascular Disease Using A Large Database
|
Park, T
|
|
|
27 |
6S |
p. S186
|
artikel
|
| 709 |
EPH7 Examination of Weight-Related Coding Practices in Administrative Claims: Implications for Future Analyses
|
Brady, B
|
|
|
27 |
6S |
p. S155
|
artikel
|
| 710 |
EPH124 Examining the Effect of Hypertension, Type-2 Diabetes Mellitus, Hyperlipidemia, and Obesity on Endometrial Cancer Staging
|
Bhuyan, A
|
|
|
27 |
6S |
p. S176
|
artikel
|
| 711 |
EPH223 Excess of Mortality By Asthma during COVID-19 Pandemic in Colombia
|
Alvis-Guzman, N
|
|
|
27 |
6S |
p. S192
|
artikel
|
| 712 |
EPH233 Exploring Disparities in Prep Prescriptions for High-Risk HIV Patients Using Real-World Data
|
Murdock, A
|
|
|
27 |
6S |
p. S194
|
artikel
|
| 713 |
EPH144 Exploring the Effectiveness and Engagement of Local Communities in Maternity Care Models for Women with Refugee and Migrant Backgrounds and Its Impact on Enhancing Perinatal Health Outcomes: A Comprehensive Systematic Review
|
Yeshitila, Y
|
|
|
27 |
6S |
p. S179
|
artikel
|
| 714 |
EPH116 Factors Influencing the Use of Second-Generation Antipsychotics in Patients With Autism Spectrum Disorders
|
Daggolu, J
|
|
|
27 |
6S |
p. S174
|
artikel
|
| 715 |
EPH103 Fatal Outcomes from Drug Interactions: Insights from the FDA Adverse Event Reporting System
|
Gómez-Lumbreras, A
|
|
|
27 |
6S |
p. S172
|
artikel
|
| 716 |
EPH145 Feasibility of a Network Meta-Analysis Assessing Relative Effectiveness and Safety of Remdesivir Versus Other Treatments for COVID-19 Inpatients
|
Papadakis-Sali, A
|
|
|
27 |
6S |
p. S179
|
artikel
|
| 717 |
EPH205 Frequency of Moderate to Severe Atopic Dermatitis and Clinical Characteristics in a Colombian HMO: Results for 2015-2022
|
Gonzalez, FJ
|
|
|
27 |
6S |
p. S189
|
artikel
|
| 718 |
EPH125 Geographic Disparities in Chronic Kidney Disease Hospitalizations: Exploring Associations with Neighborhood Socioeconomic Status in Texas
|
Zhong, L
|
|
|
27 |
6S |
p. S176
|
artikel
|
| 719 |
EPH94 Healthcare Access and Health Equity Outcomes Among Adults With Cardiometabolic Conditions
|
Daniel, S
|
|
|
27 |
6S |
p. S170-S171
|
artikel
|
| 720 |
EPH44 Healthcare Expenditures Among Older Adult with Polypharmacy in the United States: A Propensity Score-Matched Cross-Sectional Study
|
Pan, S
|
|
|
27 |
6S |
p. S161
|
artikel
|
| 721 |
EPH90 Health Characteristics and Adherence Patterns in Electronic Wearable Device Users: A Study in Low- and Middle-Income Countries
|
França, de Lima R
|
|
|
27 |
6S |
p. S170
|
artikel
|
| 722 |
EPH75 Herpes Zoster Risk Among Immunocompromised Adults in the United States: A Retrospective Cohort Analysis
|
Gatwood, J
|
|
|
27 |
6S |
p. S167
|
artikel
|
| 723 |
EPH1 High Throughput Screening for Roflumilast Adverse Effects in Real-World Settings: A Sequence Symmetry Analysis
|
Abdelaziz, A
|
|
|
27 |
6S |
p. S154
|
artikel
|
| 724 |
EPH79 HPV-Associated Cancers in Men: Epidemiological and Economic Burden in Costa Rica
|
Betancur, M
|
|
|
27 |
6S |
p. S167-S168
|
artikel
|
| 725 |
EPH231 HPV Genotyping in Invasive Cervical Cancer Samples from Women Attended at an Oncological Hospital between 2017-2021 in Ecuador
|
García, Muentes GD
|
|
|
27 |
6S |
p. S194
|
artikel
|
| 726 |
EPH172 Humanistic and Economic Burden Among COPD Patients in China: How Does It Compare With Other Common NCDs?
|
Huang, Z
|
|
|
27 |
6S |
p. S184
|
artikel
|
| 727 |
EPH128 Identifying Diabetic Ketoacidosis Events at Diagnosis Among Type 1 Diabetes Patients in Claims Data
|
McQueen, R
|
|
|
27 |
6S |
p. S177
|
artikel
|
| 728 |
EPH227 Identifying Prediabetes Patients Using Administrative Claims Linked with Lab Data to Assess Progression to Type 2 Diabetes
|
Ip, Q
|
|
|
27 |
6S |
p. S193
|
artikel
|
| 729 |
EPH77 Identifying the Characteristics of Tramadol Usage Among West Virginians
|
Adhikari, K
|
|
|
27 |
6S |
p. S167
|
artikel
|
| 730 |
EPH154 Impact of COVID-19 Response on Primary Care Utilization
|
Chen, C
|
|
|
27 |
6S |
p. S180
|
artikel
|
| 731 |
EPH135 Impact of Demographics and Social Determinants of Health on Hospitalization Costs in US Adults With Respiratory Syncytial Virus
|
Sato, R
|
|
|
27 |
6S |
p. S178
|
artikel
|
| 732 |
EPH214 Impact of Preoperative Anxiety and Depression on Chronic Postoperative Opioid Use in Orthopedic Surgery Patients
|
Beyene, K
|
|
|
27 |
6S |
p. S191
|
artikel
|
| 733 |
EPH235 Impact of Real-Time Containment Measures on COVID-19 Pandemic Outcomes in African Countries
|
Mgbere, O
|
|
|
27 |
6S |
p. S194-S195
|
artikel
|
| 734 |
EPH74 Incidence and Lethality of Adult Pneumonia, Bacteremia, or Meningitis in Colombia From 2015 to 2022: A Retrospective, Database Study
|
Bello, C
|
|
|
27 |
6S |
p. S167
|
artikel
|
| 735 |
EPH206 Incidence and Risk Factors for Empiric Treatment Failure Among Females With Uncomplicated Urinary Tract Infections in an Integrated Health Delivery Network
|
Ellis, JJ
|
|
|
27 |
6S |
p. S189
|
artikel
|
| 736 |
EPH67 Incidence of Mortality and the Impact of Malnutrition on Chronic Kidney Disease Patients Undergoing Dialysis: A Systematic Review and Meta-Analysis
|
Teali, IR
|
|
|
27 |
6S |
p. S165
|
artikel
|
| 737 |
EPH168 Incidence of Pre-Dialysis Depression and Its Impact on Chronic Kidney Disease (CKD) Progression
|
Jeun, KJ
|
|
|
27 |
6S |
p. S183
|
artikel
|
| 738 |
EPH120 Incidence, Prevalence and Clinical Characteristic of Patients with Unresectable/Metastatic Melanoma in Colombia: A Real World Study
|
Bolaños-López, J
|
|
|
27 |
6S |
p. S175
|
artikel
|
| 739 |
EPH123 Incorporating Social Determinants of Health Into Transmission Modeling of COVID-19 Vaccine in the US: A Scoping Review
|
Duong, K
|
|
|
27 |
6S |
p. S175-S176
|
artikel
|
| 740 |
EPH229 Inequalities According to Health Regime, in the Survival of Colorectal Cancer in a Colombian Caribbean City
|
Vargas-Moranth, R
|
|
|
27 |
6S |
p. S193
|
artikel
|
| 741 |
EPH169 Integrating Structured and Unstructured Data in Total Hip Arthroplasty Evaluation: A Comprehensive Analysis for Enhanced Device Safety
|
Gressler, L
|
|
|
27 |
6S |
p. S183
|
artikel
|
| 742 |
EPH87 Invasive Meningococcal Disease Risk Factors in Individuals With Commercial and Medicare Insurance in the United States
|
Herrera-Restrepo, O
|
|
|
27 |
6S |
p. S169
|
artikel
|
| 743 |
EPH95 Leveraging Data Aggregators to Annotate Deidentified Genomic Data Derived from Commercial Laboratory Specimens to Study COVID-19 Severity
|
Dandiker, S
|
|
|
27 |
6S |
p. S171
|
artikel
|
| 744 |
EPH78 Lung Cancer Screening Eligibility and Use in the US: A Cross-Sectional Analysis of 2022 Behavioral Risk Factor Surveillance System Data
|
Maki, KG
|
|
|
27 |
6S |
p. S167
|
artikel
|
| 745 |
EPH85 Machine Learning-Based Prediction of Unplanned Readmission Due to Major Adverse Cardiovascular Events (MACE) Among Hospitalized Patients With Blood Cancers
|
Le, N
|
|
|
27 |
6S |
p. S169
|
artikel
|
| 746 |
EPH25 Maternal Sexually Transmitted Infection Trends and Characteristics in the United States: 2018-2022
|
Strey, K
|
|
|
27 |
6S |
p. S157-S158
|
artikel
|
| 747 |
EPH72 Mortality From Diabetes Mellitus in the Department of Bolívar, Colombia: A 5-Year Analysis
|
Fernandez, Mercado J
|
|
|
27 |
6S |
p. S166
|
artikel
|
| 748 |
EPH83 Mortality Rate By Tuberculosis in Colombia, 2012-2021: Regional Inequalities
|
Alvis-Guzman, N
|
|
|
27 |
6S |
p. S168
|
artikel
|
| 749 |
EPH130 Mortality Related with Respiratory Syncytial Virus (RSV) Specific and Unspecified Acute Bronchiolitis in Under 2 Years in Colombia, 2012-2021
|
Alvis-Guzman, N
|
|
|
27 |
6S |
p. S177
|
artikel
|
| 750 |
EPH156 Multimorbidity and Its Associations with Adverse Cardiovascular Events and Healthcare Costs Among Patients with Atherosclerotic Cardiovascular Disease: A Real-World Evidence Study
|
Dai, D
|
|
|
27 |
6S |
p. S181
|
artikel
|
| 751 |
EPH105 Obesity Continues to be Associated With Poor Health-Related Quality of Life During the Third Year of the COVID-19 Pandemic
|
Madhavan, S
|
|
|
27 |
6S |
p. S172
|
artikel
|
| 752 |
EPH163 Off-Label Use of Semaglutide in the United States: Increasing Prevalence, Variability in Prescribing Provider Specialty, and Patient Characteristics
|
Noxon, V
|
|
|
27 |
6S |
p. S182
|
artikel
|
| 753 |
EPH19 Opioid-Related Overdose Death Rates in the US From 2005 to 2021
|
Skiera, J
|
|
|
27 |
6S |
p. S157
|
artikel
|
| 754 |
EPH80 Outpatient Transfusions and Occurrence of Febrile Non-Hemolytic Transfusion Reactions Among U.S. Medicare Beneficiaries, Ages 65 and Older, During 2016-2022: Utility of Real-World Data
|
Menis, M
|
|
|
27 |
6S |
p. S168
|
artikel
|
| 755 |
EPH81 Patient Characteristics and Health Care Resource Utilization of Cognitive Impairment Among Patients with Schizophrenia in the Veterans Affairs Administration System
|
Nili, M
|
|
|
27 |
6S |
p. S168
|
artikel
|
| 756 |
EPH51 Patient Characteristics and Treatment Patterns in Patients with Mantle Cell Lymphoma in China: A Real-World, Contemporary Cohort Study
|
Liu, Y
|
|
|
27 |
6S |
p. S162
|
artikel
|
| 757 |
EPH184 Patient Journey of Head & Neck Squamous Cell Cancer in Oncology Centers in Colombia
|
Aurachán, Vesga S
|
|
|
27 |
6S |
p. S186
|
artikel
|
| 758 |
EPH179 Patterns of Glucocorticoid Use Among Persons with Systemic Lupus Erythematosus (SLE) over Fifteen Years
|
Katz, P
|
|
|
27 |
6S |
p. S185
|
artikel
|
| 759 |
EPH138 Pneumococcal Vaccine Trends Among Older Adults in the United States from 2008 to 2022
|
Bandy, S
|
|
|
27 |
6S |
p. S178
|
artikel
|
| 760 |
EPH150 Post-Market Safety Assessment Associated with JAK Inhibitors of Xeljanz, Olumiant, and Rinvoq Using Faers Database from 2012 to 2022
|
Mikaeili, B
|
|
|
27 |
6S |
p. S180
|
artikel
|
| 761 |
EPH3 Potential Public Health Impact of Bivalent Respiratory Syncytial Virus Stabilized Prefusion F Subunit Vaccine (RSVpreF) Among Older Adults in Canada
|
Goyette, A
|
|
|
27 |
6S |
p. S154
|
artikel
|
| 762 |
EPH66 Pre-Exposure Prophylaxis Adherence Trajectories and HIV and Sexually Transmitted Infections Risk
|
Unigwe, I
|
|
|
27 |
6S |
p. S165
|
artikel
|
| 763 |
EPH88 Pregnancy and Perinatal Outcomes Following Exposure to Medications for Opioid Use Disorder: An Analysis of FAERS (FDA Adverse Event Reporting System)
|
Gokhale, P
|
|
|
27 |
6S |
p. S169
|
artikel
|
| 764 |
EPH208 Prevalence and Average Annual Percent Change of Potentially Inappropriate Medication Use in Older Adults before and during the COVID-19 National Emergency
|
DeShazo, J
|
|
|
27 |
6S |
p. S190
|
artikel
|
| 765 |
EPH17 Prevalence and Characteristics of Urinary Tract Infections in Office-Based Physician Practices in the United States, 2016–2019
|
Advani, SD
|
|
|
27 |
6S |
p. S156-S157
|
artikel
|
| 766 |
EPH121 Prevalence and Correlates of Alcohol Use Disorder Diagnosis Among Cancer Survivors in the United States: Insights From a Real-World Study
|
Lai, JH
|
|
|
27 |
6S |
p. S175
|
artikel
|
| 767 |
EPH49 Prevalence and Incidence of ROS1 and NTRK Rearrangements in Real-World Patients With Advanced Non–Small Lung Cancer in the United States
|
Ma, X
|
|
|
27 |
6S |
p. S162
|
artikel
|
| 768 |
EPH53 Prevalence and Trends of Medication Utilization Among Children With Sickle Cell Disease in the United States: A Retrospective Cohort Study
|
Ologunowa, A
|
|
|
27 |
6S |
p. S162-S163
|
artikel
|
| 769 |
EPH57 Prevalence of Hypertension Among Women Initiating a Combined Hormonal Contraception in the US
|
Hamid, A
|
|
|
27 |
6S |
p. S163
|
artikel
|
| 770 |
EPH112 Prevalent Comorbidities and Disease-Related Conditions in Heavily Pre-Treated Patients With Multiple Myeloma: A Real-World Retrospective Database Analysis
|
Giri, S
|
|
|
27 |
6S |
p. S174
|
artikel
|
| 771 |
EPH29 Prevention and Treatment in the Global Tuberculosis Epidemic: Approaches and Strategies in Current Clinical Trials
|
Knoth, R
|
|
|
27 |
6S |
p. S158
|
artikel
|
| 772 |
EPH46 Prognostic and Risk Factors of Psoriatic Arthritis Among Adult Psoriasis Patients in the United States: A Systematic Literature Review
|
Bisht, G
|
|
|
27 |
6S |
p. S161
|
artikel
|
| 773 |
EPH104 Public Health Impact of Pediatric BNT162b2 XBB1.5-Adapted COVID-19 Vaccine in the United States
|
Yehoshua, A
|
|
|
27 |
6S |
p. S172
|
artikel
|
| 774 |
EPH28 Public Health Impact of Switching From a 13-Valent to a 15-Valent Pneumococcal Conjugate Vaccine in the Chilean National Immunization Program
|
Hirata, L
|
|
|
27 |
6S |
p. S158
|
artikel
|
| 775 |
EPH119 Public Health Results in the Department of Bolívar, Colombia: An Analysis of Indicators in 2023
|
Fernandez, Mercado J
|
|
|
27 |
6S |
p. S175
|
artikel
|
| 776 |
EPH30 Real-World Adherence to Glycemic Self-Monitoring and Associated Factors Among Type 2 Diabetes Patients in Algeria: A Descriptive Cross-Sectional Study
|
Achouri, MY
|
|
|
27 |
6S |
p. S158-S159
|
artikel
|
| 777 |
EPH106 Real-World Assessment of Cardiovascular Risk Factors Among Women with a Combined Hormonal Contraception Prescription in the United States: An Electronic Health Records Study
|
Hamid, A
|
|
|
27 |
6S |
p. S172
|
artikel
|
| 778 |
EPH186 Real-World Biomarker Prevalence and Treatment Patterns Among Metastatic Colorectal Cancer Patients Who Underwent NGS Testing
|
Shao, C
|
|
|
27 |
6S |
p. S186
|
artikel
|
| 779 |
EPH234 Real-World Clinical Characteristics and Disease Management of Immunoglobulin a Nephropathy Patients Across the United States
|
Abner, S
|
|
|
27 |
6S |
p. S194
|
artikel
|
| 780 |
EPH181 Real World Retrospective Analysis of Short-Term Disability Claims for the Genitourinary System in the United States
|
Schramm, SA
|
|
|
27 |
6S |
p. S185
|
artikel
|
| 781 |
EPH70 Real-World Second-Line Treatment Pattern and Disease Burden of Patients With Unresectable or Advanced Hepatic Carcinoma in China: A Retrospective Database Study
|
Wu, J
|
|
|
27 |
6S |
p. S166
|
artikel
|
| 782 |
EPH110 Real-World Treatment Patterns in Adults Living With Primary Chronic Immune Thrombocytopenia in the United States
|
Yeakey, M
|
|
|
27 |
6S |
p. S173
|
artikel
|
| 783 |
EPH60 Real-World Treatment Patterns in Adults with Pemphigus Vulgaris in the United States
|
Blein, C
|
|
|
27 |
6S |
p. S164
|
artikel
|
| 784 |
EPH167 Real-World Treatment Patterns, Sequencing, and Unmet Need in Metastatic Colorectal Cancer (mCRC)
|
Desai, K
|
|
|
27 |
6S |
p. S183
|
artikel
|
| 785 |
EPH215 Recent Trends in the Incidence and Prevalence of Atopic Dermatitis in the United States: Eliciting Differences by Age and Sex
|
Doshi, R
|
|
|
27 |
6S |
p. S191
|
artikel
|
| 786 |
EPH118 Reduction of Adolescent Pregnancy and the Increase in Intrauterine Device Insertion: Data from a Private Health Insurance Company in Brazil
|
Alves, Junior JM
|
|
|
27 |
6S |
p. S175
|
artikel
|
| 787 |
EPH149 Regional Dynamics and Prevalence of COVID-19 Variants in US Health and Human Services Regions
|
Hu, L
|
|
|
27 |
6S |
p. S180
|
artikel
|
| 788 |
EPH84 Relationship between the Effectiveness of Municipal Public Health Plans and Programs for the Prevention of Suicide and Suicide Attempts with Their Operational and Financial Performance
|
Conde-Rivera, MT
|
|
|
27 |
6S |
p. S169
|
artikel
|
| 789 |
EPH178 Representing Thyroid Cancer Epidemiology in the US Over Time: A Microsimulation Modeling Approach Incorporating Temporal Differences in Thyroid Ultrasound Utilization by Sex and Age
|
Alagoz, O
|
|
|
27 |
6S |
p. S185
|
artikel
|
| 790 |
EPH164 Results and Impact of the Acceleration Plan Implementation for Maternal Mortality Reduction in the Department of Bolívar, Colombia
|
Fernandez, Mercado J
|
|
|
27 |
6S |
p. S182
|
artikel
|
| 791 |
EPH82 Risk Perception of Tobacco and Nicotine Products: Which Consumer Reported Outcome Measures for Evidence Generation in Support of Regulatory Engagement?
|
Mainy, N
|
|
|
27 |
6S |
p. S168
|
artikel
|
| 792 |
EPH9 Safety Assessment of Nirmatrelvir-Ritonavir in the FDA Adverse Event Reporting System: A Data Mining Approach
|
Teng, C
|
|
|
27 |
6S |
p. S155
|
artikel
|
| 793 |
EPH153 Screening Interval for Colonoscopic Screening for Colorectal Cancer: A Systematic Review of Interval Cancer Rates of Colonoscopic Screening for Colorectal Cancer
|
Hamashima, C
|
|
|
27 |
6S |
p. S180
|
artikel
|
| 794 |
EPH35 Self-Reported Hypertension and the Likelihood of Aspirin Use and Associated Adverse Effects Among Adults Aged 18 Years and Older
|
Coulibaly, N
|
|
|
27 |
6S |
p. S159
|
artikel
|
| 795 |
EPH10 Serotype Distribution Among Streptococcus Pneumoniae Isolates in Puerto Rico (PNEUMOSER STUDY)
|
Beltran, C
|
|
|
27 |
6S |
p. S155
|
artikel
|
| 796 |
EPH115 Sex Differences on Limitations in Physical Functioning and Overall Quality of Life of People Living with Myasthenia Gravis from the MGFA Global MG Patient Registry (MGFAPR) in the US
|
Sangha, O
|
|
|
27 |
6S |
p. S174
|
artikel
|
| 797 |
EPH195 Social and Political Correlates of Geographic Disparities in HIV and Cardiovascular Medication Utilization
|
Hammond, B
|
|
|
27 |
6S |
p. S187
|
artikel
|
| 798 |
EPH199 Social Determinants of Health Associated with Delayed Medical Care in an Online Health Community
|
Cerrada, C
|
|
|
27 |
6S |
p. S188
|
artikel
|
| 799 |
EPH117 Sociodemographic Factors Associated With E-Cigarette Use Among US Adults With Diabetes, Pre-Diabetes, or Risk of Diabetes
|
Ghodke, O
|
|
|
27 |
6S |
p. S174
|
artikel
|
| 800 |
EPH147 Socioeconomic Burden of Ischemic Heart Diseases in the Japanese Healthcare System – A System Dynamics Simulation for Policy Decision-Making
|
Uda, A
|
|
|
27 |
6S |
p. S179-S180
|
artikel
|
| 801 |
EPH221 Stigma As a Barrier to Treatment: Evidence from the National Health and Wellness Survey
|
Way, N
|
|
|
27 |
6S |
p. S192
|
artikel
|
| 802 |
EPH45 Survey of Residents’ Perceptions and Concerns on Air Pollution in Maharashtra, India
|
Sanjeev, S
|
|
|
27 |
6S |
p. S161
|
artikel
|
| 803 |
EPH43 Systematic Review of Real-World Data: Assessing Cancer, Major Adverse Cardiovascular Events, Venous Thromboembolism, Infection, and Mortality Risk Associated With Jak Inhibitors in Rheumatoid Arthritis Patients in the United States
|
Bazzazzadehgan, S
|
|
|
27 |
6S |
p. S161
|
artikel
|
| 804 |
EPH89 Telehealth Utilization Among Children with Autism Spectrum Disorder in Employer-Sponsored Plans, 2019–2022
|
Lamsal, R
|
|
|
27 |
6S |
p. S170
|
artikel
|
| 805 |
EPH183 The Association Between the Minority Health Social Vulnerability Index and Pneumococcal Disease Incidence Among Medicare Beneficiaries (2016-2019)
|
Mohanty, S
|
|
|
27 |
6S |
p. S186
|
artikel
|
| 806 |
EPH218 The Clinical and Economic Epidemiology of Breast Cancer in Brazil from 2016 to 2022: A Real-World Evidence Study of 295,000 Outpatients in Public System
|
Costa e Silva, M
|
|
|
27 |
6S |
p. S191
|
artikel
|
| 807 |
EPH109 The Effect of Metformin Adherence on the Reduction of Fracture Risk Among Type 2 Diabetes Patients
|
Chen, CL
|
|
|
27 |
6S |
p. S173
|
artikel
|
| 808 |
EPH27 The Efficacy of Interventions Utilized in Communicating Risk Information to Improve Behavioral Outcomes Among Individuals Who Are Genetically Predisposed of Type 2 Diabetes: A Systematic Review
|
Adjeroh, L
|
|
|
27 |
6S |
p. S158
|
artikel
|
| 809 |
EPH165 The Fiscal Costs of a Public Health Crisis: Lessons From Zika in the United States
|
Kim, Y
|
|
|
27 |
6S |
p. S182-S183
|
artikel
|
| 810 |
EPH170 The Net Environmental Impact of Preventative Healthcare - Vaccination's Potential in the Fight Against Climate Change
|
Hamilton, L
|
|
|
27 |
6S |
p. S183
|
artikel
|
| 811 |
EPH61 Timing of SGLT2 Inhibitor Initiation and Hospital Readmission in Acute Heart Failure With Type 2 Diabetes: A Target Trial Emulation Cohort Study
|
Wu, CY
|
|
|
27 |
6S |
p. S164
|
artikel
|
| 812 |
EPH129 Tobacco Product Experience: Which Consumer Reported Outcome Measures for Real World Evidence Studies?
|
Mainy, N
|
|
|
27 |
6S |
p. S177
|
artikel
|
| 813 |
EPH211 Treatment Patterns and Clinical Characteristics of Patients Diagnosed with Metastatic NSCLC in Hmo from Colombia: A Real Word Evidence Study
|
Gonzalez, FJ
|
|
|
27 |
6S |
p. S190
|
artikel
|
| 814 |
EPH71 Trend of Increase in the Use of Hormonal Intrauterine Devices in Women From a Health Insurance Company in Brazil: What Is the Explanation?
|
Alves, Junior JM
|
|
|
27 |
6S |
p. S166
|
artikel
|
| 815 |
EPH33 Trend of Mortality By Asthma in Colombia, 1998 - 2021
|
Alvis-Guzman, N.
|
|
|
27 |
6S |
p. S159
|
artikel
|
| 816 |
EPH190 Trends and Disparities in Perinatal Health Outcomes Among Women from Refugee Backgrounds in Victoria, Australia: A Population-Based Study
|
Yeshitila, Y
|
|
|
27 |
6S |
p. S186-S187
|
artikel
|
| 817 |
EPH93 Trends and Regional Variation in New Opioid Prescriptions and Long-Term Prescription Opioid Use Among Older Adults in the United States, 2012-2020
|
Bazzazzadehgan, S
|
|
|
27 |
6S |
p. S170
|
artikel
|
| 818 |
EPH20 Trends in New Prescriptions for Opioids, Non-Opioids, and Opioid Antagonists in the United States, 2019 - 2023
|
Roufael, J
|
|
|
27 |
6S |
p. S157
|
artikel
|
| 819 |
EPH222 Trends of Mortality Related With Dengue in Colombia 2012-2021
|
Alvis-Guzman, N.
|
|
|
27 |
6S |
p. S192
|
artikel
|
| 820 |
EPH219 Understanding the Impact of Physical Exercise in People Living with Myasthenia Gravis from the MGFA Global MG Patient Registry (MGFAPR) in the US (2013-2023)
|
Zurinaga, A
|
|
|
27 |
6S |
p. S192
|
artikel
|
| 821 |
EPH69 Uptake of 20-Valent Pneumococcal Conjugate Vaccine (PCV20) Among United States (US) Adults Following 2022 Update to Recommendations
|
Averin, A
|
|
|
27 |
6S |
p. S166
|
artikel
|
| 822 |
EPH158 Using Data to Develop Precision Medicine Approaches to Public Health Initiatives
|
Holmes, H
|
|
|
27 |
6S |
p. S181
|
artikel
|
| 823 |
EPH209 Using Real-World General Practitioner Data To Study the Diagnosis and Management of Dementia: Rationale and Design
|
Baak, BN
|
|
|
27 |
6S |
p. S190
|
artikel
|
| 824 |
EPH193 Validated Case-Identifying Algorithms Using Canadian Administrative Health Data: A Targeted Literature Review
|
Bowie, AC
|
|
|
27 |
6S |
p. S187
|
artikel
|
| 825 |
EPH56 Validation of an Algorithm to Identify HR+/HER2- Metastatic Breast Cancer in Claims Data
|
Chin, A
|
|
|
27 |
6S |
p. S163
|
artikel
|
| 826 |
EPH48 Would Exposure to Metformin Reduce Mortality in Patients With Glioblastioma?
|
Shah, R
|
|
|
27 |
6S |
p. S161-S162
|
artikel
|
| 827 |
HPR13 A County-Level Deprivation Index for China in 2020 and Its Association With Life Expectancy and Infant Mortality
|
Peisong, D
|
|
|
27 |
6S |
p. S197-S198
|
artikel
|
| 828 |
HPR149 Americans' Views on Health Inequality in the United States: Results from a General Population Survey
|
Slejko, JF
|
|
|
27 |
6S |
p. S219-S220
|
artikel
|
| 829 |
HPR62 Analysis of FDA-Issued Warning Letters for Fraudulent Claims Within the Economic, Clinical, and Humanistic Outcomes (ECHO) Framework
|
Urena, D
|
|
|
27 |
6S |
p. S205
|
artikel
|
| 830 |
HPR130 Analysis of Forty-One Years of U.S. Food and Drug Administration Approvals, Regulatory Pathways, and Review Time of New Drugs and Biologics: A Retrospective Cohort Study
|
Seoane-Vazquez, E
|
|
|
27 |
6S |
p. S217
|
artikel
|
| 831 |
HPR138 A Non-Representative Sample: Racial and Ethnic Diversity in Clinical Trials of FDA-Approved Drugs
|
Andrawes, M
|
|
|
27 |
6S |
p. S218
|
artikel
|
| 832 |
HPR145 Anti-VEGF Molecule Utilization in Ophthalmology and Potential Impact of Market Dynamics after Biosimilar Entry
|
Xin, Q
|
|
|
27 |
6S |
p. S219
|
artikel
|
| 833 |
HPR140 Are North Americans Willing-to-Pay More for Life and Limb?
|
Schlander, M
|
|
|
27 |
6S |
p. S218
|
artikel
|
| 834 |
HPR118 Are We Closing the Gap? A Review of Health Equity Focused Interventions Along the Liver Cancer Care Cascade in the US
|
Cheng, S
|
|
|
27 |
6S |
p. S215
|
artikel
|
| 835 |
HPR65 Assessing Rare Disease Reimbursement Levels and Economic Burden on Patients in China
|
Chen, Y
|
|
|
27 |
6S |
p. S205-S206
|
artikel
|
| 836 |
HPR87 Assessing the Implementability of Regulatory Agencies’ Guidance on Diversity in Clinical Trials
|
Metcalfe, R
|
|
|
27 |
6S |
p. S209
|
artikel
|
| 837 |
HPR82 Assessment of Supporting Evidence and Postmarketing Requirements for Therapeutic Indications With Real-Time Oncology Drug Review, 2018-2023
|
Mooghali, M
|
|
|
27 |
6S |
p. S208
|
artikel
|
| 838 |
HPR92 Assessment of Surrogate Endpoints in Real-World Oncology Studies, a Systematic Literature Review
|
Wang, Y
|
|
|
27 |
6S |
p. S210
|
artikel
|
| 839 |
HPR31 A Targeted Literature Review To Identify the Dimensions of Sustainable Global Biosimilars Markets
|
Dayer, V
|
|
|
27 |
6S |
p. S200
|
artikel
|
| 840 |
HPR36 Barriers to Getting New Cancer Medicines to Patients in Kazakhstan
|
Kostyuk, A
|
|
|
27 |
6S |
p. S201
|
artikel
|
| 841 |
HPR128 Benchmarking Clinical Trial Diversity: Methods to Characterize Eligibility-Based Representativeness
|
Benedum, C
|
|
|
27 |
6S |
p. S216
|
artikel
|
| 842 |
HPR150 Beyond the Headline: Inflation-Adjusting ICER's Unsupported Price Increase Results
|
Wagner, TD
|
|
|
27 |
6S |
p. S220
|
artikel
|
| 843 |
HPR105 Breadth of Patient and Stakeholder Input in CMS's Drug Price Negotiation Program: A Content Analysis of the 2023 Patient-Focused Listening Sessions
|
Patterson, J
|
|
|
27 |
6S |
p. S213
|
artikel
|
| 844 |
HPR73 Breast Cancer-Related Healthcare Resource Utilization and Staging before and after the COVID-19 Pandemic Among White and Black Patients with Newly Diagnosed Breast Cancer
|
Devine, F
|
|
|
27 |
6S |
p. S206-S207
|
artikel
|
| 845 |
HPR103 Calcimimetic Prescriptions Following the Transitional Drug Add-on Payment Adjustment in Fee-for-Service Medicare Patients on Dialysis
|
Caldwell, J
|
|
|
27 |
6S |
p. S213
|
artikel
|
| 846 |
HPR75 Can Multi-Cancer Early Detection Screening Result in Early Cancer Detection? A Modeling Study
|
Chhatwal, J
|
|
|
27 |
6S |
p. S207
|
artikel
|
| 847 |
HPR10 Cell and Gene Therapy Access in the US and European Countries
|
Mycka, J
|
|
|
27 |
6S |
p. S197
|
artikel
|
| 848 |
HPR74 Challenges Encountered When Using Required Machine-Readable Files From the 2022 Transparency in Coverage Rule: A Blue Cross and Blue Shield of Louisiana Case Study
|
Zhang, H
|
|
|
27 |
6S |
p. S207
|
artikel
|
| 849 |
HPR133 Clinical Benefits of the Accelerated Approval Program in Oncology
|
Ortendahl, J
|
|
|
27 |
6S |
p. S217-S218
|
artikel
|
| 850 |
HPR94 Clinical Trial Engagement in Hepatocellular Carcinoma: Understanding Demographic and Clinical Characteristics
|
Patel, MV
|
|
|
27 |
6S |
p. S211
|
artikel
|
| 851 |
HPR77 CMS Coverage Lift on PET Beta Amyloid Imaging Impact on mAb Treatment and Beneficiary Out-Of-Pocket Spending
|
Celli, J
|
|
|
27 |
6S |
p. S207-S208
|
artikel
|
| 852 |
HPR20 Comparison of Biosimilar Reimbursement Policies in the US and Select European Markets
|
Stylianou, M
|
|
|
27 |
6S |
p. S199
|
artikel
|
| 853 |
HPR15 Comparison of Price Index Methods and Drug Price Inflation Estimates for Medications for Opioid Use Disorder (MOUD)
|
Ben-Umeh, K
|
|
|
27 |
6S |
p. S198
|
artikel
|
| 854 |
HPR98 Consumption of Hospital Resources in Intensive Care Units in Brazil: A Challenge for Health Financing
|
Tavares, Malheiro D
|
|
|
27 |
6S |
p. S211-S212
|
artikel
|
| 855 |
HPR25 Current Reimbursement Landscape for Re-Treatment with Anti-PD-(L)1 Agents after Treatment in Early-Stage Cancers: A Payer Survey
|
Aguiar-Ibáñez, R
|
|
|
27 |
6S |
p. S199-S200
|
artikel
|
| 856 |
HPR19 Determining the Impact of Social Determinants of Health in the Prevalence of Diabetes in Mid-Atlantic Area
|
Hossain, MF
|
|
|
27 |
6S |
p. S198-S199
|
artikel
|
| 857 |
HPR111 Disease Burden and Medical Insurance Expenditure of National Price-Negotiated Drugs for Multiple Sclerosis Under Dual-Channel Model in China: A Budget Impact Model
|
Zhao, Z
|
|
|
27 |
6S |
p. S214
|
artikel
|
| 858 |
HPR76 Disparities in NMOSD Hospitalization Outcomes: A 5-Year Analysis of the Impact of Sociodemographic Factors on Healthcare Utilization and Charges
|
Abbatemarco, JR
|
|
|
27 |
6S |
p. S207
|
artikel
|
| 859 |
HPR52 Disparity in New Cancer Drug Launches Worldwide: 1990-2022
|
Li, M
|
|
|
27 |
6S |
p. S203
|
artikel
|
| 860 |
HPR59 Do All US Payer Archetypes Consider the Same Sources of Evidence to Inform Their Drug Policies?
|
Da, Conceicao R
|
|
|
27 |
6S |
p. S204-S205
|
artikel
|
| 861 |
HPR35 Does Accelerated Approval Result in Favorable Access: Examining the Burden of Evidence Necessary for Appropriate Payer Coverage of Accelerated Approval Products
|
Zhu, A
|
|
|
27 |
6S |
p. S201
|
artikel
|
| 862 |
HPR22 Does Expedited Regulatory Approval Status Increase Rare Disease Drug Non-Coverage?
|
Fraser, M
|
|
|
27 |
6S |
p. S199
|
artikel
|
| 863 |
HPR40 Do State Direct Access Laws to Physical Therapy Influence Healthcare Utilization and Costs Among Medicare Patients With Atraumatic Rotator Cuff Tears? An Instrumental Variable Approach
|
Jindal, D
|
|
|
27 |
6S |
p. S202
|
artikel
|
| 864 |
HPR116 Do US Managed Care Organizations Restrict Coverage More Than the Food and Drug Administration Label?
|
Da, Conceicao R
|
|
|
27 |
6S |
p. S214-S215
|
artikel
|
| 865 |
HPR78 Eliciting Inequality Aversion in the United States: Results from a Benefit Trade-Off Experiment
|
Slejko, JF
|
|
|
27 |
6S |
p. S208
|
artikel
|
| 866 |
HPR117 Emergency Room Utilization Among Multiple Sclerosis Patients Treated with Disease-Modifying Therapy in a Real-World Hybrid Claims Database
|
Kuranz, S
|
|
|
27 |
6S |
p. S215
|
artikel
|
| 867 |
HPR132 Employer Perspectives on Alternative Funding Programs
|
Huff, L
|
|
|
27 |
6S |
p. S217
|
artikel
|
| 868 |
HPR90 Equity Effects of Public Health Insurance on Hypertension in Peru: Insights from a Panel Analysis of the Peruvian Demographic and Health Survey 2013-2019
|
Kim, T
|
|
|
27 |
6S |
p. S210
|
artikel
|
| 869 |
HPR113 Equity in Antenatal Care Quality: An Analysis of 11.382 Cases from 23 Municipalities in Colombia
|
Collazos-Rivera, S
|
|
|
27 |
6S |
p. S214
|
artikel
|
| 870 |
HPR85 Estimating the Income Elasticity of Abortion: A Cross-National Study of 99 Countries
|
Akiyode, O
|
|
|
27 |
6S |
p. S209
|
artikel
|
| 871 |
HPR38 Estimating the Outcome Disparities in BIPOC and Economically-Disadvantages Patients With Systemic Lupus Erythematosus (SLE)
|
Wang, B
|
|
|
27 |
6S |
p. S202
|
artikel
|
| 872 |
HPR109 Evaluation of Evidence Informing Medicare’s Coverage With Evidence Development Decision Updates
|
Mooghali, M
|
|
|
27 |
6S |
p. S214
|
artikel
|
| 873 |
HPR127 Examine the Use of Real-World Evidence To Support FDA Decision-Making for New Drug Applications and Biologics License Applications From 2021 to 2022
|
Cheng, CH
|
|
|
27 |
6S |
p. S216
|
artikel
|
| 874 |
HPR139 Examining the Intersectionality of Race, Ethnicity, and Social Vulnerabilities in Predicting Severe Maternal Morbidities Among Blue Cross and Blue Shield of Louisiana Mothers
|
Kiggans, M
|
|
|
27 |
6S |
p. S218
|
artikel
|
| 875 |
HPR17 Exploring Financing Models for CAR-T Cell Therapies in Global Healthcare Systems: A Comprehensive Scoping Review
|
de Araujo, CLP
|
|
|
27 |
6S |
p. S198
|
artikel
|
| 876 |
HPR3 Exploring the Inequity of HRQoL in Individuals With Long COVID Symptoms
|
McCullough, A
|
|
|
27 |
6S |
p. S196
|
artikel
|
| 877 |
HPR48 Factors Associated With Drug Overdose Mortality Rate in California
|
Eshtiaghi, K
|
|
|
27 |
6S |
p. S202
|
artikel
|
| 878 |
HPR136 Geographic Trends in Chimeric Antigen Receptor (CAR) T-Cell Therapy Access and Utilization
|
McBride, K
|
|
|
27 |
6S |
p. S218
|
artikel
|
| 879 |
HPR21 Healthcare Expenditure and Its Association with Under Five Mortality: A Cross-Country Analysis in the Eastern Mediterranean Region
|
Alam, M
|
|
|
27 |
6S |
p. S199
|
artikel
|
| 880 |
HPR100 Health Technologies Value Assessment Through the Lens of Health Equity; How Far From Being Incorporated Routinely? An Environmental Scan of Health Equity Frameworks and Policy Gaps
|
Sarri, G
|
|
|
27 |
6S |
p. S212
|
artikel
|
| 881 |
HPR53 How Does the Inclusion of New Drugs in National Reimbursement Drug List Influence Health Outcomes and Financial Burden for Multiple Sclerosis Patients
|
Jia, Y
|
|
|
27 |
6S |
p. S203
|
artikel
|
| 882 |
HPR50 How Do We Define Value in Health? Well, That Depends
|
Bibi, M
|
|
|
27 |
6S |
p. S203
|
artikel
|
| 883 |
HPR104 How Well Can Insurers Police Off-Label Use? Evidence from GLP-1s in Medicare Part D
|
Levy, J
|
|
|
27 |
6S |
p. S213
|
artikel
|
| 884 |
HPR68 How Will the New VPAG Rebate Regulations Affect Launch Strategy in the UK?
|
Robert, A
|
|
|
27 |
6S |
p. S206
|
artikel
|
| 885 |
HPR148 Identifying and Addressing Social Determinants of Health: A Health System Specialty Pharmacy Approach
|
Fitzpatrick, C
|
|
|
27 |
6S |
p. S219
|
artikel
|
| 886 |
HPR61 Impact of Changes in US Medicaid Reimbursement for Long-Acting Reversible Contraceptives in the Immediate Postpartum Period
|
Walker, SE
|
|
|
27 |
6S |
p. S205
|
artikel
|
| 887 |
HPR123 Impact of Mandated Use of the Texas Prescription Monitorsing Program on Carisoprodol Dispensing in Texas
|
Zeng, Z
|
|
|
27 |
6S |
p. S215
|
artikel
|
| 888 |
HPR121 Impacts of National Drug Price Negotiation on Chronic Myeloid Leukemia Drugs Price, Volume and Spending in China
|
Tong, X
|
|
|
27 |
6S |
p. S215
|
artikel
|
| 889 |
HPR101 Impacts of the CDC’s 2016 Guideline for Prescribing Opioids for Chronic Pain on Opioid Prescribing and Pain Management Outcomes: A Systematic Review
|
Kang, HA
|
|
|
27 |
6S |
p. S212
|
artikel
|
| 890 |
HPR44 Implications of Regulatory Telemedicine Prescribing Flexibilities on Patients With Opioid Use Disorder
|
Johnson, J
|
|
|
27 |
6S |
p. S202
|
artikel
|
| 891 |
HPR153 Improving Prediction of Medical Costs Among Medicare Beneficiaries By Incorporating Social Determinants of Health Indicators in Risk Prediction
|
Chen, Z
|
|
|
27 |
6S |
p. S220
|
artikel
|
| 892 |
HPR6 Inflation Reduction Act: How Will the First 10 Drugs Selected for Medicare Price Negotiations Impact US Commercial Payers?
|
Sidhu, C
|
|
|
27 |
6S |
p. S197
|
artikel
|
| 893 |
HPR124 Is Obesity a Disease or a Lifestyle Issue in Europe and the United States? Payer Perception
|
Tyrała-Chowaniec, I.
|
|
|
27 |
6S |
p. S215-S216
|
artikel
|
| 894 |
HPR14 Lessons From History: Gauging Part D Plan Access Restrictions of Protected Class Drugs as a Harbinger for Coverage of Negotiated Drugs
|
Washington, J
|
|
|
27 |
6S |
p. S198
|
artikel
|
| 895 |
HPR55 Limiting the Potency of Delta-9-Tetrahydrocannabinol (THC) in Cannabis Products: What Policymakers Need to Know
|
Bhuiya, NMMA
|
|
|
27 |
6S |
p. S204
|
artikel
|
| 896 |
HPR58 Mapping Medicaid: A Comparative Analysis of State-Level Racial and Ethnic Data Collection to Federal Guidelines
|
Salih, RK
|
|
|
27 |
6S |
p. S204
|
artikel
|
| 897 |
HPR99 Medicare Drug Price Negotiation: The Complexities of Selecting Therapeutic Alternatives for Estimating Comparative Effectiveness
|
Cousin, E
|
|
|
27 |
6S |
p. S212
|
artikel
|
| 898 |
HPR141 Model Analysis on Budget Impact and Patients’ Burden of National Price-Negotiated Drugs and Different Reimbursement Payment Modes in China: Hyperkalemia As an Example
|
Liu, J
|
|
|
27 |
6S |
p. S218-S219
|
artikel
|
| 899 |
HPR126 Monitoring Drug Volume-Based Procurement in Shanghai, China: A Data-Driven Situation Analysis
|
Xu, Q
|
|
|
27 |
6S |
p. S216
|
artikel
|
| 900 |
HPR80 Moving Towards Inclusion: A Review of Access to Oncologic Therapies in the Light of Global Efforts to Advance Gender Equality
|
Perez-Kempner, L
|
|
|
27 |
6S |
p. S208
|
artikel
|
| 901 |
HPR81 Multi-Stakeholder Approach to Rare Disease Care in Latin America
|
Rico, M
|
|
|
27 |
6S |
p. S208
|
artikel
|
| 902 |
HPR5 National US Health Equity Survey Demonstrates Some Progress on Organizational Health Equity Goals, Emerging Priorities on Activation, Analytics, and Capacity Building
|
Hildreth, C
|
|
|
27 |
6S |
p. S196-S197
|
artikel
|
| 903 |
HPR125 Novel Drug Approvals By the U.S. Food and Drug Administration in Rare Diseases: Findings from 2020–2023
|
Dubey, A
|
|
|
27 |
6S |
p. S216
|
artikel
|
| 904 |
HPR41 One Step Away From the Abyss? Analysis of the Supplementary Health System in Brazil
|
Pereira, da Veiga CR
|
|
|
27 |
6S |
p. S202
|
artikel
|
| 905 |
HPR144 Optimization in Universal Health Coverage Design in South Africa Considering Both Health Outcomes and Health-Induced Poverty Outcomes
|
Chen, P
|
|
|
27 |
6S |
p. S219
|
artikel
|
| 906 |
HPR27 Optimizing Drug Market Exclusivity in the US and EU Markets
|
Dahlberg, S
|
|
|
27 |
6S |
p. S200
|
artikel
|
| 907 |
HPR1 Prescription Nutraceutical Clinical Evidence Requirements in the Treatment of Depression: Comparing US and EU Guidance for Phase II and III Clinical Trials
|
Orzechowski, AL
|
|
|
27 |
6S |
p. S196
|
artikel
|
| 908 |
HPR93 Price Evolution of Selected Cancer Immunotherapies in the US and Key European Markets
|
Jochymek, I
|
|
|
27 |
6S |
p. S210-S211
|
artikel
|
| 909 |
HPR106 Pricing of New Oncology Products in the US and Key European Markets
|
Kloc, K
|
|
|
27 |
6S |
p. S213
|
artikel
|
| 910 |
HPR91 Public Sector Replacement of Privately Funded Pharmaceutical R&D: Cost and Efficiency Considerations
|
Neumann, U
|
|
|
27 |
6S |
p. S210
|
artikel
|
| 911 |
HPR9 Racial and Ethnic Inequities in Endometrial Cancer Survival From 2017 to 2022: Assessing the Influence of Social Determinants of Health
|
Pittell, H
|
|
|
27 |
6S |
p. S197
|
artikel
|
| 912 |
HPR37 Racial Disparities in Homologous Recombination Repair (HRR) Biomarker Testing in the United States: A Real-World Database Analysis Among White and Non-White Patients with Metastatic Prostate Cancer
|
Schoenewald, J
|
|
|
27 |
6S |
p. S201
|
artikel
|
| 913 |
HPR96 Racial Disparity and Awareness of Disease-Risk Genetic Testing: A Nationwide Sampling Survey Analysis
|
Song, C
|
|
|
27 |
6S |
p. S211
|
artikel
|
| 914 |
HPR70 Racial Disparity and Utilization of Disease-Risk Genetic Testing: A Nationwide Sampling Survey Analysis
|
Song, C
|
|
|
27 |
6S |
p. S206
|
artikel
|
| 915 |
HPR49 Real World Evidence and Rare Disease Considerations Across Regulatory and Health Technology Assessment Frameworks in the US, UK, and Canada
|
Blackmore, L
|
|
|
27 |
6S |
p. S203
|
artikel
|
| 916 |
HPR129 Real-World Policy Effects of Implementing Multi-Gene Panel Sequencing for Advanced Cancers in British Columbia, Canada: An Interrupted Time Series Analysis
|
Weymann, D
|
|
|
27 |
6S |
p. S216-S217
|
artikel
|
| 917 |
HPR26 Reimbursement of Medical Devices for Home Care: Worldwide Scenario, Challenges and Proposed Solutions
|
Pandey, R
|
|
|
27 |
6S |
p. S200
|
artikel
|
| 918 |
HPR63 Research and Development (R&D) Investment By the Biopharmaceutical Industry: A Global Ecosystem Update
|
Neumann, U
|
|
|
27 |
6S |
p. S205
|
artikel
|
| 919 |
HPR11 Revenue-Sharing or Revenue Lost? The Hidden Costs of 340B to Employers
|
Sun, C
|
|
|
27 |
6S |
p. S197
|
artikel
|
| 920 |
HPR142 Review of Gene Therapy Access Landscape
|
Fraser, M
|
|
|
27 |
6S |
p. S219
|
artikel
|
| 921 |
HPR33 Short- and Long-Term Impacts of the National Essential Medicines Policy on Drug in Rural China
|
Xiong, X
|
|
|
27 |
6S |
p. S200-S201
|
artikel
|
| 922 |
HPR69 State-Level Trends in Access to Medicaid Family Planning Services, 2008 – 2023
|
Williams, A
|
|
|
27 |
6S |
p. S206
|
artikel
|
| 923 |
HPR97 Strategic Implications for Biopharmaceuticals: Navigating the Medicare Price Negotiation Provisions of the Inflation Reduction Act
|
Briggs, S
|
|
|
27 |
6S |
p. S211
|
artikel
|
| 924 |
HPR71 Successfully Remaining in Community for Home Health Care Patients With Alzheimer's Disease and Related Dementia: The Role of Living Arrangements and Rural Living
|
Jung, D
|
|
|
27 |
6S |
p. S206
|
artikel
|
| 925 |
HPR83 The Distribution and Influential Factors Analysis of National Price-Negotiated Drugs in Medical Institutions and Pharmacies in China: A Case Study of Hyperkalemia
|
Liu, J
|
|
|
27 |
6S |
p. S208-S209
|
artikel
|
| 926 |
HPR34 The Effect of Medical Insurance Outpatient Pooling Policy on Medical Service Utilization of Insured People: Evidence from CHARLS
|
孙 凤,
|
|
|
27 |
6S |
p. S201
|
artikel
|
| 927 |
HPR54 The European Health Data Space (EHDS): Probable Impact, Possible Challenges and Proposed Solutions to Using Electronic Health Records (EHRS) for Research and Policy Shaping in the Region
|
Azad, M
|
|
|
27 |
6S |
p. S204
|
artikel
|
| 928 |
HPR152 The Impact of Insurance Reform on Health Resource Utilization and Persistence for Chinese Patients With Crohn’s Disease, Taking Ustekinumab as an Example: Evidence From a Natural Experiment Study
|
Shi, J
|
|
|
27 |
6S |
p. S220
|
artikel
|
| 929 |
HPR86 The Impact of Mandated Prescription Drug Monitoring Program Registration on Prescription Opioid-Related Mortality in California
|
Bhatjire, P
|
|
|
27 |
6S |
p. S209
|
artikel
|
| 930 |
HPR108 The Patient Access Landscape for Rare Disease Medicines in Brazil: A Multi-Stakeholder Perspective
|
Rico, M
|
|
|
27 |
6S |
p. S213-S214
|
artikel
|
| 931 |
HPR131 The Risk of Osteoporotic Fractures in Elderly Asthmatic Patients According to Prescribing Patterns of Systemic Corticosteroid in South Korea
|
Suh, HS
|
|
|
27 |
6S |
p. S217
|
artikel
|
| 932 |
HPR2 The Use of Performance-Based Agreements in Common Diseases in EU3 and US
|
Wilk, M
|
|
|
27 |
6S |
p. S196
|
artikel
|
| 933 |
HPR89 Trends in Hospital Charging Practices from 2019-2022 Among Hospitals with and without Chimeric Antigen Receptor (CAR) T-Cell Therapy Utilization
|
Snyder, S
|
|
|
27 |
6S |
p. S210
|
artikel
|
| 934 |
HPR102 Trends in Specialty Pharmacy Use Among US Medicare Beneficiaries: Implications for Part D Policy
|
Doshi, JA
|
|
|
27 |
6S |
p. S212
|
artikel
|
| 935 |
HPR24 Understanding Pharmacy Benefit Manager (PBM) Adoption of Humira Biosimilars and Identifying Their Preferred Humira Biosimilars in Comparison with Humira
|
Okorozo, P
|
|
|
27 |
6S |
p. S199
|
artikel
|
| 936 |
HPR60 Use of Brand-over-Generic Preferred Drugs in Medicaid Programs
|
Gabriele, S
|
|
|
27 |
6S |
p. S205
|
artikel
|
| 937 |
HPR57 Use of External Control Arms in Novel Drug Approvals By U.S. Food and Drug Administration: A Targeted Review
|
Gupta, P
|
|
|
27 |
6S |
p. S204
|
artikel
|
| 938 |
HPR51 Use of Real World Evidence in 2023 Novel Drug Approvals
|
Ritchey, ME
|
|
|
27 |
6S |
p. S203
|
artikel
|
| 939 |
HPR84 Variation in Commercial Coverage of Accelerated Approval Drugs
|
LaMountain, F
|
|
|
27 |
6S |
p. S209
|
artikel
|
| 940 |
HPR112 Variation in Coverage of Specialty Therapies and Barriers to Fair Access
|
Beinfeld, M
|
|
|
27 |
6S |
p. S214
|
artikel
|
| 941 |
HPR30 Variation in per Beneficiary Prescription Utilization and Spending By Race/Ethnicity in Medicare and Medicaid Insurance Claims
|
Wagner, TD
|
|
|
27 |
6S |
p. S200
|
artikel
|
| 942 |
HPR88 Variation in State Medicaid Use of Brand-over-Generic Preferred Drug Lists
|
Gabriele, S
|
|
|
27 |
6S |
p. S209-S210
|
artikel
|
| 943 |
HPR18 What Is the Impact of Including Outcomes-Based Agreements on the Cost-Effectiveness of Cell and Gene Therapies? A Case Example of Zynteglo for Transfusion-Dependent Beta Thalassemia
|
Richardson, M
|
|
|
27 |
6S |
p. S198
|
artikel
|
| 944 |
HPR4 What Makes an Orphan Medicine? Determining Characteristics of Non-Oncology Orphan Approvals from 2015-2022
|
Privett, B
|
|
|
27 |
6S |
p. S196
|
artikel
|
| 945 |
HPR95 Why It Is Important to Ensure the Price Is Right: Access Restrictions for Therapies Treating Duchenne Muscular Dystrophy
|
Desai, A
|
|
|
27 |
6S |
p. S211
|
artikel
|
| 946 |
HSD34 Analysis of Changes in the Number of Cases of Gynecological Surgeries for Benign Indications in Hungary
|
Gárdos, L
|
|
|
27 |
6S |
p. S227
|
artikel
|
| 947 |
HSD31 Analyzing Factors Affecting Length of Emergency Department Stay in Patients With Hemophilia
|
Ndai, A
|
|
|
27 |
6S |
p. S226-S227
|
artikel
|
| 948 |
HSD67 A Retrospective Study Assessing Clinical and Economic Impacts of a Multidisciplinary Approach for Reducing Risk of Catheter-Related Thrombosis in a U.S. Health System
|
Zazyczny, KA
|
|
|
27 |
6S |
p. S232
|
artikel
|
| 949 |
HSD1 Assessing Community Pharmacist Expectation, Satisfaction, and Intentions in the Wasfaty E-Service: Using the Expectation Conformation Theory
|
Alshehri, A
|
|
|
27 |
6S |
p. S221
|
artikel
|
| 950 |
HSD54 Assessing the Impact of Telehealth Delivery on Adherence to Medications for Opioid Use Disorder
|
Wang, Y
|
|
|
27 |
6S |
p. S230
|
artikel
|
| 951 |
HSD109 Association Between Routine Colorectal Cancer Screening and the Risk of Colorectal Cancer Diagnosed at Advanced Stage and Total Cost of Care Among US Adults
|
Do, D
|
|
|
27 |
6S |
p. S239-S240
|
artikel
|
| 952 |
HSD44 Association of Penicillin Allergy Documentation and First-Line Penicillin Prescribing for Common Infections in Primary Healthcare Facilities in Beijing
|
Fu, M
|
|
|
27 |
6S |
p. S228-S229
|
artikel
|
| 953 |
HSD76 A Systematic Literature Review (SLR) to Evaluate the Role of Socioeconomic Factors Associated with Treatment Practices Among Oncology Patients
|
Mansy, Y
|
|
|
27 |
6S |
p. S234
|
artikel
|
| 954 |
HSD82 A Technology-Enabled Model to Define the Total Costs of Comprehensive Management of Hip and Knee Osteoarthritis: The Missing Link in Value Based Musculoskeletal Care
|
Sayegh, G
|
|
|
27 |
6S |
p. S235
|
artikel
|
| 955 |
HSD28 Barriers and Provision of Emergency and Pharmacist-Prescribed Contraception: Insights from Pharmacy Practices in Utah State
|
Tawfik, AG
|
|
|
27 |
6S |
p. S226
|
artikel
|
| 956 |
HSD72 Baseline A1C and BMI Trends for People with Type 2 Diabetes Receiving First-Time GLP-1 Ra Prescriptions
|
Cartwright, B
|
|
|
27 |
6S |
p. S233
|
artikel
|
| 957 |
HSD98 Benefits and Barriers to Same-Day Long-Acting Reversible Contraceptive Insertion: Evidence and Its Implications from US Settings
|
Kennedy, AR
|
|
|
27 |
6S |
p. S237-S238
|
artikel
|
| 958 |
HSD103 Burden of Disease in Patients With Uncontrolled Gout in the USA
|
Kragh, N
|
|
|
27 |
6S |
p. S238
|
artikel
|
| 959 |
HSD117 Causes and Characteristics of Drug Shortages in the United States
|
Stino, M
|
|
|
27 |
6S |
p. S240-S241
|
artikel
|
| 960 |
HSD70 Characteristics of Medicare Patients Initiating Long-Acting Injectable Antipsychotic Medications
|
Grabner, M
|
|
|
27 |
6S |
p. S232-S233
|
artikel
|
| 961 |
HSD14 Characteristics of US Commercially Insured Patients with Type 2 Diabetes (T2D) Initiating Tirzepatide
|
Desai, K
|
|
|
27 |
6S |
p. S223
|
artikel
|
| 962 |
HSD92 Clinical Outcomes of Patients With Obesity in a US Employer-Funded Medical Weight Management Program: A Pilot Study
|
Olsson, K
|
|
|
27 |
6S |
p. S237
|
artikel
|
| 963 |
HSD53 Community Oncologists’ Perceptions of Molecular Profiling: Insights into Precision Oncology Integration
|
John, W
|
|
|
27 |
6S |
p. S230
|
artikel
|
| 964 |
HSD33 Contraceptive Use Among Female Patients Who Underwent Bariatric Surgery in the U.S. Commercial Insurance Plans
|
Goto, D
|
|
|
27 |
6S |
p. S227
|
artikel
|
| 965 |
HSD74 COVID-19's Impact on Healthcare Access for Arthritis Patients: Insights From the 2020 Medical Expenditure Panel Survey
|
Alharbi, RA
|
|
|
27 |
6S |
p. S233
|
artikel
|
| 966 |
HSD57 Current Status of Off-Label IV Ketamine Utilization for Mood Disorders: A Nationwide Survey of Ketamine Clinics, Treatment Processes, and Provider Perceptions of Outcomes
|
Aslam, A
|
|
|
27 |
6S |
p. S231
|
artikel
|
| 967 |
HSD64 Data Visualization of Patterns of Adjuvant Endocrine Therapy Among Older Women With Hormone-Positive Early-Stage Breast Cancer
|
Yoon, H
|
|
|
27 |
6S |
p. S232
|
artikel
|
| 968 |
HSD26 Descriptive Landscape for Precision Medicines in Second-Line Biliary Tract Cancer: A Targeted Literature Review
|
Su, W
|
|
|
27 |
6S |
p. S225-S226
|
artikel
|
| 969 |
HSD87 Determinants of Innovative Drugs' Adoption: Evidence from Lithuania
|
Kvedaraviciene, G
|
|
|
27 |
6S |
p. S236
|
artikel
|
| 970 |
HSD126 Diagnosing Rare Diseases: Referral Behaviors of Physicians in the United States
|
Omri, A
|
|
|
27 |
6S |
p. S242
|
artikel
|
| 971 |
HSD41 Disparities by Gender, Race and Geography Exist in Whether Patients Receive a Confirmatory Celiac Disease Endoscopy and Biopsy After Screening Positive
|
Miller, E
|
|
|
27 |
6S |
p. S228
|
artikel
|
| 972 |
HSD45 Effectiveness of Aseptic and Disinfection Measures in Dental Offices in Barranquilla, Colombia
|
Moreno-Juvinao, V
|
|
|
27 |
6S |
p. S229
|
artikel
|
| 973 |
HSD100 Effectiveness of Data-to-Care Proactive Adherence Interventions on Retention and Relinkage to HIV Care Amid COVID Pandemic
|
Lee, TY
|
|
|
27 |
6S |
p. S238
|
artikel
|
| 974 |
HSD120 Effectiveness of Pharmacist-Led Interventions on Medication Use and Related Health Outcomes in Patients With Alzheimer's Disease and Related Dementias: A Systematic Review
|
Ezeala, O
|
|
|
27 |
6S |
p. S241
|
artikel
|
| 975 |
HSD79 Evaluation of Real-World Treatment Patterns in Patients With Uncontrolled Gout in the USA
|
Kragh, N
|
|
|
27 |
6S |
p. S234-S235
|
artikel
|
| 976 |
HSD51 Evaluation of the Healthcare System Burden Associated With Intravenous Treatment for Paroxysmal Nocturnal Hemoglobinuria
|
Mulherin, BP
|
|
|
27 |
6S |
p. S230
|
artikel
|
| 977 |
HSD22 Extending External Validity of Rcts and Meta-Analysis through Transportability Analysis and Integration of Mechanistic Research Evidence
|
Metcalfe, R
|
|
|
27 |
6S |
p. S224-S225
|
artikel
|
| 978 |
HSD75 Factors Associated With the Use of Immune Checkpoint Inhibitors in Older Adults With Metastatic Non-Small Cell Lung Cancer and Pre-Existing Autoimmune Disease: A SEER-Medicare Study
|
Gohil, S
|
|
|
27 |
6S |
p. S234
|
artikel
|
| 979 |
HSD38 Factors Influencing Willingness To Utilize the Emergency Department Among Individuals Living With Sickle Cell Disease
|
Ibiloye, E
|
|
|
27 |
6S |
p. S228
|
artikel
|
| 980 |
HSD4 First-Generation Antipsychotic Shortages in the United States: Analysis of Switching and Utilization Patterns
|
Tabah, A
|
|
|
27 |
6S |
p. S221
|
artikel
|
| 981 |
HSD86 Health Care Utilization before and during the COVID-19 Pandemic in Patients with Epithelial Ovarian Cancer
|
Mukherjee, A
|
|
|
27 |
6S |
p. S236
|
artikel
|
| 982 |
HSD8 Homologous Recombination Repair Testing Patterns and Barriers in Metastatic Hormone-Sensitive and Metastatic Castration-Resistant Prostate Cancer across Europe: A Real-World Survey
|
Castro, E
|
|
|
27 |
6S |
p. S222
|
artikel
|
| 983 |
HSD99 Impact of Pink October in Mammographic Screening in a Health Care Plan in Brazil
|
Stefani, S
|
|
|
27 |
6S |
p. S238
|
artikel
|
| 984 |
HSD81 Impact of Specialty Pharmacy: A Study in Inflammatory Conditions
|
Cartwright, A
|
|
|
27 |
6S |
p. S235
|
artikel
|
| 985 |
HSD24 Impact of Telehealth on Health-Related Quality of Life in Depression: A Medical Expenditure Panel Survey Study
|
Ganna, S
|
|
|
27 |
6S |
p. S225
|
artikel
|
| 986 |
HSD108 Impacts of Long-Term Prescription Policy on Primary Care Utilization and Costs Among Hypertensive Patients in China: A Difference-in-Differences Analysis
|
Yu, C
|
|
|
27 |
6S |
p. S239
|
artikel
|
| 987 |
HSD71 Implementing Patient-Reported Outcomes in Clinical Practice: The PROTEUS-Practice Framework & Guide
|
Crossnohere, N
|
|
|
27 |
6S |
p. S233
|
artikel
|
| 988 |
HSD3 Implications of Non-Medical Switching in Medicare Part D: An Updated Review of the Literature
|
Edwards, A
|
|
|
27 |
6S |
p. S221
|
artikel
|
| 989 |
HSD127 Inappropriate Prescribing and Intent to Change Associated With Academic Detailing
|
Kulbokas, V
|
|
|
27 |
6S |
p. S242
|
artikel
|
| 990 |
HSD30 Incidence of Platinum-Resistant, Stage III/IV Ovarian Cancer Patients in the US: A Mixed Source Estimation Approach
|
Kumar, D
|
|
|
27 |
6S |
p. S226
|
artikel
|
| 991 |
HSD65 Influence of Research Findings and Systems on Minimal Residual Disease (MRD) Testing and FLT3 Inhibitor Maintenance Prescribing Behavior Post-Transplant for Patients with Acute Myeloid Leukemia (AML) of U.S. Oncologists
|
Sharpe, J
|
|
|
27 |
6S |
p. S232
|
artikel
|
| 992 |
HSD91 ‘It Is Not in Stock’: Identifying Determinants of Patient Deception in Community Pharmacies
|
Chi, W
|
|
|
27 |
6S |
p. S237
|
artikel
|
| 993 |
HSD102 Job Preferences of Caregivers in Integrated Medical and Nursing Care Facilities: A Discrete Choice Experiment
|
Ziwei, X
|
|
|
27 |
6S |
p. S238
|
artikel
|
| 994 |
HSD122 Medication Adherence, Persistence, and Treatment Switching in Patients Receiving Advanced Therapies for Rheumatoid Arthritis in Clinical Practice
|
Bergman, M
|
|
|
27 |
6S |
p. S241-S242
|
artikel
|
| 995 |
HSD106 Metastatic Colorectal Cancer (mCRC) Patients Treated with Later Lines of Treatment (LOT): A Retrospective Analysis By Race and Ethnicity in the United States (US) Community Oncology Setting
|
Barzi, A
|
|
|
27 |
6S |
p. S239
|
artikel
|
| 996 |
HSD13 Missed Opportunities for Respiratory Disease Diagnosis in the United States During Endemic Spread of SARS-CoV-2
|
Chase, J
|
|
|
27 |
6S |
p. S223
|
artikel
|
| 997 |
HSD83 Multimorbidity Patterns and Related Treatment Costs Among Middle-Aged and Older Diabetes Patients in China
|
Li, K
|
|
|
27 |
6S |
p. S235
|
artikel
|
| 998 |
HSD73 Neoadjuvant & Adjuvant Therapy for Early-Stage/Resectable Non-Small Cell Lung Cancer (NSCLC): Physician Practices, Therapy Choice, and Challenges Among US Oncologists
|
Aggarwal, P
|
|
|
27 |
6S |
p. S233
|
artikel
|
| 999 |
HSD9 Oncology Practice Setting Classification in the US: Considerations for Real World Evidence
|
Meadows, E
|
|
|
27 |
6S |
p. S222
|
artikel
|
| 1000 |
HSD128 Opioid Utilization in Rheumatoid Arthritis: Changes in Opioid Use after Advanced Therapy Initiation and Its Moderators
|
Huang, Y
|
|
|
27 |
6S |
p. S243
|
artikel
|
Tijdschrift beschrijving